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Abstract
Age-related  muscle  wasting  and  weakness  (sarcopenia)  ultimately  lead  to  a  dependent 
lifestyle. The relative contribution of myofibre loss, atrophy and reduced myofibre function to 
the age-related decline in muscle function is, however, unknown. Resistance exercise is an 
effective means to  enhance muscle strength via  muscle  hypertrophy,  but  the hypertrophic 
response may be attenuated at old age. Therefore, the overall aim of this PhD-project was to 
examine  the  factors  that  contribute  to  the  impaired  muscle  function  and  attenuated 
hypertrophic response in old age. To investigate this we assessed plantaris muscle function in  
vivo in adult (9-month-old) and old mice (25-month-old). An additional group of old mice 
received  0.4%  resveratrol.  To  determine  the  hypertrophic  response  we  overloaded  one 
plantaris muscle, while the contra-lateral muscle served as internal control.
This thesis identified a reduction in specific force, rather than myofiber atrophy and myofiber 
loss, as the main contributor to the age-related muscle weakness in a model representing the 
onset  of  sarcopenia.  The  reduced  specific  force  was  partly  explained  by  an  increase  in 
intramuscular  connective tissue.  At the same time, it  was observed that  aged muscle also 
developed hypertrophy in response to chronic overload, although less so than in adult muscle. 
The blunted hypertrophic response in old muscle was associated with a lower SC density and 
impaired  angiogenesis,  but  there  was  no  evidence  for  a  lower  SC proliferation  capacity. 
Resveratrol did not ameliorate muscle weakness or rescue the hypertrophic response, but even 
reduced the number of SCs in hypertrophic muscles. Finally, a literature study illustrated that 
effects of ageing on determinants of muscle force showed qualitatively the same patterns as 
observed in men. This overview showed that to translate data gained in rodent models of 
muscle ageing to humans, it is important to correct for relative ages. 
In conclusion, although with increasing age loss of muscle mass and function do take place, 
the capacity of muscle to adapt to overload, although weakened, remains until old age. This 
plasticity of muscles provides hope that exercise interventions are effective into old age and 
may be implemented to attenuate or even reverse the increased dependent life style and hence 
improve the quality of life in aged people. The side effect would be a decreased burden on 
healthcare systems.
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Chapter 1
General introduction
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1 Introduction
In Western societies the proportion of people older than 65 years is increasing at the 
fastest pace ever (United Nations, 2011) and will most likely result in increased age-related 
health  care  problems.  Loss  of  independence,  inability  to  perform  daily  tasks,  increased 
number of falls and bone fractures are examples of these problems. These issues have a major 
impact on the quality of life of the older person and their treatment and care also places a  
burden on healthcare. 
Sarcopenia is one of the major factors causing a decrease in independence in old age. 
Sarcopenia  is  Greek  for  “poverty  of  flesh”.  It  indicates  the  loss  of  muscle  mass  and 
concomitant loss in muscle function with age (Marzetti et al., 2013; Roseberg, 1989). The 
age-related loss of muscle mass is not only accompanied with a loss of muscle strength, but 
also with a reduction in endurance capacity. A better understanding of the aetiology of muscle 
ageing will help in the design of interventions to a) minimise the age-related reduction in the 
quality of life and b) lower the social and economic impact of the greying of society. 
The force generating capacity of a muscle is determined by the quantity (mass) and 
quality (specific force) of the muscle. Muscle mass is determined by the total number and 
cross-sectional area (CSA) of the individual fibres, while specific force is determined by the 
force normalized to the CSA of the muscle. During ageing both the quantity and the quality of 
the muscle are  negatively affected.  However,  to  date  the relative contributions  of  loss  of 
fibres, fibre atrophy and reduction in muscle specific force to the age-related reduction in 
muscle force is not known.
Not only muscle strength, but also muscle endurance capacity declines with increasing 
age.  The  two  major  factors  determining  muscle  endurance  or  fatigue  resistance  are 
mitochondrial  function and the capillary network (Degens and Veerkamp,  1994).  An age-
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related decline in both factors also contributes to the age-related decrease in maximal oxygen 
consumption, which can be as much as 10% per decade (Heath et al., 1981). 
The age-related reduction in physical activity is thought to be one of the strongest, but 
not the sole, contributor to sarcopenia (Degens and Alway, 2006). Also, chronic low-grade 
systemic  inflammation  (Degens,  2010)  and  impaired  mitochondrial  function  (Degens  and 
Veerkamp, 1994) may impair muscle function and cause the decrease in muscle mass with 
increasing  age.  Resistance  training  is  an  effective  means  to  counteract  the  age-related 
deterioration  in  muscle  mass  and  function  (Leenders  et  al.,  2013),  though  the  effect  of 
resistance exercise seems to be somewhat attenuated in old, compared to adult human muscle 
(Kosek  et  al.,  2006).  The  cause  of  the  attenuated  hypertrophic  response  is  not  well 
understood.  It  could  be  that  either  the  loss  of  muscle  fibres  or  the  reduced  ability  to 
hypertrophy  per  muscle  fibre  decreases  the  absolute  gain  in  muscle  volume  after  a 
hypertrophic stimulus. 
In  addition  to  training,  administration  of  anti-oxidants  may  attenuate  muscle 
deterioration during ageing. Resveratrol is a polyphenol, which has been shown to reduce the 
oxidative stress and inflammation in aged mice muscle (Jackson et al., 2011). Administration 
of resveratrol may potentially improve muscle function (Lagouge et  al.,  2006),  counteract 
mitochondrial  impairment  and  even  age-related  muscle  wasting  (Marzetti  et  al.,  2011). 
However, the effects of resveratrol on the determinants of muscle force generating capacity 
and endurance have not been studied extensively yet. 
The purpose of this thesis is to better understand the determinants that underlie the 
reduced  muscle  force  and  endurance  in  old  age,  and  how  a  hypertrophic  stimulus  and 
supplementation  with  an  anti-oxidant  like  resveratrol  could  potentially  influence  these 
determinants. Thereto, there were the following objectives: (1) to quantify the contribution of 
muscle fibre loss, fibre atrophy and reduction in specific tension to the age-related loss in 
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muscle force, (2) to assess whether, and if so, why the hypertrophic response in old mouse 
muscle is  attenuated,  (3) to test  whether the age-related loss of muscle mass and blunted 
hypertrophic response can be rescued by supplementation with the ant-inflammatory anti-
oxidant resveratrol and (4) to assess the impact of ageing, overload and resveratrol on muscle 
oxygenation. 
The insights gained may help in the design of exercise programs and diet to improve 
muscle  fitness  in  old  people,  by  e.g.  combining  resistance  exercise  with  anti-oxidant 
supplementation. Thus, ultimately this work would help old people to age healthier, remain 
independent longer and thereby reduce the burden on healthcare systems. 
The following sections will first discuss the determinants of muscle force and secondly 
the impact of age on each of these determinants. Then the effects of overload and resveratrol 
on muscle contractile function of old muscle will be discussed. In addition, the impact of 
ageing on determinants of muscle endurance and oxygenation will be discussed. 
2 Normal skeletal muscle function, physiology and morphology
The  main  function  of  skeletal  muscle  is  to  enable  locomotion  and  maintain  body 
posture. A muscle contracts after it receives an action potential. This action potential, except 
from reflexes,  originates  in  the brain and travels  to the motoneuron.  The action potential 
travels  through  the  neuron  until  it  reaches  the  neuro-muscular  junctions  of  the  fibres  it 
innervates where it, through various chemical events at the cell surface, causes the release of 
Ca2+ from  the  sarcoplasmic  reticulum.  The  consequent  rise  in  the  intracellular  [Ca2+] 
ultimately  causes  the  contraction  of  the  muscle  fibres.  The  motoneuron  activates  all  its  
innervating fibres and works as a unit, hence the term motor unit for the motoneuron and the 
fibres it innervates. The number of motor units within one muscle varies with muscle size and 
function. 
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2.1 The muscle fibre
A muscle consists of muscle fibres (a muscle cell  is referred to as a muscle fibre) 
which are made up of myofibrils, which in turn are built up of thousands of sarcomeres in 
series. The major constituents of the sarcomere are the filaments actin and myosin. When the 
intracellular Ca2+ concentration is elevated, the myofilaments myosin and actin start to interact 
with each other, forming crossbridges between myosin and actin. Every time a myosin-head 
hydrolyses ATP, the energy currency of the cell,  the myosin-head undergoes a mechanical 
power stroke, causing, depending on the resistance, actin to slide along the myosin filament 
and/or the development of force by the myosin-head. 
The muscle fibre is multi-nucleated.  Inside the cell  every nucleus is thought to be 
responsible for maintenance of a small part of that cell, its myonuclear domain (Van der Meer 
et al., 2011a). During muscle growth and repair new myonuclei are required to maintain the 
nuclear domain size. These myonuclei can be derived from satellite cells (SCs), the stem cells  
of muscles. The SCs remain quiescent until activation, after which the cells proliferate and 
differentiate to form new myonuclei. This process occurs after an anabolic stimulus or during 
repair of an injured muscle (Hawke and Garry, 2001). 
2.2 Muscle fibre types 
There is a whole range of different muscle fibre types expressing different kinds of 
myosin heavy chains (MHCs); in muscles from adult rodents one can distinguish type I, IIA, 
IIX and IIB myosin heavy chain. Type I fibres are slow but have a high fatigue resistance. On 
the other end, type IIB fibres are fast contracting, but have a poor fatigue resistance, while 
type IIA and IIX are intermediate fibre types. Note that in human muscle the predominant 
types are type I, IIA and IIX. In older literature the type IIX fibre in humans is often referred 
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to as IIB, but comparisons with rodent muscles showed that human IIB fibres express MHCs 
similar to rodent IIX (Jones et al., 2004). Differences in contractile shortening velocity are 
largely caused by the different MHC isoforms. A fibre with IIB MHC contracts the fastest and 
a fibre containing the type I MHC the slowest (Degens and Larsson, 2007). Differences in 
fatigue  resistance  are  mostly attributable  to  a  higher  mitochondrial  content  in  the  slower 
compared  to  the  faster  muscle  fibres.  Muscles  involved  in  control  of  balance  or  posture 
usually have a slower phenotype,  while muscles needed to generate force quickly,  have a 
faster phenotype. Two calf muscles illustrate this perfectly: in mice, but less clearly so in men, 
the m. soleus is mainly involved in maintenance of posture and is a slow muscle, while the m. 
gastrocnemius is mainly used for locomotion and predominately contains fast type II muscle 
fibres (Augusto et al., 2004). 
2.3 Muscle fatigue
Fatigue is defined here as the inability of muscle to sustain a given force or power 
output. When power output of a muscle during a series of repeated contractions is maintained 
the rate of ATP synthesis equals the rate of ATP hydrolysis (Brooks and Faulkner, 1991). If 
power output declines during a series of repeated contractions it may be that the cell is not 
able to generate the ATP required for the given power output. There are different systems and 
levels of organisation where fatigue may originate, ranging from problems in the motor cortex 
to problems in the excitation-contraction coupling (Fig. 1.2).
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Figure 1.1 Possible sites of fatigue. From Jones et al. 2004, Skeletal muscle from molecules to  
movement, Elsevier. 
While the CSA and type of the muscle fibre determine its power output, endurance is 
largely  determined  by  the  mitochondrial  content  of  the  fibre.  Mitochondria  are  the 
powerhouses of the cell, where ATP is formed through oxidation of different substrates. For 
the oxidative breakdown of substrates to generate ATP the mitochondria require oxygen and 
produce carbon dioxide and water. More specifically, glucose is broken down into pyruvate 
and via acetyl-CoA it enters the citric acid cycle, in which NADH and FADH2 are formed and 
subsequently oxidised in the electron transport chain to form ATP. Fat is broken down in the 
β-oxidation,  producing acetyl-CoA which then also enters the citric  acid cycle  for further 
oxidation. The more mitochondria there are in a fibre the larger the capacity of that fibre to 
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generate  ATP aerobically.  One enzyme that  is  often  studied  to  histochemically  obtain  an 
indication of the mitochondrial content of a fibre is succinate dehydrogenase (SDH). SDH is a 
good marker for mitochondrial function as it is involved both in the citric acid cycle and the 
electron  transport  chain  and  the  intensity  of  the  staining  of  a  fibre  in  a  given  period  is 
proportional to its VO2max (van der Laarse et al., 1989).
The aerobic generation of ATP requires an adequate supply of oxygen, removal of 
carbon dioxide,  other  waste  products and heat.  This exchange between the fibres and the 
blood takes place in the capillaries.  Muscles are therefore supplied with a dense capillary 
network and at  the level of the individual fibres there is a strong correlation between the 
number of capillaries around a muscle fibre, its type of MHC, its CSA and the metabolic 
activity of surrounding fibres (Degens et al., 1992; Wust et al., 2009a). One of the causes of 
muscle fatigue is an inadequate supply of ATP to maintain a given task and an insufficient 
capillary  supply  and/or  oxidative  capacity  can  thus  cause  a  limitation  of  the  endurance 
performance of a muscle (Degens and Veerkamp, 1994). 
Different protocols have been used to study muscle fatigue in rodents. Muscle fatigue 
measured during a 4-min protocol with 330-ms contractions at 30 Hz every second leads to a 
rapid decline in force (Degens and Alway, 2003). This protocol has been used successfully to 
classify the different types of motor units (Burke et al., 1973) and appears to correlate well 
with the aerobic capacity to supply the muscle with enough energy and age-related changes in 
those elements. Note, however, that a limitation in the aerobic supply of ATP is not the sole 
factor that leads to the development of fatigue, but also accumulation of Pi in the cytosol 
(Jones, 2010) and sarcoplasmic reticulum (Fryer et al., 1995), impaired Ca2+ release from the 
sarcoplasmic reticulum (Allen et al.,  2008) and accumulation of K+ in the T-tubuli (Jones, 
1996). However, many of these causes of muscle fatigue can also be improved by enhancing 
the oxidative capacity, mitochondrial function and/or capillary supply. 
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3 Effects of ageing on determinants of muscle force generating capacity
Ageing affects a muscle in many ways. First of all, muscle power decreases with age. 
Muscle power is the product of muscle force and velocity. While the force generating capacity 
is  largely  determined  by  the  number  of  sarcomeres  arranged  in  parallel,  the  maximal 
shortening velocity is determined by the number arranged in series and the MHC composition 
of the fibre. The latter has been reported to shift to a slower profile during ageing (Degens and 
Alway, 2006; Larsson and Ansved, 1995). With ageing there is a progressive reduction in the 
force  generating  capacity  approximately amounting  up to  ~50% when comparing  healthy 
adult  (~30yrs)  and  old  (~80yrs)  humans  (Doherty,  2003;  Porter  et  al.,  1995),  further 
progressing beyond the 8th decade (Murray et al., 1980; Vandervoort and McComas, 1986). 
Many studies have examined the age-related reduction in muscle mass  in humans. 
However,  direct measurement of muscle mass in humans is not possible.  Therefore,  most 
studies have measured the anatomical CSA (ACSA) of the muscle and found it to be ~40% 
smaller in ~80-yr- than ~30-yr-old humans (Lexell et al., 1988). This decay starts at an age of 
50-60 yrs and continues progressively in more advanced ages.  How these changes relate to 
changes in muscle force generating capacity is not well known. In addition, what causes the 
age-related reduction in CSA is still a subject of investigation. 
3.1 Fibre loss and fibre atrophy
The age-related muscle wasting is attributable to a loss of muscle fibres and atrophy of 
the remaining muscle fibres (Faulkner et al., 2007b; Larsson and Ansved, 1995; Lexell et al., 
1988). The human  m. vastus lateralis has been studied extensively for the effect of age on 
FCSA (Lexell,  1995; Lexell et al.,  1988; Nilwik et al.,  2013; Porter et al.,  1995) showing 
consistently that in old subjects fast type II fibres show 20-50% atrophy, while slow type I 
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fibres remain largely unaffected compared to adult subjects. In addition to fibre atrophy some 
studies observe an almost 50% age-related decline in the number of muscle fibres (Lexell et 
al., 1988). This is not unequivocal, however, as others report almost no loss of muscle fibres 
(Klein et al., 2003; Nilwik et al., 2013). Why such differences exist remains to be elucidated, 
but  it  may be related to  the  age  of  the  old group used and differences  in  activity levels 
between studies.
3.2 Muscle specific force
While the loss of muscle mass contributes significantly to muscle weakness in old age, 
this  is  aggravated  by an  age-related  reduction  in  specific  force  of  the  muscle,  the  force 
generating capacity per CSA of the remaining muscle tissue (Degens et al., 2009a; Frontera et 
al., 2000a; Frontera et al., 2000b; Larsson et al., 1997b; Morse et al., 2005). Several factors 
may contribute to this decline in the quality of the muscle, such as a preferential atrophy of 
type II fibres, an increased antagonist co-activation, a decreased agonist activation (Macaluso 
et  al.,  2002) and/or  the inclusion of  non-functional  (denervated)  fibres  (Urbanchek et  al., 
2001). Besides these factors also the specific tension of the fibres themselves may be reduced 
(Degens and Larsson, 2007).
In  summary,  it  is  clear  that  the  loss  of  muscle  strength  in  old  age  is  due  to  a 
combination of loss of muscle fibres, muscle fibre atrophy and a reduction in the specific 
tension of individual fibres. Most studies investigate changes in determinants separately, not 
collectively. Therefore, the relative contribution of the changes in the different determinants 
of muscle force generating capacity remains to be determined and a model to elucidate the 
relative contribution of each of these factors to muscle weakness in old will be informative. 
4 Effects of ageing on determinants of muscle fatigue resistance
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4.1 Effects of age on muscle endurance capacity
An age-related earlier onset of muscle fatigue (Faulkner and Brooks, 1995; Pagala et 
al., 1998) can have several causes: 1)  For an old smaller and weaker muscle, any repeated 
workload at a given absolute intensity will be closer to the maximal power output than in a 
young  larger  muscle  and  thus  result  in  the  earlier  development  of  fatigue.  2)  Since  the 
endurance capacity of a muscle is largely dependent on the ability of a muscle to meet its 
metabolic demand, a decrease in the aerobic capacity would also contribute to an earlier onset 
of muscle fatigue in old age. It is thus important in this context that a decline in respiratory 
chain  activity  or  function  in  human  skeletal  muscle  has  been  found with  increasing  age 
(Konopka and Sreekumaran Nair, 2013; Marzetti et  al.,  2013). 3) The transmission of the 
action potential and the excitation-contraction coupling may be altered by ageing and limit 
muscle performance during ongoing contractile activity. 4) A reduced blood flow or capillary 
density (CD) in old muscle may cause an earlier onset of muscle fatigue. Indeed some studies 
reported an age-related decrease in the capillarisation of the muscle (Degens et al., 1993b; 
Hepple et al., 1997), but not all (Proctor et al., 1995).
Some however, report an improved fatigue resistance of old muscle (Harris, 2005). At 
first this may be counterintuitive, but when it is considered that fibre atrophy occurs mainly in 
fast muscle fibres, the fraction in the muscle consisting of slow, type I fibres will increase. 
Also an age-related increase in the proportion of slow fibres, if existing (Ballak et al., 2014b), 
may explain the increased fatigue resistance in old muscle (Callahan and Kent-Braun, 2011). 
Another  factor  explaining  this  discrepancy  may  be  the  type  of  contraction,  the  applied 
contraction velocity and the reporting of data absolute or relative to the maximal force (Avin 
and Law, 2011). More research is needed to elucidate these conflicting results. To test which 
factors  contribute to  fatigue  resistance with increasing  age,  here  the  capillary supply and 
mitochondrial function will be related to sustained endurance capacity. 
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4.2 Causes of age-related muscle wasting and weakness
An age-related increased oxidative stress, systemic low-grade inflammation (Degens, 
2010) and glycation (Nishikawa et al., 2000), a decreased IGF-1 expression (Sattler, 2013) 
and decreased daily physical activity levels (Degens and Korhonen, 2012) are all factors that 
contribute to the age-related muscle weakness. An increase in oxidative stress may lead to 
impaired mitochondrial function (Conley et al.,  2007; Kayani et al.,  2010b) and enhanced 
glycation of proteins (Nishikawa et al., 2000). Glycation of the myosin molecule leads to a 
slowing at which it can propel actin in an in vitro motility assay (Ramamurthy et al., 2001), 
while peroxide reduces both the force and velocity and thereby the power generating capacity 
of muscle fibres (Gilliver et al., 2010a). Impaired mitochondrial function would also require 
more oxygen for a given amount of ATP to be generated and may thus reduce the mechanical 
efficiency and hence cause an earlier  onset  of fatigue in old age (Degens and Veerkamp, 
1994).  IGF-1 serum levels are shown to decrease in aged rodents (Velasco et al., 1998) and 
humans  (O'Connor  et  al.,  1998).  Since  it  is  essential  for  muscle  mass  maintenance  and 
anabolic signaling (Clemmons, 2009), an age-related drop in IGF-1 levels may result in a 
decreased  muscle  mass  and  muscle  maintenance.  In  addition,  an  age-related  decline  in 
physical activity may be a major determinant, influencing all abovementioned factors, that 
contributes  to  age-related  muscle  wasting  and  weakness  (Degens  and  Korhonen,  2012). 
Together this shows that age-related muscle wasting is multifactorial and complex. 
5 Effects of overload/training on determinants of muscle force during overload
Resistance exercise is widely used to increase muscle mass (hypertrophy) and muscle 
strength,  also  in  the  elderly (Fiatarone  et  al.,  1990;  Leenders  et  al.,  2013).  However,  the 
absolute increase in muscle mass or strength seems to be attenuated compared to young adults 
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in humans (Kosek et al., 2006; Slivka et al., 2008) and in rodents (Blough and Linderman, 
2000b; Degens and Alway, 2003). For instance, in weight-lifting master athletes there is a 
progressive loss of power during ageing despite their maintained intense training program 
(Pearson et al., 2002). Since the activation of the AKT/mTOR pathway was not decreased in 
old muscle (Mayhew et al., 2009), a diminished SC activation and subsequent accretion of 
myonuclei may underlie the blunted hypertrophic response seen in aged muscle. As it was 
observed that subjects with the most SCs pre-training (Petrella et al., 2008) accreted the most 
new myonuclei  and had the largest  degree of hypertrophy (Petrella  et  al.,  2006),  an age-
related  decrease  in  SC  number  (Chakkalakal  et  al.,  2012)  may  impair  the  hypertrophic 
response  in  old  age.  Therefore,  it  was  studied  whether  hypertrophy was  blunted  in  aged 
muscle and whether this was related to a reduced SC density.
To  answer  the  abovementioned  questions,  we  used  an  overload  model  of  the  m. 
plantaris in mice in which its synergistic muscles (i.e. m. gastrocnemius and m. soleus) were 
denervated.  This  model  has  as  a  benefit  that  the  m.  plantaris hypertrophies,  with  a 
concomitant proportional increase in maximal muscle force. In addition, fatigue resistance has 
been reported to increase with 25% even in 33-month-old rats (Degens and Alway, 2003). 
Muscle hypertrophy is mainly a product of an increase in FCSA. However, with the increase 
in FCSA capillaries will be pushed apart, thereby increasing the diffusion distances from the 
capillaries to the mitochondria (Degens, 2012). There is an inverse relationship between the 
size of the fibre and its oxidative capacity (van der Laarse et al., 1998; van Wessel et al., 
2010). According to this inverse relationship it is to be expected that an increase in FCSA 
during hypertrophy would be accompanied with a reduction in oxidative capacity. Yet, during 
compensatory hypertrophy the oxidative capacity has been reported to increase (Degens et al., 
1993c), while the capillary density is reduced (Degens et al., 1992; Degens et al., 1993c). It 
may well be that a limit is reached here, and when one considers that the capillary density in 
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old muscles is already reduced, such an increase in both FCSA and oxidative capacity may 
compromise  the  muscle.  It  maybe  that  this  looming  compromised  muscle  structure  and 
function underlies the blunted hypertrophic response in old age.  The relationship between 
capillarisation,  oxidative  capacity  and fibre  size  in  the  normal  muscle  and the  degree  of 
hypertrophy that can be developed is hitherto not been investigated. An additional possibility 
is that in old age the hypertrophy of the fibre is  accompanied with decreased rather than 
increased oxidative capacity. Hence, we investigated whether the hypertrophic response was 
impaired at  old age  and how the oxidative  capacity,  FCSA and fibre  capillarisation  were 
related in both normal and hypertrophied old mouse m. plantaris. 
6 Effects of resveratrol on muscle
During the production of ATP by the electron transport chain also reactive oxygen 
species (ROS) are formed. ROS are very reactive molecules and when reacting with proteins, 
DNA and other structures cause damage to these molecules, which is called oxidative stress 
(Fig. 1.1). The oxidative modifications impair the functionality of the affected structure and 
could lead to  long-lasting reductions  in muscle  homeostasis  and function (Marzetti  et  al., 
2013). Fortunately the body has different systems to counteract (the effects of) ROS. One of 
these is  the neutralisation of ROS by anti-oxidants, like vitamin C and E (see for review 
(Powers and Lennon, 1999)). Supplementation of different kinds of anti-oxidants could thus 
potentially reduce oxidative stress.
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Figure 1.2 Formation of ROS by the electron transport chain and its consequences leading to  
oxidative stress. From Murphy 2009, Biochem J. 
It  has  been  suggested  that  impaired  organelle  function,  such  as  enhanced  mitochondrial 
uncoupling, may via positive feedback loops cause further impaired organelle function and 
hence reduce muscle function during ageing (Degens, 2010). If oxidative stress is one of those 
factors it may prove beneficial to administer anti-oxidants, like resveratrol, to improve muscle 
function, and enhance the hypertrophic response via attenuation of oxidative stress-induced 
activation of proteolytic pathways (Tisdale, 2005). Resveratrol (3,5,4’–trihydroxystilbene) is 
an anti-inflammatory anti-oxidant polyphenol (Timmers et al., 2012) present in several plants 
and in the skin of red grapes. Howitz et al. were the first to find a potential connection of 
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resveratrol with Sirt-1 (Howitz et al., 2003), a factor linked to, among other things, longevity. 
Although the latter has not been conclusively proven (Marchal et al., 2013), resveratrol has 
been linked to beneficial effects on metabolism and healthy ageing in humans, by decreasing 
chronic diseases (Timmers et al., 2012).
6.1 Effect of resveratrol on age-related muscle weakness
The effects  of resveratrol on muscle and more specifically sarcopenia are less clear. 
There is an ongoing debate, whether resveratrol directly activates AMPK, which would then 
upregulate  Sirt-1 (Dasgupta  and Milbrandt,  2007;  Park et  al.,  2012;  Um et  al.,  2010),  or 
whether resveratrol directly stimulates Sirt-1 (Price et al., 2012). Either way, both Sirt-1 and 
AMPK are up-regulated in the presence of resveratrol, potentially resulting in the stimulation 
of many pathways conferring health benefits. For instance, AMPK stimulates PGC-1α, which 
is a factor responsible for mitochondrial biosynthesis. Indeed, beneficial effects of resveratrol 
on mitochondrial function and endurance performance have been reported (Lagouge et al., 
2006;  Murase  et  al.,  2009).  However,  not  everybody  observed  effects  of  resveratrol  on 
maximal or sustained muscle force (Jackson et al., 2011; Ryan et al., 2010) in aged mice. In 
addition, age-related muscle wasting does not seem to be attenuated by resveratrol (Jackson et 
al., 2011). Therefore, the efficacy of resveratrol on age-related muscle weakness is still not 
clear. On the other hand, resveratrol has been reported to improve markers of oxidative stress 
(Jackson et al., 2011; Olesen et al., 2013; Ryan et al., 2010) and mitochondrial biogenesis 
(Murase et al., 2009) in aged muscle. It remains to be investigated whether the reduction in 
oxidative stress induced by resveratrol supplementation is enough to improve SC function and 
augment age-related attenuated hypertrophy in aged muscle. 
6.2 Appropriate doses of resveratrol
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The conflicting results on the effect of resveratrol on the aged muscle may be due to 
differences  in  supplemented  resveratrol  doses.  Even  though  resveratrol  down-regulated 
mitochondrial-mediated  apoptotic  signalling  pathways,  it  did  not  attenuate  sarcopenia 
(Jackson et al., 2011). In that study, the 0.05% resveratrol in the diet of the male C57BL6 
mice for 10 months may have been too little to prevent muscle wasting, as the effects of 
resveratrol are concentration dependent (Dolinsky et al., 2012; Lagouge et al., 2006; Murase 
et  al.,  2009). Together,  this suggests that a higher resveratrol concentration may attenuate 
sarcopenia (Marzetti et al., 2011). 
7 The outline of the thesis 
This  thesis  describes  a  series  of  studies  on the  effects  of  ageing on muscle  force 
generating and endurance capacity in a mouse model. The aim of this thesis was to obtain a 
better insight in the understanding of the factors contributing to muscle dysfunction in old 
age.  In  addition,  it  was  studied  whether,  and  if  so,  why  the  hypertrophic  response  was 
attenuated in old compared to adult muscle. In addition, studies were performed to elucidate 
the effect of resveratrol on age-related muscle weakness and whether it could rescue the age-
related reduction in muscle force generating capacity. Finally, it was investigated how muscle 
capillarisation  and  oxidative  capacity  are  affected  by  ageing  and  how  they  change  in 
overloaded young and old mouse muscle. 
To this end, the effects of age, overload and resveratrol administration on the maximal 
isometric force and fatigue resistance of the in situ m. plantaris of 9- and 25-month-old mice 
were studied. The morphology of the muscles was investigated to gain insight in the factors 
underlying  the  age-related,  overload-  and resveratrol-induced changes  in  muscle  function. 
Further details of the conducted studies are described below.
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Chapter 2  describes a literature study comparing determinants of force generating 
capacity in human and rodent models of muscle ageing. 
Chapter 3 investigated the relative contribution of changes in key determinants of 
maximal muscle force – i.e. number of muscle fibres, muscle cross-sectional area (CSA) and 
specific muscle force to the loss of muscle force between 9 and 25 months in mice. 
The impact of overload and resveratrol on muscle force during ageing was studied in 
chapter 4 in the same mouse model. The first objective of chapter 3 was to assess whether the 
hypertrophic response was attenuated in old muscle,  and if so, whether this was due to a 
reduced  number  of  muscle  fibres  in  old  muscle  or  due  to  an  attenuated  muscle  fibre 
hypertrophy.  The second objective was to determine whether  the attenuated response was 
associated with a lower SC content in the older muscles. The third objective was to establish 
the possible beneficial effects of resveratrol on muscle (specific) force and the hypertrophic 
response of the old muscle.
Muscle capillarisation plays an important role in fatigue resistance.  To study muscle 
capillarisation  the  method  of  capillary  domains  is  often  used.  Chapter  5 describes  the 
validation of a new semi-automated method to establish capillary domains. Since the method 
of capillary domains is a time consuming task, a Matlab ® based application was developed 
to  improve this.  The new method was  used  to  study the  effects  of  ageing,  overload and 
resveratrol  on muscle capillarisation in  chapter 6.  In addition,  muscle capillarisation was 
linked to  mitochondrial  function (SDH) and fatigue resistance.  The first  objective was to 
establish whether the fatigue resistance in old muscle was impaired compared to adult muscle 
and if so, to what extent this was related to age-related changes in muscle oxidative capacity 
and capillarisation.  The second objective was to obtain more knowledge on the impact of 
overload and resveratrol on indices of muscle oxygenation in both adult and old muscle.
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In  chapter 7 the results of this thesis are summarized and discussed. Furthermore, 
future perspectives are given and final conclusions are drawn. 
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Chapter 2
Aging related changes in determinants of muscle 
force generating capacity: A comparison of muscle 
aging in men and male rodents
This chapter is published as:
Sam B. Ballak, Hans Degens, Arnold de Haan, Richard T. Jaspers. Aging related changes in 
determinants of muscle force generating capacity: A comparison of muscle aging in men and 
male rodents. Aging research reviews (2014) 14: 43-55
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Abstract
Human aging is  associated  with a  progressive  decline  in  skeletal  muscle  mass  and force 
generating capacity, however the exact mechanisms underlying these changes are not fully 
understood.  Rodent  models  have  often  been  used  to  enhance  our  understanding  of 
mechanisms of age-related changes in human skeletal muscle. However, to what extent age-
related alterations in determinants of muscle force generating capacity observed in rodents 
resemble those in humans has not been considered thoroughly.  This  review compares the 
effect  of  aging  on  muscle  force  generating  determinants  (muscle  mass,  fiber  size,  fiber 
number,  fiber  type  distribution  and muscle  specific  tension),  in  men and male  rodents  at 
similar relative age. It appears that muscle aging in male F344*BN rat resembles that in men 
most; 32-35-month-old rats exhibit similar signs of muscle weakness to those of 70-80-yr-old 
men, and the decline in 36-38-month-old rats is similar to that in men aged over 80 yrs. For 
male C57BL/6 mice, age-related decline in muscle force generating capacity seems to occur 
only at  higher  relative age than in  men.  We conclude that  the effects  on determinants  of 
muscle force differ between species as well as within species, but qualitatively show the same 
pattern as that observed in men.
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Comparing human and rodent models of sarcopenia and their underlying mechanisms 
1. Introduction 
In humans, aging is accompanied by a progressive decline in muscle mass and force 
generating capacity, referred to as sarcopenia (Fielding et al., 2011), which starts at the age of 
40-60  (Faulkner  et  al.,  2007b;  Porter  et  al.,  1995).  At  the  age  of  80,  the  muscle  force 
generating capacity is on average approximately 60% of that at the age of 20-30 (Doherty,  
2003). This progressive decline in muscle function and muscle mass is presumed to be a 
significant contributor to the increased incidence of falls, transition to a dependent life-style 
and reduced quality of life in old age (Kamel, 2003; Roubenoff and Hughes, 2000; Visser and 
Schaap,  2011).  Furthermore,  a  decrease in  muscle  mass  is  associated with an increase in 
morbidity and mortality (Morley, 2003; Morley et al., 2006; Newman et al., 2001). This and 
the impact of increased frailty, incidence of falls and associated fractures on the associated 
cost  of  care  pose  an  enormous  burden  on  healthcare  systems.  Moreover,  demographic 
prognoses of economically developed countries worldwide predict that the proportion of older 
people increases at the fastest pace ever (United Nations, 2011), which makes muscle aging 
investigations even more urgent. 
Clearly, maintenance of muscle mass up to old age or even reversal of the age-related 
muscle wasting and weakness has important beneficial implications for the quality of life of 
the older person. To develop adequate strategies to  maintain muscle function,  a profound 
understanding of the mechanisms and causes of age-related muscle wasting are a prerequisite. 
Daily life physical activities require skeletal muscle power, which is the product of muscle 
force and velocity of contraction. While the force generating capacity is largely determined by 
the number of sarcomeres arranged in parallel, the maximal shortening velocity is determined 
by the number of sarcomeres arranged in series and myosin heavy chain (MHC) composition 
(Degens and Larsson, 2007; Larsson and Moss, 1993). The latter has been reported to shift to 
39
a slower profile during aging (Degens and Alway, 2006; Larsson and Ansved, 1995). Thus, 
not only the age-related decrease in muscle mass, but also slowing of the muscle as a result of  
a shift to a slower myosin heavy chain profile would negatively impact the ability to produce 
power (Brooks and Faulkner, 1994c). 
The age-related muscle wasting (Degens, 2010; Degens and Alway, 2003; Deschenes, 
2004; Doherty, 2003; Janssen et al., 2000) is attributable to a loss of muscle fibers and an 
atrophy of the remaining muscle fibers (Faulkner et al., 2007b; Larsson and Ansved, 1995; 
Lexell  et  al.,  1988).  While  the  loss  of  muscle  mass  contributes  significantly  to  muscle 
weakness  in  old  age,  this  is  aggravated  by a  reduction  in  the  specific  tension,  the  force 
generating capacity per cross-sectional area of the remaining muscle tissue (Degens et al., 
2009a; Frontera et al., 2000b; Gonzalez et al., 2000; Larsson et al., 1997b; Morse et al., 2005). 
It is, however, difficult to measure force, and particularly the physiological cross-sectional 
area  of  a  human  muscle  in  vivo,  accurately.  This  stresses  the  importance  of  models 
investigating sarcopenia. Animal models of sarcopenia may be helpful in overcoming some of 
these problems. In particular rodents have been used to study the impact of aging on skeletal 
muscle structure and function. An important question is to what extent the information gained 
from aging animal models can be translated to humans. 
In this review we will address this question by evaluating the similarities in muscle 
aging  in  rodents  and  men.  We  will  give  particular  attention  to  the  widely  used  male 
Fischer344, Fischer344 x Brown Norway (F344*BN) and Wistar rats, and C57BL/6 mice. In 
addition, the vast majority of the studies on muscle aging in rodents used male animals (~70% 
vs  ~20% female,  ~10% are  undefined).  Therefore,  only studies  using  male  rodents  were 
included,  because  this  decreases  the  variability  and  complexity  of  the  comparisons. 
Furthermore, factors influencing the ‘rate of muscle aging’ (Degens, 2012), such as maximal 
life  span,  environment,  nutrition  and  activity  levels  are  discussed.  We  conclude  with  a 
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summary of the strengths and weaknesses of these models and discuss to what extent aging 
rodents can be used as models of muscle aging in men. 
2. Advantages of rodent models of muscle aging
Aging  rodents  have  often  been  used  as  models  to  enhance  our  understanding  of 
processes  and  biological  mechanisms  of  age-related  changes  in  human  skeletal  muscle 
(Alway et  al.,  2005;  Cartee,  1995).  The  use  of  rodents  to  study muscle  aging  has  some 
obvious advantages. First of all, longitudinal studies in humans require a very long follow-up 
period, which makes these studies more difficult, in contrast to the relatively short life span of 
rodents (only 2-3 yrs), which makes it much easier to study the aging process. Secondly, it is 
ethically less problematical to perform invasive procedures in rodents than in humans (Cartee, 
1995). Thirdly, environmental conditions and nutrition can be tightly controlled, and activity 
can be accurately monitored in laboratory animals,  which again is  virtually impossible  in 
humans (Alway et al.,  2005). Fourthly, terminal experiments can be performed in rodents, 
allowing one to  dissect  whole muscles,  which  increases  the opportunities  to  study whole 
muscle  morphology and  cellular  and  molecular  mechanisms,  compared  to  human  studies 
where at best a small muscle biopsy can be analyzed. Finally, laboratory animals have a much 
more homogeneous gene pool than humans (Alway et al., 2005). Although it may be argued 
that the experimental control of animal models compromises the validity and relevance of 
these models to humans (Alway et al., 2005), it is this possibility to control many factors that 
will help us gain a better understanding of the extent at which various environmental factors 
contribute to the observed variation in the rate of muscle aging between people (Degens, 
2012).
3. Age-related changes in force generating capacity
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During  aging  there  is  a  progressive  reduction  in  the  force  generating  capacity 
approximately amounting up to 40% when comparing healthy young (20-30 yrs) and old (70-
80 yrs)  humans  (Doherty,  2003;  Porter  et  al.,  1995),  continuing in  the  ninth  decade  and 
beyond (Murray et al., 1985; Murray et al., 1980; Vandervoort and McComas, 1986). 
An important factor to consider when comparing human and rodent aging studies is 
how a given age of a rodent compares with that of humans. In order to do so we introduce the  
‘relative age’ in this review. ‘The relative age’ is expressed as a percentage of the mean life 
span (MLS) of men and rodent species or rodent  strain.  Table 2.1 shows values of MLS 
reported for men, different male rat strains and C57BL/6 mice. Since our interest is aging,  
relative differences in the duration of the nurture stage and time to reach sexual maturity 
between humans and rodents (Flurkey, 2007; Quinn, 2005) are of less interest in the context 
of this review.
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Table  2.:  Mean  and  maximal  reported  life  spans  of  men  in  developed  countries,  male  
C57BL/6 mice and male F344*BN, F344 and Wistar rats. 
Mean  Life  Span 
(MLS)
Maximal  life  span 
(men)  /  10%  life 
survival (rodents)
References
Men 80yrs 120yrs (Smith, 1993; WHO, 2013)
Male C57BL/6 26.7mths 31.5mths (Blackwell  et  al.,  1995;  Sheard  and 
Anderson,  2012;  Storer,  1966; 
Turturro et al., 2002; Wolf et al., 2000; 
Yuan  et  al.,  2009;  Zurcher  and  Van 
Zweiten, 1982)
Male F344*BN 32.7mths 38mths (NIA,  2012;  Thompson  and  Brown, 
1999; Turturro et al., 1999)
Male F344 24.6mths 27.3mths (Masoro,  1980;  NIA,  2012; 
Shimokawa et  al.,  1993; Thurman et 
al., 1994; Wolf et al., 2000; Yu et al., 
1982)
Male Wistar 23.5mths 36mths (Edstrom and Larsson, 1987; Masoro, 
1980; van der Meer et al., 2011b)
For each species and strain, the average reported life expectancy was taken at 100% MLS.  
This allows to calculate relative ages from reported absolute ages in months and years.
Note  that  most  human  studies  have  investigated  the  age-related  changes  in  force 
generating capacity of the quadriceps femoris muscles, while in rodents mainly muscles of the 
triceps surae complex have been studied. This may complicate direct comparisons between 
rodents and humans as thigh and calf muscles may show different age-related changes. The 
two human studies (Davies et al., 1986; Vandervoort and McComas, 1986) we are aware of 
that  investigated  age-related changes  in  the force generating capacity of  m. triceps  surae 
showed a similar decline (approximately 40% between 20-30 yrs and 70 yrs and older) as that 
observed in the m. quadriceps femoris (Frontera et al., 1991; Frontera et al., 2000b; Murray et 
al.,  1980; Young et  al.,  1984; Young et al.,  1985). In addition, in both muscle groups the 
decline in force generating capacity was shown to be negligible before the sixth decade of life 
(Doherty et al., 1993; Vandervoort and McComas, 1986). Effects of aging on the masses of 
43
both  soleus  and  m. vastus  lateralis muscles  within the same animal  showed considerable 
reductions  in  m.  vastus  lateralis (58-60%)  and  soleus (36-50%)  mass  (Bua  et  al.,  2002; 
McKiernan et  al.,  2004).  These observations  indicate  that  in  both human and rodents  the 
quadriceps  femoris and  triceps  surae show  comparable  age-related  reductions  in  force 
generating capacity and muscle mass. This suggests that the use of triceps surae complex in 
rodent models does not preclude a fair comparison with the age-related changes in the human 
quadriceps complex.
When  comparing  studies  on  men  and  rodent  maximal  muscle  force  generating 
capacity, it appears that both human and rodent muscles exhibit their peak force at similar 
relative MLS (men 25-44%; rodents 24-51% MLS) (Brooks and Faulkner, 1988; Brooks and 
Faulkner, 1991; Brown and Hasser, 1996; Degens and Alway, 2003). Figure 2.1 shows that 
after reaching this peak in maximal force (set at 100%), it decreases after ~80% MLS. At 
MLS, force generating capacity in muscles of men and male rats and mice was reduced by 
~40%,  ~30%  and  ~20%,  respectively,  compared  to  peak  value.  For  mice  and  rats,  the 
reduction in muscle force generating capacity seems to occur at a relatively later stage of life,  
compared to that for men. In addition, a large variation was observed between rat strains. 
Male F344*BN rats show the largest age-related decline in maximal muscle force (45%) at 
100% MLS, whereas male Wistar rats lose only 10% of maximal muscle force at 100% MLS. 
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Figure 2.: Effects of aging on men and male rodent muscle force generating capacity for men  
male  rats  and  mice.  Literature-based  values  of  muscle  force  generating  capacity  are  
expressed  as  function  of  age.  The  force  generating  capacity  represents  maximal  in  situ  
isometric muscle force or maximal net joint moments. These values are normalized for the  
mean force generating capacity calculated from reported values in literature. Mean life span  
(MLS) was calculated for each species and strain from reported life expectancies (Table 6.1).  
For men, peak force was taken as the maximal force or net moment reported between 25-44%  
MLS and for rodents between 24-51%. Average values were calculated when multiple studies  
reported  for  the  same  muscles,  and  sampling  techniques  were  similar.  The  dashed  line  
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represents 100% of maximal force/net moment as estimated for the respective periods of life.  
Note that for rodents only hind limb muscles were tested, whereas for humans mostly knee  
flexor  and extensor muscles were tested (Aniansson et  al.,  1986; Blough and Linderman,  
2000a; Brooks and Faulkner, 1988; Brooks and Faulkner, 1991; Brown and Hasser, 1996;  
Carter et  al.,  2010; Davies et  al.,  1986; Gutmann and Carlson, 1976; Ivey et  al.,  2000;  
Kadhiresan et al., 1996; Kayani et al., 2010a; Larsson and Edstrom, 1986; Larsson et al.,  
1979; Linderman and Blough, 2002; Lynch et al., 2001; Murray et al., 1980; Overend et al.,  
1992; Pettigrew and Gardiner, 1987; Phillips et al., 1991; Rice et al., 2005; Vandervoort and  
McComas, 1986; Young et al., 1985; Zerba et al., 1990b). 
Although there is a difference in magnitude, all models show a drop in muscle force 
generating capacity with increasing age. To answer whether in the different models the major 
determinants  of  maximal  muscle  force  are  equally  affected  during  aging,  we  listed  the 
reported  effects  of  aging  on  muscle  mass,  muscle  fiber  CSA,  muscle  fiber  number, 
motoneurons,  muscle  fiber  type and specific tension,  which will  be discussed in the next 
section. 
4. Determinants of muscle function
4.1 Age-related changes in muscle mass
As mentioned above, a large proportion of the loss in muscle force generating capacity 
with  age  is  attributable  to  a  reduction  in  muscle  mass.  Most  of  the  studies  examining 
anatomical cross-sectional area (ACSA) of muscles in humans, used computed tomography or 
MRI (Klitgaard et al., 1990; Overend et al., 1992; Rice et al., 1989; Young et al., 1984; Young 
et al., 1985), because a direct measurement of muscle mass in humans is not possible. These 
studies reported an average decrease for the human  quadriceps femoris, elbow flexors and 
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extensors in ACSA of ~35%, from young (24-31 yrs, 30-39% MLS) to old (68-75 yrs, 85-
94% MLS) (Klitgaard et al., 1990; Rice et al., 1989; Young et al., 1984; Young et al., 1985). 
The ACSA of the m. vastus lateralis from human cadavers at the age of 51 (64% MLS) was 
shown  to  be  ~10%  lower compared to  those  in  cadavers  from 19-yrs-old 
people  (24%  MLS). Thereafter (at the age of 73, 91% MLS), the 
decrease  of  ACSA accelerated 
(Lexell et al., 1988). At an age of 80 yrs (100% 
MLS)  a  40% decline  was observed  (Lexell 
et al., 1988). This indicates, as also  applies  to  the 
force generating capacity (Fig 2.1),  that  there 
is  a  threshold  age  beyond  which  the muscle 
wasting accelerates. It is important to take  into  account  that 
besides  the  aging process  itself,  also lower levels  of 
physical  activity contribute to a  decreased 
muscle  mass  at  advanced age  (Morley  et  al., 
2001).
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Figure  2.2:  Comparison  of  age-related  changes  in  muscle  mass  between  men  and  male  
rodents. A) Muscle mass normalized for the mean mass calculated from reported values for  
an  age  range  varying  between  24-51%  MLS  (Ansved  and  Larsson,  1989;  Blough  and  
Linderman, 2000a; Brooks and Faulkner, 1988; Brown and Hasser, 1996; Carter et al., 2010;  
Daw et al., 1988; Degens and Alway, 2003; Eddinger et al., 1985; Edstrom and Larsson,  
1987; Frontera et al., 2000b; Jackson et al., 2011; Kadhiresan et al., 1996; Kanda et al.,  
1996; Klitgaard et al., 1990; Larkin et al., 2003; Larsson and Edstrom, 1986; Lexell et al.,  
1988; Linderman and Blough, 2002; Lushaj et al., 2008; Lynch et al., 2001; McKiernan et  
al., 2004; Overend et al., 1992; Pagala et al., 1998; Pettigrew and Gardiner, 1987; Rowan et  
al., 2012; Schuenke et al., 2011; Sheard and Anderson, 2012; van der Meer et al., 2011b;  
Young et al., 1985; Zerba et al., 1990b). B) Comparison of age-related changes on muscle  
mass  between  male  F344*BN,  F344  and  Wistar  rats  as  function  of  absolute  age.  C)  
Comparison of age-related mass of normalized m. vastus lateralis muscle (%) between male  
F344*BN rat (Lushaj et al., 2008) and humans (Lexell et al., 1988) expressed as a function of  
relative age. For rodents, mean maximal muscle mass was calculated for the age ranging  
from 24 to 51% MLS, when multiple studies reported for the same muscles and sampling  
techniques were similar. The dashed line represents 100% muscle mass as estimated for the  
respective periods of life. Note that for rodents only hind limb muscles were tested, whereas  
for humans mostly knee flexor and extensor muscles were tested.
The question remains whether age-related decreases in men and rodent muscle mass 
are comparable. Figure 2.2A shows age-related reductions in muscle mass reported for men 
and male rats and mice as a function of the relative age. At 100% MLS, the average loss of  
muscle  mass  in  adult  rat  and  mouse  was  ~20%  (mean  of  all  rat  species)  and  ~15%, 
respectively. These changes are somewhat smaller than the changes in maximal muscle force 
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generating capacity reported for these species (Fig. 2.1). However, those relative reductions in 
muscle mass for rodents are strikingly lower and occur later in life than those reported for 
muscles of men. 
A more detailed analysis of the studies regarding effects of aging on rat muscle reveals 
that there is a huge variety in age-related losses in muscle mass. For some rat species (Wistar) 
the decline in muscle mass is rather small (~5%), whereas for the F344*BN rats this was 
~25%, which is  much closer to that reported for muscles  in men (Frontera et  al.,  2000b; 
Klitgaard et al., 1990; Lexell et al., 1988; Young et al., 1985). This variance could be the 
result  of  a  different  prevalence  of  co-morbidities  (which  is  discussed  more  extensively 
below), affecting potentially identical life spans in all rat strains. Figure 2.2B indeed shows 
that a part of the variation between rat strains may be explained by absolute age.
It is interesting to compare the decline in muscle mass and the relative threshold age 
(losing <10% muscle mass) of the m. vastus lateralis, because of its common use in human 
studies. Although the magnitude of the decline seems to be equivalent, the threshold age for 
male F344*BN rats (30 months, ~90% MLS (Lushaj et al., 2008)) seems to be later in life  
than for men (60 yrs, ~75% MLS) (Fig. 6.2C) (Lexell et al., 1988). 
For mice, an age-related decrease of only ~15% was observed in muscle mass at 100% 
MLS. This age-related loss of muscle mass was much lower than that in men. Furthermore, 
the relative age at which mice start losing muscle mass (~90% MLS) was higher than that for 
men (~75% MLS). 
In summary, age-related reductions in muscle strength and mass seem to take place in 
both rodents and men. In both rodents and men there appears to be a threshold age beyond 
which muscle wasting and weakness develops. However, particularly in mice the reduction in 
muscle mass seems to occur relatively later in life than in men. To better understand the initial 
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stages  of  age-related  muscle  deterioration,  more data  on middle-aged men and rodents  is 
needed. 
4.2 Age-related changes in muscle fiber number 
Grimby and Saltin were among the firsts to recognize that muscle fiber atrophy alone 
could not explain all of the age-related loss of muscle mass (Grimby and Saltin, 1983). Later 
on, Lexell et al. in a cadaver study showed that the reduction in  m. vastus lateralis mass of 
men with increasing age was mainly due to a loss in the number of muscle fibers (Lexell and 
Downham, 1992). These observations were confirmed by other studies, reporting substantial 
fewer fibers at 70-80 years (88-100% MLS), compared to those in young adults (Lexell et al.,  
1986; Lexell et al., 1988). This is, however equivocal, as other studies report no change in 
fiber number in the  m. vastus  lateralis (29% MLS vs. 89% MLS) (Nilwik et al., 2013), or 
biceps brachii (21 yrs; 26% MLS vs. 82 yrs; 103% MLS) (Klein et al., 2003). However, these 
latter studies calculated the fiber number indirectly, opposed to Lexell et al. (Lexell et al., 
1988). Why such differences exist between indirect and direct measurements of muscle fiber 
number still remains to be elucidated. It is also possible that difference in activity level may 
cause differences in the rate of fiber loss. 
Also  in  rats,  the  effect  of  aging on muscle  fiber  number  is  equivocal  and differs 
between strains  (Fig.  2.3).  For  Wistar  and F344 rats,  reported  reductions  in  muscle  fiber 
number of gastrocnemius medialis,  soleus,  extensor digitorum longus and tibialis  anterior 
muscles range from 5-15% at 100% MLS (Ansved and Larsson, 1989; Brown, 1987; Daw et  
al., 1988; Eddinger et al., 1985; Edstrom and Larsson, 1987; Kadhiresan et al., 1996; Larkin 
et al., 2003; Larsson and Ansved, 1995; Larsson and Edstrom, 1986). For both strains this loss 
explains ~50% of the reported reduction in muscle mass. In contrast, at MLS for F344*BN 
rats, the reported muscle fiber number is reduced by ~20%. Note that most of these studies 
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investigated quadriceps muscles (m. vastus lateralis and medialis, and m. rectus femoris) (Bua 
et al., 2002; Lushaj et al., 2008; McKiernan et al., 2004; Wanagat et al., 2001). The  soleus 
muscle,  the only other muscle  of which muscle fiber  number was investigated in this  rat 
strain, showed a decrease of ~15% at MLS (Bua et al., 2002; McKiernan et al., 2004). 
Figure 2.3: Comparison between rat strains of literature-based age related changes in muscle  
fiber number. Peak fiber number for male F344*BN, F344 and Wistar rats was taken as the  
maximal fiber number reported between 24-51% (Ansved and L., 1990; Brown, 1987; Bua et  
al., 2002; Daw et al., 1988; Eddinger et al., 1985; Edstrom and Larsson, 1987; Kadhiresan et  
al., 1996; Larkin et al., 2003; Larsson and Ansved, 1995; Larsson and Edstrom, 1986; Lushaj  
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et al., 2008; McKiernan et al., 2004; Wanagat et al., 2001). Mean maximal fiber number was  
calculated for the 24-51% interval, when multiple studies reported for the same muscles and  
sampling techniques were similar. The dashed line represents 100% maximal fiber number as  
estimated for the respective periods of life.
Very little  is  known  about  the  effects  of  aging  on  muscle  fiber  number  in  male 
C57BL/6 mice (Sheard and Anderson, 2012; Zerba et al., 1990b). The muscle fiber number in 
extensor  digitorum  longus of  old  (26-27  months,  97-101% MLS)  mice  was  15%  lower 
compared to that in young mice (2-3 months, 7-11% MLS) (Zerba et al., 1990b). Furthermore, 
muscle fiber numbers within extensor digitorum longus and soleus muscles of 24-months-old 
mice (90% MLS) were 12% and 10% lower compared to that in mice at the age of 4-6 months 
(15-22% MLS) (Sheard and Anderson, 2012). These results suggest that for mice the effects 
of aging on muscle fiber number become substantial only after an age of 90% MLS (> 24 
months).
Taken together, at 100% MLS, human muscles (Lexell et al., 1986; Lexell et al., 1988) 
seem to lose relatively more muscle fibers, when counting all muscle fibers, than those of 
most rodents, even those of F344*BN rats. It is likely that similar mechanisms of neuronal 
death and loss of motor units cause this loss of fibers in both human and rodent muscles. Male 
F344*BN is the only rodent model which displays muscle fiber loss similar to that reported in 
men,  but  this  occurs  only  later  in  life  (~110%)  (Bua  et  al.,  2002;  Lushaj  et  al.,  2008; 
McKiernan et al., 2004; Wanagat et al., 2001). Therefore, studies investigating the effects of 
aging on muscle fiber number in rodent models should use rodents at >100% MLS. 
4.3 Age-related change in muscle fiber cross-sectional area
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In humans, numerous studies have investigated the effects of aging on muscle fiber 
size in  m. vastus lateralis (see for review) (Lexell, 1995; Porter et al., 1995; Vandervoort, 
2002). Comparison of muscle fiber cross-sectional area (FCSA) of subjects at ~25% MLS 
with  those  of  ~90%,  and  ~75%  with  ~115%  MLS  consistently  shows  that  aging  is 
accompanied by a 20-50% atrophy of type II muscle fibers, while type I muscle fiber size 
remains largely unaffected (Essen-Gustavsson and Borges, 1986; Larsson, 1978; Lexell et al., 
1988; Nilwik et al., 2013; Scelsi et al., 1980; Singh et al., 1999; Tomonaga, 1977).
To our knowledge no studies have investigated this issue in male Wistar rats, therefore 
only male F344*BN and F344 rats were included in this section. Both strains showed a larger 
decrease in FCSA for type IIB than type I and IIA muscle fibers, when comparing muscles 
from rats at the age of 20-30% MLS with those of rats at the age of 90-100% MLS (Brown 
and Hasser, 1996; Carter et al., 2010; Kadhiresan et al., 1996; Larkin et al., 2003; Rowan et 
al.,  2012;  Schuenke et  al.,  2011;  Wineinger  et  al.,  1995).  Of both  rat  models,  only male 
F344*BN rats  show age-related reductions  in FCSA similar  to those of men.  For this  rat 
strain,  reductions  in  FCSA of  type  I  and  IIA fibers  were  less  evident  (~10%),  whereas 
reductions for type IIB fibers were shown to be 30% at 100% MLS (Brown and Hasser, 1996; 
Carter et al., 2010; Rowan et al., 2012; Wineinger et al., 1995). Furthermore, it seems as if the 
age-related drop in FCSA for type I muscle fibers is more distinct for slow muscles that have 
no or only small numbers of type IIB fibers, while the age-related drop in FCSA for type IIB 
muscle fibers is more pronounced for fast muscles, at least for the F344*BN strain (Brown 
and Hasser, 1996; Carter et al., 2010; Rowan et al., 2011). For F344 rats the effects of aging 
on FCSA are less pronounced. Plantaris and gastrocnemius medialis muscles of male F344 
showed similar decreases in all FCSAs of less than 25% at 100% MLS (Kadhiresan et al., 
1996; Larkin et al., 2003; Schuenke et al., 2011).
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Only one study investigated the effect of aging on FCSA in C57BL6 mice. In both 
extensor digitorum longus and soleus muscles no age-related decrease in FCSA was observed 
(Sheard and Anderson, 2012), most likely because the 6-months-old mice did not reach their 
peak muscle mass yet. Therefore, the effect of aging on the FCSA in C57BL6 mice could not 
be established.
Taken together, the data on aging related effects on FCSA suggest that over the same 
relative age range, muscle fibers of male F344*BN rats seem to undergo age-related atrophy 
similar to that observed in men. The difference between F344*BN and F344 rats may exist 
because F344*BN rats  survive much longer than other rat  strains.  Therefore,  they can be 
tested at higher absolute ages (up to 39 months), which clearly results in a larger cumulative 
effects of the aging induced fiber atrophy and a larger muscle atrophy at a given MLS. 
4.4 Age-related changes in motoneurons 
Age-related  degenerative  changes  in  the  nervous  system,  particularly  in  the 
motoneurons  have  been  suggested  to  be  an  important  cause  of  reductions  in  muscle 
performance (Aagaard et al., 2010; Doherty et al., 1993), muscle mass (Aagaard et al., 2010; 
Doherty,  2003;  Doherty et  al.,  1993;  Faulkner  et  al.,  2007b;  Lexell,  1995),  muscle  fiber 
muscle CSA (Aagaard et al., 2010; Lexell, 1995), muscle fiber number (Aagaard et al., 2010; 
Doherty et al., 1993; Faulkner et al., 2007b; Lexell, 1995), and in particular preferential type 
II  muscle  fiber  loss  (Doherty  et  al.,  1993;  Lexell,  1995).  As  a  result  of  an  on-going 
denervation-reinnervation  process,  other  consequences  of  age-related  motoneuron  loss  are 
fiber type grouping (Scelsi et al., 1980), larger variation in fiber sizes (Degens et al., 2009b) 
and irregular muscle fiber shapes (Kirkeby and Garbarsch, 2000).
Tomlinson and Irving provided the first evidence of age-related motoneuron loss in the 
human lumbosacral cord (Tomlinson and Irving, 1977), in which up to the age of 60 yrs the 
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loss of motoneurons was negligible. Thereafter, at the age of 80 (100% MLS), a gradual loss 
of motoneurons of ~25% was observed, with even greater losses beyond that age (Tomlinson 
and Irving, 1977). Another study observed a motoneuron loss of approximately 10% between 
the 2nd and 8th decade at lumbar vertebrae 3 to 5 (Kawamura et al., 1977). In addition, for 
humans age-related reductions in both numbers and diameters of motor axons in the ventral 
roots have been reported to be 5% per decade (Kawamura et al., 1977). In accordance, a drop 
of 25% was observed between the age of 25 yrs (31% MLS) and 80 yrs (100% MLS) (Mittal 
and Logmani, 1987). 
Like  humans,  also  different  rat  strains  (male  F344*BN,  F344,  F344/Crj  rats  and 
female Wistars) showed a 20% motoneuron loss (Kanda et al.,  1996; Rowan et al.,  2012; 
Sugiura and Kanda, 2004) at the age of 30 months or older. Note that here male F344Crj and 
female  Wistar  rats  were  included in the  comparison between species  and strains,  since  a 
considerable part of the studies reported in the literature on this topic used these two particular 
rat strains. However, no MLS for these strains was determined and therefore these strains 
were excluded in the discussion about the other determinants. 
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Figure 2.4: Literature-based values for motoneuron loss in different rat strains expressed as a  
function of age. An inventory of the loss of motoneurons in rat over the age range from 27 to  
36  months  shows  a  significant  loss  of  1.4% of  the  population  motoneurons  per  month  
(Chopek  and  Gardiner,  2010;  Hashizume  and  Kanda,  1990;  Hashizume  et  al.,  1988b;  
Ishihara and Araki, 1988; Ishihara et al., 1987; Kanda, 2002; Kanda et al., 1996; Rowan et  
al., 2012; Sugiura and Kanda, 2004) (R2 = 0.40, P = 0.05).
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Age  rather  than  strain  seems  an  important  determinant  of  the  percentage  of 
motoneuron loss (Fig. 2.4). The same has been shown for humans (Kawamura et al., 1977; 
Tomlinson and Irving, 1977) and this indicates that the absolute age of rats is important when 
studying  factors  determining  muscle  function  during  aging.  Female  Wistar  rats  of  28-31 
months showed a decrease in motoneurons, particularly α-motoneurons of approximately 20% 
for the  tibialis anterior and  extensor digiorum longus muscles, compared to 2.5-month-old 
rats (Ishihara and Araki, 1988; Ishihara et al., 1987). This distinct α-motoneuron loss (30% 
compared to 22% loss of total  number of motoneurons) was also found in  gastrocnemius  
medialis of male F344/DuCrJ rats (comparing 31 months with 11.5-months-olds) (Hashizume 
et al., 1988b). However, of all rat species, 36-month-old (110% MLS) F344*BN rats showed 
the largest decrease (27%) in motoneuron count vis-à-vis to that of adult rats at 28% MLS 
(Rowan et al., 2012). Therefore, the male F344*BN model seems the model that resembles 
aging changes in human motoneuron number and size most, because rats are tested at more 
advanced ages. To our knowledge, age-related motoneuron loss in male C57BL/6 mice has 
not yet been investigated. 
Although  aging  related  motoneuron  loss  seems  to  be  involved  in  sarcopenia  and 
critically determines the decline in muscle force generating capacity, little is known about the 
mechanisms underlying age-related motoneuron loss. Possibly, reactive oxygen species (ROS) 
compromise metabolism in motoneurons, which are very vulnerable to oxidative stress due to 
their long life span (post-mitotic cells) (Sohal et al., 1994). Indeed, a pronounced 4-to-5 fold 
higher  accumulation  of  age-related  (oxidative)  damaged  proteins  was  found  within 
myelinated peripheral nerves in 38 months (116% of MLS) compared to 8-months-old (24% 
MLS)  male  F344*BN  rats  (Opalach  et  al.,  2010).  Moreover,  aging  related  increases  in 
expression  of  tumor  necrosis  factor-α  (TNF-α),  a  cytokine  playing  an  important  role  in 
chronic low-grade inflammation (Degens, 2010), were found in peripheral nerves (Opalach et 
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al.,  2010).  Such  increased  cytokine  expression  may  contribute  to  the  progression  of 
degeneration  of  motoneurons,  slowing  axonal  regeneration  and  may  contribute  to 
neuromuscular junction remodeling, adding up to the decline in muscle function during aging 
(Manini et al., 2013).
In summary, the literature indicates that there is a 20% loss of motoneurons in both 
humans  and  rats  at  100-120%  MLS  (Mittal  and  Logmani,  1987;  Rowan  et  al.,  2012; 
Tomlinson and Irving, 1977). In addition, in both rats (Hashizume et al., 1988b; Ishihara and 
Araki,  1988;  Ishihara  et  al.,  1987)  and in  humans (Brown,  1972;  Campbell  et  al.,  1973; 
Doherty and Brown, 1993; Doherty and Brown, 1997), evidence suggests that the age-related 
loss of muscle mass is in part a consequence of loss of α-motoneurons.
4.5 Age-related changes in muscle fiber type proportion 
Since  some (Bottinelli  et  al.,  1996;  Bottinelli  et  al.,  1999;  Frontera  et  al.,  2000b; 
Widrick et al.,  1996a), but not all studies (Degens and Larsson, 2007; Larsson and Moss,  
1993) report that slow fibers have a lower specific tension than fast fibers, it is possible that  
part  of  the  age-related  reduction  in  specific  tension  is  due  to  a  fast-to-slow  transition. 
Preferential loss of large α-motoneurons during aging (discussed in the previous section) has 
been proposed to cause this shift, via denervation of IIB fibers and subsequent innervation by 
slower motoneurons. Several studies investigating human m. vastus lateralis found this age-
related shift towards slow muscle fibers (Hakkinen et al., 1998; Larsson, 1978; Scelsi et al., 
1980). However, there are also studies, including longitudinal assessments and a post-mortem 
study, which did not observe such a shift  (Aniansson et  al.,  1986; Frontera et  al.,  2000a; 
Grimby et al., 1984; Kirkeby and Garbarsch, 2000; Lexell et al., 1988; Verdijk et al., 2012). In 
a 12-yrs longitudinal study, in which a group of old men was investigated, the proportion of 
type II muscle fibers increased from 40% at the age of 65 (82% MLS) to 60% at the age of 78 
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(97%  MLS)  (Frontera  et  al.,  2000a),  suggesting  an  increased  rather  than  a  decreased 
proportion of type II fibers! More evidence that no shift towards a slower muscle fiber type 
occurs with aging was found by another 7-yrs longitudinal study, in which 70-year-old men 
(88% MLS) did not show a significant change in fiber type composition (Aniansson et al., 
1986). Furthermore, a study which investigated fiber type distributions within the quadriceps 
femoris by counting fibers in every 48th square (1 x 1 mm) throughout the whole muscle, 
found no age-related difference in fiber type proportion, although a very pronounced effect of 
aging on muscle mass and the total number of fibers was found (Lexell et al., 1988). The 
latter study investigated the whole muscle, instead of taking a single biopsy. It therefore was 
not prone to sampling bias when analyzing muscle biopsies, because of the large variability in 
muscle  fiber  type  proportions  within  a  whole  muscle  (Lexell  et  al.,  1985).  Part  of  this 
variation is related to differences in fiber type composition along the length and the depth of 
the muscle (Andersen, 2003). For a biopsy consisting of ~600 muscle fibers with 50% type I 
muscle fibers, the 95% confidence interval has been shown to be as large as 40-60% (Lexell 
et al., 1985). Given that the differences in specific tension between fiber types, if existent, are 
rather small, the relatively small fast-to-slow transition, if at all occurring, is likely to have 
only a minor impact on the specific tension of the muscle as whole.
Even in rodents, in which usually whole muscles are analyzed, there is considerable 
variation in the reported age-related changes in fiber type composition. Several studies have 
investigated age-related muscle fiber type distribution changes in male F344*BN rats at an 
age of at least 107% MLS (Brown and Hasser, 1996; Carter et al., 2010; Lushaj et al., 2008). 
In fast twitch muscles (m. vastus lateralis, m. rectus femoris and m. vastus medialis) at 110% 
MLS, an increase in proportion of type I muscle fibers was reported (Lushaj et al., 2008). In 
agreement with those results, an increase in proportion of slow type muscle fibers was shown 
in  gastrocnemius medialis of male F344*BN rats, when comparing rats at the age of ~25% 
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and 107% MLS (Carter et al., 2010). In contrast, for high-oxidative  soleus  muscle, a shift 
towards fast  MHC was observed (Carter  et  al.,  2010).  The authors  argued that  the aging 
related direction of the fiber type shift was determined by the prevailing muscle fiber type, i.e. 
the shift is away from the dominant adult MHC isoform (Carter et al., 2010). This is however 
contradicted by another report, in which the shift was reported to be towards the dominant 
MHC isoform, when comparing rats of 18% and 110% MLS (Brown and Hasser, 1996). Also, 
studies in other rat strains (male Wistar and F344) reported ambiguous results (Eddinger et al., 
1985; Kadhiresan et al., 1996; Larsson and Edstrom, 1986).
To  our  knowledge,  in  C57BL  mice  this  issue  has  been  investigated  using 
immunohistochemistry in only one study, which reported an age-related muscle fiber type 
shift towards a slower muscle fiber type in soleus and towards a faster muscle fiber type in 
extensor digitorum  longus muscles in male C57BL/6J mice (Sheard and Anderson, 2012). 
These results contradict a shift away from the dominant muscle fiber type as shown in several 
rat  studies.  However,  the  lack  of  changes  in  force-velocity  curves  in extensor  digitorum 
longus  muscle of 26-27 compared to that in 9-12-months-old male C57BL/6 mice suggests 
that an age-related shift in myosin composition may not occur (Brooks and Faulkner, 1988; 
Brooks and Faulkner, 1994a), although a shift between type II isoforms could not be excluded 
(Brooks and Faulkner, 1994a). More information on fiber type distribution in male C57BL 
mice is therefore needed. 
Abovementioned findings are difficult to interpret with the preferential loss of fast (α-) 
motoneurons as established in rats (Ishihara and Araki, 1988; Ishihara et al., 1987). Surely the 
method of analysis, type of muscle, rodent strain and (relative) age also affect the results. It is 
a  possibility that  the  preferential  loss  of  fast  (α-)  motoneurons  is  not  as  widespread and 
common in humans and rodents as generally presumed. Therefore, for humans and rodents the 
age-related shift towards a slower phenotype, but also the possible differences in muscle fiber 
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specific tension, should not be regarded as established. More investigation on this subject, for 
instance whole muscle studies in rodents, is therefore necessary. 
4.6 Age-related changes in specific muscle tension
In  addition  to  changes  in  muscle  physiological  cross-sectional  area  (PCSA),  the 
maximal muscle force is also determined by the specific tension of the muscle. As discussed 
above,  aging  is  accompanied  with  a  decrease  in  muscle  mass,  but  the  decrease  in  force 
generating capacity is more than proportional to the decrease in muscle mass (Degens et al.,  
2009a; Delmonico et al., 2009; Jubrias et al., 1997). One explanation for the reduced force 
generating capacity is the reduction in specific tension. In aged men (76 yrs, ~95% MLS), 
specific muscle tension is reported to be approximately 20% lower than in (young) adults (25 
yrs, ~31% MLS) (Davies et al., 1986; Klein et al., 2001; Klitgaard et al., 1990; Morse et al.,  
2005; Vandervoort and McComas, 1986; Young et al., 1985). However, some studies did not 
find an age-related reduction in specific tension (Frontera et al., 1991; Frontera et al., 2000b; 
Young et al., 1984). A possible explanation for this discrepancy may be an inappropriate age 
window (50 vs. 69 yrs) to pick up changes in specific tension (Frontera et al., 1991). Two 
longitudinal studies,  investigating men beyond the age of 60 yrs (>75% MLS), showed a 
reduction in specific tension (Delmonico et al., 2009; Frontera et al., 2008a). These results 
suggest that in men a reduction (~20%) in specific muscle tension above 60 yrs does exist and 
contributes significantly to the age-related muscle weakness. 
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Figure 2.5: Literature-based values for age-related specific muscle tension in men and male  
rat and mice. Specific muscle tension is expressed as a percentage of the mean values of those  
reported in literature for the age range from 24 to 51% MLS. Mean maximal specific tension  
was taken as the maximal tension reported between 25-44% MLS for men and 24-51% MLS  
for  rodents.  For  the  calculation  of  the  estimate  of  the  maximal  specific  tension  multiple  
studies were included reporting for the same muscles and using similar sampling techniques.  
The  dashed  line  represents  100% specific  tension.  Note  that  for  rodents  only  hind  limb  
muscles  were  tested,  whereas  for  humans  mostly  knee  flexors  and  extensors  were  tested  
(Blough and Linderman, 2000a; Brooks and Faulkner, 1988; Brooks and Faulkner, 1991;  
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Carter et al., 2010; Davies et al., 1986; Degens and Alway, 2003; Frontera et al., 2000b;  
Kadhiresan et al.,  1996; Kayani et  al.,  2010a; Klein et  al.,  2001; Klitgaard et  al.,  1990;  
Larsson and Edstrom, 1986; Linderman and Blough, 2002; Lodder et al., 1993; Lynch et al.,  
2001;  Morse  et  al.,  2005;  Phillips  et  al.,  1991;  Phillips  et  al.,  1993;  Rice  et  al.,  2005;  
Thompson and  Brown,  1999;  Vandervoort  and  McComas,  1986;  Wineinger  et  al.,  1995;  
Young et al., 1985; Zerba et al., 1990b).
In contrast to men, in rodents the precision and reliability of estimations of PCSA is 
higher (Brooks and Faulkner, 1994c). Overall in rats, similar to men, a decrease in specific 
muscle  tension  with  increasing  age  has  been  shown  (Fig.  2.5).  All  studies  using  male 
F344*BN rats comparing adult rats of 8 months (24% MLS) with aged rats of 35 months or 
older (>107% MLS) showed a significant reduction in specific tension (varying from 36 to 
72%) (Blough and Linderman, 2000a; Carter et al., 2010; Degens and Alway, 2003; Rice et 
al., 2005; Thompson and Brown, 1999). For male F344 and Wistar rats age-related reductions 
were also reported, but these were only ~15% and 10%, respectively (Kadhiresan et al., 1996; 
Larsson and Edstrom, 1986; Linderman and Blough, 2002; Lodder et al., 1993). 
Also in male C57BL/6 mice, decreases in specific muscle tension have been reported 
of  ~15% (Brooks and Faulkner,  1988;  Brooks and Faulkner,  1991;  Brooks and Faulkner, 
1994a; Lynch et al., 2001; Phillips et al., 1993; Zerba et al., 1990b). These values are in the 
same order of magnitude as those reported for Wistar and F344 rat strains. 
The F344*BN rats where studied at a relatively higher age (107% MLS) than men and 
other  rodents  (strains).  Therefore,  it  is  a  possibility  that  the  decrease  in  specific  muscle 
tension accelerates when the mean life span is reached. 
Several explanations have been proposed for the observed reduction in specific muscle 
tension in older men. The age-related decrease in specific muscle tension may be due to a loss 
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of specific muscle fiber tension (D'Antona et al., 2003; Gonzalez et al., 2000; Larsson et al.,  
1997a; Larsson et al., 1997b; Lowe et al., 2001; Thompson and Brown, 1999). In biopsies of 
m. vastus lateralis from older persons at 90% MLS, the myosin concentrations of both type I 
and IIA muscle fibers were lower than in those from adult controls at 38% MLS, suggesting 
that a decrease in the potential maximum number of cross-bridges may in part explain the 
reduced muscle fiber specific tension (D'Antona et al.,  2003). Furthermore, a reduction in 
peak  intracellular  Ca2+ in  muscles  from  aging  mice  would  lead  to  a  larger  number  of 
ryanodine receptors (Ryrs1) being uncoupled to dihydropyridine receptors (DHPR) in skeletal 
muscle fibers (Wang et al., 2000), causing an impaired excitation-contraction coupling and 
therewith a decline in specific muscle force (Delbono, 2002; Gonzalez et al., 2000). 
Note that in addition to these explanations other factors such as the degree of selective 
type II muscle fiber atrophy, an increase in the co-activation of antagonist muscles and/or a 
decrease in agonist muscle activation may all further contribute to the reduction of maximal 
muscle  force  generating  capacity  (Macaluso  et  al.,  2002).  Likewise,  the  inclusion  of 
denervated  muscle  fibers  in  the  assessment  of  PCSA has  been  shown to  contribute  to  a 
reduced muscle force to PCSA ratio in old rats (Urbanchek et al., 2001). Although the amount 
of connective tissue content increases in both men (Overend et al., 1992; Rice et al., 1989) 
and rodents (Lushaj et al., 2008), this does not seem to be a factor that reduces the specific 
tension significantly (Brooks and Faulkner, 1994c; Degens et al., 1995).
5. Discussion 
5.1 Are age-related reductions in muscle mass and force during aging comparable in men and  
male rodent models?
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This review provides an overview of the factors that contribute to the loss in muscle 
mass and maximal muscle force. For this purpose we compared data of men with those of 
male rats and mice.
The  rat  strains  included  in  this  review  were  male  Fischer344  x  Brown  Norway, 
Fischer344 and Wistar. Mouse studies were only included when male C57BL/6 mice were 
used.  These  rodent  strains  were  chosen  for  practical  and  scientific  reasons.  Most  of  the 
determinants of aging related muscle weakness have been studied in the four abovementioned 
strains. 
Rodents  and  humans  differ  considerably  with  respect  to  body size,  life  span  and 
metabolic  rate.  It  might  therefore  be  difficult  to  directly  compare  humans  with  rodents. 
However,  for  the  proper  translation  of  knowledge  gained  in  rodents  to  humans,  this 
comparison has to be made. To do this, it is important to compare them at similar relative 
ages. Therefore, mean and maximal life span were used to determine relative ages per species. 
For men, we used a mean life span of 80 yrs and a maximal life span of 120 yrs. The mean 
and maximal life spans of the rodent models discussed in this review are shown in table 6.1. 
The  time  to  reach  sexual  maturity  is  relatively  shorter  in  rodents  (~8%  MLS) 
compared to humans (~15% MLS) (Flurkey, 2007; Quinn, 2005). Since the purpose of this 
review was to provide an overview of the effects of aging on skeletal muscle function and its 
determinants, the difference in growth rates up to adulthood did likely not affect the validity 
of  the  comparisons  made in  this  review.  After  sexual  maturation  both  rodent  and human 
muscles  continue  to  develop.  We  found  that  the  peak  values  for  muscle  force  and  all 
determinants were reached between 25-51% MLS. 
One  obvious  difference  between  male  F344*BN  rats  and  other  rat  strains  is  the 
difference in life expectancy (NIA, 2012; Turturro et al., 1999). The MLS of F344*BN rats is 
32.7  months  and  the  10% survival  is  38  months  (NIA,  2012;  Turturro  et  al.,  1999).  In 
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comparison, for both male F344 and Wistar rats, MLS is only around 24 months (Deerberg et 
al., 1980; Masoro, 1980; Takeuchi et al., 2009; Thurman et al., 1994; Wolf et al., 2000). The 
difference in effects of aging on muscle force generating capacity between the F344*BN and 
the other inbred strains may exist because inbreeding can lead to homozygosity of detrimental 
recessive genes which is minimized by crossing inbred strains (Sprott and Ramirez, 1997). 
Therefore, a lower abundance of homozygous detrimental genes in hybrid models is likely to 
be responsible for the delayed onset of co-morbidities in the F344*BN strain. This increases 
the period in which age-related changes in the body can be observed (Lipman et al., 1996; 
Sprott, 1991). In addition, this strain does not develop renal pathology like F344 rats, and is  
less susceptible to develop specific tumors than other common rat models (Sprott, 1991). If 
co-morbidities do not kick in at the early stage in life, it is likely that the life span and the  
muscle aging processes of the other rat strains are similar (Degens and Alway, 2003). This 
raises the question whether the F344 and Wistar model can show signs of advanced muscle 
aging at  all?  Therefore,  the  choice  of  rodent  strains  as  models  for  sarcopenia  or  muscle 
atrophy during cachexia may have implications for testing interventions to maintain muscle 
function.
5.2  Is  the  age-related  reduction  in  muscle  force  explained  by  the  sum  of  individual  
determinants and is this the same for men and male rodents? 
For all determinants contributing to the age-related loss in muscle force generating 
capacity the effects of aging were estimated at 100% MLS by linear interpolation, compared 
to adult controls (24-51% MLS) (Table 2.2). This table shows that men have lost ~40% of 
maximal muscle force when they reach the age of 80, while the interpolated reductions in 
muscle  mass  and  specific  tension  are  ~35%  and  ~20%,  respectively.  Based  on  the 
multiplication of the remaining fractions of muscle mass and specific muscle tension,  the 
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change is calculated to be 48%. This seems to be more than the reported decline in maximal 
muscle force estimated at MLS. For F344*BN rats, no difference between the interpolated 
and combined reduction in muscle force was observed. The estimated reduction for maximal 
muscle force was found to be 45%. The multiplication of the remaining fractions of muscle 
mass and specific tension, the age-related decreases were 25% and 30%, respectively, would 
account  for  a  47%  reduction  in  maximal  muscle  force.  Interpolation  of  the  mice  data 
established a reduction in maximal muscle force of 20%, while a loss of 23% was calculated 
when the remaining fractions in mass and specific muscle tension at MLS were multiplied. 
What may explain any discrepancies between the sum of determinants and the reported age-
related decline in force at MLS, mostly observed in men? 
One reason may be that different studies investigated determinants individually and 
not  in  combination.  Alternatively,  when studies  did investigate  multiple  determinants,  but 
reported opposite outcomes, this can affect the current calculations enormously. For example, 
one study reported that fiber loss explained most of the loss in muscle ACSA (Lexell and 
Downham, 1992). In contrast, a recent study explained the age-related decrease in ACSA of 
the  m. vastus lateralis solely by atrophy of type II fibers (Nilwik et al.,  2013). Finally, if 
muscle  mass  and  specific  tension  do  not  change  independently,  but  these  changes  are 
interrelated,  this  could  explain  part  of  the  overestimation  of  the  calculated  muscle  force 
generating capacity. 
Several  studies  investigated effects  of  age on reductions  in muscle  fiber  CSA and 
specific tension as well as those on maximal muscle force of the quadriceps of men of 30 yrs 
(38% MLS) and 75 yrs (94% MLS) (Frontera et al., 2000b; Young et al., 1985). The average 
age-related loss of maximal muscle force was 37%, of which 75% was explained by the loss  
of muscle mass and 25% by the loss of specific tension (Frontera et al., 2000b; Young et al.,  
1984; Young et al., 1985). Comparable studies in the F344*BN model found ~60% loss of 
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muscle force in lower leg muscles at 110% MLS, of which 50% was explained by the loss of 
muscle mass and the other 50% by reduction in specific tension (Blough and Linderman, 
2000b; Brown and Hasser, 1996; Carter et al., 2010; Degens and Alway, 2003; Thompson and 
Brown, 1999). In both F344 and Wistar strain the decline in maximal muscle force was much 
less.  Nevertheless,  the  decline  was  explained  by an  equal  reduction  in  muscle  mass  and 
specific tension. Likewise, in mice the decline in muscle force was shown to be 23% of which 
~50% was explained by both the age-related loss of muscle mass as well as specific tension, 
in  extensor digitorum longus and  soleus muscles at an average of 101% MLS (Brooks and 
Faulkner,  1988;  Brooks  and  Faulkner,  1991;  Lynch  et  al.,  2001;  Zerba  et  al.,  1990b). 
Therefore, these studies indicate that in men the age-related loss of muscle mass is the most 
important  factor  contributing  to  the  reduced  maximal  muscle  force,  while  in  rodents  the 
contribution of the loss of muscle mass and specific tension seems to be equal. 
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Table 2.2: Effects of aging on determinants of maximal muscle force or net joint moment in  
men and male C57BL mice and male F344*BN, F344 and Wistar rats. 
Male
Wistar
Male F344 Male 
F344*BN
Male 
C57BL
Men 
10% 20% 45% 20% 40% ΔForce
10% 15% 25% 15% 35% 
(CSA)
ΔMass
5% 10% 20% 20% 25% ΔMyofibe
r number
5-10% (I)
15-20% 
(IIA)
15-20% 
(IIB)
0-10% (I)
0-15% (IIA)
10-25% 
(IIB)
10% (I)
10% (IIA)
30% (IIB)
- 5% (I)
35% (II)
ΔMyofibe
r CSA
0% 10% 30% 10% 20% ΔSpecific 
tension
- 10% 20% - 10-25% ΔMoto-
neuron
69
(Ansved and L., 1990; Brown, 
1987;  Edstrom  and  Larsson, 
1987;  Gutmann  and  Carlson, 
1976;  Ishihara  et  al.,  1987; 
Larsson  and  Ansved,  1995; 
Larsson  and  Edstrom,  1986; 
Lodder  et  al.,  1993;  van der 
Meer et al., 2011b)
(Daw et al., 1988; Degens and 
Alway,  2003; Eddinger  et  al., 
1985; Kadhiresan et al., 1996; 
Kanda  et  al.,  1996;  Larkin et 
al.,  2003;  Linderman  and 
Blough,  2002;  Pettigrew  and 
Gardiner,  1987;  Schuenke  et 
al., 2011)
(Blough  and  Linderman, 
2000a;  Brown  and  Hasser, 
1996; Bua et al., 2002; Carter 
et  al.,  2010;  Degens  and 
Alway,  2003;  Lushaj  et  al., 
2008; McKiernan et al., 2004; 
Rice et al., 2005; Rowan et al., 
2012;  Thompson  and  Brown, 
1999;  Wanagat  et  al.,  2001; 
Wineinger et al., 1995)
(Brooks  and 
Faulkner,  1988; 
Brooks  and 
Faulkner,  1991; 
Jackson et al., 2011; 
Kayani et al., 2010a; 
Lynch  et  al.,  2001; 
Pagala  et  al.,  1998; 
Phillips et al., 1991; 
Phillips et al., 1993; 
Sheard  and 
Anderson,  2012; 
Zerba et al., 1990b)
(Andersen,  2003; 
Aniansson  et  al., 
1986;  Davies  et  al., 
1986;  Essen-
Gustavsson  and 
Borges,  1986; 
Frontera  et  al., 
2000b;  Hakkinen  et 
al., 1998; Ivey et al., 
2000;  Kawamura  et 
al.,  1977;  Klein  et 
al.,  2001;  Klitgaard 
et al., 1990; Larsson, 
1978; Larsson et al., 
1979;  Lexell  et  al., 
1988;  Morse  et  al., 
2005; Murray et al., 
1980; Overend et al., 
1992;  Scelsi  et  al., 
1980;  Tomlinson 
and  Irving,  1977; 
Tomonaga,  1977; 
Vandervoort  and 
McComas,  1986; 
Young et al., 1985)
Reference
s
The determinants shown are: force generating capacity (force),  muscle mass (mass),  total  
myofiber  number,  myofiber  CSA,  specific  muscle  tension  and  motoneuron  number.  The  
percentages show per determinant age-related reductions (Δ) at 100% MLS, compared to  
adult  controls  (24-51%  MLS).  The  age-related  reductions  were  interpolated  by  linear  
regression with all datapoints between 60-120% MLS. As data on muscle mass in men are not  
available, this value has been replaced with muscle CSA. 
Commencing from the collected data, male F344*BN rats at an age of 32-35 months 
may be more appropriate to study aging effects corresponding to those of 70-80 year old men 
(Lushaj et al., 2008), whereas these effects in rats of 36-38-months-old seem to be similar to 
those of men aged over 80 yrs (Vandervoort and McComas, 1986). 
In mice, the reported aging related reductions in maximal muscle force and mass, are 
much lower than those reported for both men and F344*BN rats, while specific tension seems 
to be affected almost equally. This does not necessarily mean that sarcopenia in mice is a 
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result of other mechanisms. This could possibly be explained by the fact that in mice the 
aging related muscle deteriorating effects occur at a higher relative age.
In summary, in both men and male rodents the loss of force generating capacity seems 
affected by a loss in muscle mass and specific tension. However, the contribution of these 
factors may differ. 
5.3  Comparison  of  age-related  changes  in  factors  determining  muscle  force  generating  
capacity in men and male rodents
The observed effects of aging on muscle function reported for the different rat strains 
(F344*BN, F344 and Wistar) are most severe in F344*BN rats, and lowest in Wistar rats. Old 
F344*BN rats were tested at a high absolute (33 to 39 months) and relative (101% to 119% 
MLS) ages.  The F344*BN model  shows a  similar  reduction  in  maximal  muscle  force,  a 
slightly  lower  loss  of  muscle  mass,  but  a  higher  reduction  in  specific  tension  with  age 
compared with men is shown, when the effects are interpolated to 100% MLS using linear 
regression. Furthermore,  at  MLS male F344*BN rats  exhibit  a lower loss in muscle fiber 
number, but show a similar reduction in muscle fiber CSA. This suggests that male F344*BN 
rats show comparable age-related losses as men on most determinants of maximal muscle 
force. 
Male Wistar rats show very low signs of age-related muscle deterioration. A major 
reason for this seems to be the low relative and absolute ages at which these animals are  
tested. In most studies, old male Wistar rats were between 20 to 24 months (85% to 102% 
MLS). With a MLS of ~24 months, testing at an older age seems not feasible, because of the 
high disease rate from this age. Because of this, the Wistar rat is not an appropriate model to 
study progression of sarcopenia at advanced age. But it may well be suitable to study early 
signs of sarcopenia, such as the occurrence of a reduction in specific tension (Degens et al., 
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1995; Degens et al.,  1993a) and increased variability in muscle fiber sizes (Degens et al.,  
2009b),  where  the  latter  may be  an  early sign  of  the  on-going denervation-reinnervation 
process. For male F344 rats, the determinants of maximal muscle force are more affected by 
age than for Wistars. One factor could be the age range at which F344 rats were tested, which 
was from 24 months up to 32 months (i.e. 95% to 130% MLS), which was absolutely and 
relatively higher than that at which Wistar rats were tested. Note that for male Wistar rats it is 
not exactly known how the determinants of force generating capacity develop between the age 
of ~6 and ~12 months, because most studies investigating muscle aging have been done with 
control rats at the age of only ~6 months. Furthermore, studies investigating male Wistar rats 
at an age of ~12 months are rare. Studies with female Wistar rats of 5 and 13 months of age, 
indicate a small increase in muscle mass (Degens et al., 1995; Degens et al., 1993a). It is 
possible  that  male  Wistar  rats  undergo  the  same  process,  which  may  cause  a  small 
underestimation of the effect of aging on muscle wasting in Wistar rats in this review.
The relative age at which male C57BL/6 mice were tested was close to MLS (90% to 
105%). Furthermore, compared to men it seems that age-related effects of sarcopenia in mice 
appear only later in life. A reason for this could be that the MLS of C57BL/6 mice has been 
underestimated,  as  it  has  been  shown  to  increase  over  the  years  (Fig.  2.6).  Another 
explanation may be that old healthy mice show almost no age-related muscle weakness, until 
morbidities and concurrent deterioration start to kick in, after which death follows quickly. In 
contrast, the human health care system may cure or pamper old and sick human beings, who 
otherwise  would  have  died.  Thereby,  even  with  the  best  intensions,  the  number  of  aged 
individuals with an impaired quality of life and physical fitness grows, which exposes them to 
(additional) age-related muscle weakness, compared to rodents. 
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Figure 2.6: Increase in reported mean life span in male C57BL/6 mice with time, from 1957  
until 2009 (Blackwell et al., 1995; Flurkey, 2007; Kunstyr and Leuenberger, 1975; Turturro et  
al., 2002; Wolf et al., 2000; Yuan et al., 2009). The dashed line indicates 810 days (i.e. 26.7  
months), the mean reported life span for these mice since 1970. 
So there are  some differences between rodents which in  part  can be explained by 
differences in the rate or degree of senescence. The number of co-morbidities occurring in old 
age seems to be closely related to the latter. Furthermore, in all models, all determinants are 
73
affected,  meaning  that  for  all  the  investigated  organisms  the  mechanism  underlying 
sarcopenia is comparable. This implies that when comparisons are made in a correct way, 
results are transferable between male rodents and men. In addition, for most determinants of 
muscle force, the degree of muscle aging in male F344*BN rats between 32 and 35 months 
seems to be similar to that of a 80 year-old man, when compared to adult controls (20-40% 
MLS).
In this review we focused on male rodents and men, because limited data is available 
for female rodents. There are several reasons why the rate and onset of sarcopenia may differ 
between  men  and  women  and  male  and  female  rodents.  For  instance,  the  hormonal 
differences  between  men  and  women  may  affect  sarcopenia  in  a  qualitative  and/or 
quantitative different way. In addition, there may be differences in life expectancy as well as 
the age at which adulthood is reached, which both would affect the MLS comparison between 
male and female rodents. In order to focus the manuscript on the processes occurring during 
aging in different species, we decided to avoid extensive comparisons between genders. More 
detailed investigations at  similar relative ages are warranted to establish gender-dependent 
effects of aging on muscle force generating capacity. 
Normalizing  age  to  MLS  allows  one  to  compare  maximal  muscle  force  and  its 
determinants between models at similar relative ages. Obviously, variations in the calculated 
MLS may have consequences for the outcomes of this review. Per species and strain, we 
estimated MLS based on data from the literature, realizing that even after extensive searches 
the calculated values would be approximations. Furthermore, MLS is prone to change over 
time,  due  to  improving  living  conditions,  environmental  factors,  and  changing  genetic 
backgrounds of strains. Some of these factors and their effects on muscle aging and MLS are 
discussed below. 
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5.4 Factors affecting life span of humans and rodents 
Life expectancy is determined by a multitude of factors, among which genetic and 
environmental factors such as nutrition,  exercise and stress, which may all differ between 
humans and rodents. Housing conditions, protein intake, physical activity and co-morbidities 
are factors that are discussed below. 
Housing facilities have improved over time. For instance the introduction of specified 
pathogen free (SPF) barrier facilities has resulted in an increased life expectancy of laboratory 
rodents, especially C57BL mice, throughout the last decades (Fig. 2.6). The introduction of 
SPF organisms also had a dramatic impact on the quality and validity of research (Sprott, 
1991). The consequence for muscle aging research is that since that time older and healthier 
rodents can be tested, with a smaller chance of measuring effects of co-morbidities. 
Laboratory  animals  are  generally  fed  standard  industrial  food.  These  diets  often 
contain 20% or more protein (Blackwell et al., 1995; Masoro, 1980; Turturro et al., 2002; 
Turturro et al.,  1999; Wineinger et al.,  1995; Wolf et al.,  2000), which is higher than the 
average protein intake (15%) of humans throughout life (Fulgoni, 2008; National institute for 
public health and the environment, 2011). The effect of a chronic high protein diet on muscle 
mass, especially in aging rodents, is largely unknown. However, for gastrocnemius muscle of 
male F344 rats at ~100% MLS it was shown that one month of amino acids administration 
normalized total muscle protein content (Chen Scarabelli et al., 2008). In old Wistar rats (85% 
MLS) long-term oral supplementation (8 weeks) of amino acids increased muscle mass by 
10% (Pansarasa et al., 2008). More specifically, for type I muscle fibers, age-related atrophy 
at 85% MLS was attenuated by 20%, compared to a young control group (Pansarasa et al., 
2008). Another study showed that in male C57BL/6 mice administration of branched-chain 
amino acids from 67% to 79% MLS preserved muscle fiber size, and resulted in an 70 day 
increase in the mean life span (D'Antona et al., 2010). These studies suggest that in rodents a 
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high protein diet may slow down sarcopenia. Theoretically, extra supplementation of anti-
oxidants,  decreases  oxidative  stress,  and  may  therefore  have  beneficial  health  effects. 
However, whether the life-time intake of anti-oxidants differs between humans and rodents 
and whether this actually has a different effect on life span remains to be elucidated. 
The intensity and duration of daily physical activity may also affect the lifespan and 
the  process  of  sarcopenia  (Degens,  2012).  During  aging,  physical  activity  of  humans  is 
substantially reduced. The amount of energy spend during daily life is drastically decreased in 
old (90 yrs,  ~115% MLS) compared to young people (~25 yrs,  ~30% MLS) (Westerterp, 
2000).  For  laboratory rodents  discussed in  this  review,  an age-related decline  in  physical 
activity has also been reported (Ingram, 2000). In a study on male F344 and F344*BN rats it 
was shown that both species’ total activity count decreased by ~30% and ~50%, from 7 to 24 
months (98% MLS) (F344) and 31 months (F344*BN) (95% MLS), respectively (Spangler et 
al.,  1994).  Also  for  13-month-old  female  C57BL/6  mice  the  frequency  of  ambulatory 
movements was only half compared to that of 5-months-olds. Subsequently, this remained 
unchanged up to 25 months  (94% MLS) of  age (Lhotellier  and Cohen-Salmon,  1989).  It 
seems that the age-related decline in physical activity is rather similar for humans and rodents 
and as  such the  degree  of  aging  related  to  inactivity  does  not  explain  the  differences  in 
magnitude of sarcopenia.
In  summary,  it  is  important  to  be  aware  of  the  fact  that  some  factors  influencing  life 
expectancy and the rate of muscle aging may differ between men and male rodents.
6. Conclusions
In this review we present an overview of the magnitude of age-related muscle force 
deterioration and underlying causes for different aging models. The main questions of this 
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review were if knowledge about age-related reductions in maximal muscle force generating 
capacity acquired in rodents could be translated to humans, and if so, how do they relate to 
each other? 
Using relative age allows one to compare effects of human aging on muscle force 
generating capacity with those of three different rat strains and one mouse strain. The male 
F344*BN model resembles muscle aging in men most. At MLS male F344*BN rats show a 
similar age-related reduction in maximal muscle force, a slightly lower loss of muscle mass, 
but a higher reduction in specific tension than men. The most important reason for this is that  
F344*BN reach an older age than other rat strains and C57BL/6 mice, likely because of a 
delayed onset of co-morbidities. 
In designing future rodent studies to investigate mechanisms underlying sarcopenia 
and muscle weakness, attention should be paid to the age and determinants that are of interest. 
Male F344*BN rats at an age of 32-35 months seem to exhibit age-related signs of muscle 
weakness  comparable  with  those  of  70-80-yr-old  men,  whereas  rats  of  36-38-months-old 
seem to show similar declines as men aged over 80 yrs. Wistar and F344 rats seem to be less 
appropriate  for  studying  advanced  effects  of  age-related  muscle  weakness.  Instead,  these 
models may be more useful to study the initial stages of sarcopenia.
Most aging studies on mice have investigated muscle force and its determinants at 
around 90-100% MLS. At this age, the effects are moderate compared to those reported for 
men and F344*BN rats.  At present,  C57BL/6 mice seem to live longer,  also without  co-
morbidities,  compared  to  20-30  yrs  ago,  most  probably  caused  by  better  environmental 
conditions like housing facilities. These improvements make the current model much more 
suitable for studying the initial  stages of muscle aging. Furthermore,  choosing older mice 
(≥25 months) and for example changing the diet, may make them appropriate for studying 
advanced  aging  processes  in  skeletal  muscle.  Moreover,  mouse  models  are  advantageous 
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because of the large availability and of genetically engineered and mutant mice strains, which 
allows one to investigate the molecular mechanisms behind aging related muscle wasting. 
Although the rate of age-related changes in muscle force generating capacity and its 
determinants differs between species, in each of them, all determinants of muscle force are 
affected by age, suggesting that the mechanism behind sarcopenia in male rodents and men is 
comparable. This implies that when comparisons are made in a correct way, results can be 
translated from male rodents to men. However, the exact effects of aging on some parameters 
involved  in  sarcopenia  are  still  not  elucidated.  Therefore,  more  research  is  warranted,  in 
particular studies that integrate changes of all determinants of muscle aging within the same 
model. 
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Chapter 3
Plantaris muscle weakness in old mice: Relative  
contributions of changes in specific force, muscle  
mass, myofiber cross-sectional area and number
This chapter is based on:
Sam B. Ballak, Hans Degens, Tinelies Busé-Pot, Arnold de Haan and Richard T. Jaspers. 
Plantaris muscle weakness in old mice: Relative contributions of changes in specific force, 
muscle mass, myofiber cross-sectional area and number. Age (2014) 36:9726
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Abstract 
Background: The  age-related  decline  in  muscle  function  contributes  to  the  movement 
limitations in daily life in old age. The age-related loss in muscle force is attributable to loss 
of myofibers, myofiber atrophy and a reduction in specific force. The contribution of each of 
these determinants to muscle weakness in old age is, however, largely unknown.
Objective: To determine whether a loss in myofiber number, myofiber atrophy and a reduction 
in specific muscle force contribute to the age-related loss of muscle force in 25-month-old 
mouse.
Methods: Maximal isometric force of in situ m. plantaris of C57BL/6j male adult (9-months) 
and old (25-months) mice was determined and related to myofiber number, myofiber size, 
intramuscular connective tissue content and proportion of denervated myofibers. 
Results: Isometric maximal plantaris muscle force was 13% lower in old than adult  mice 
(0.97±0.05N vs. 0.84±0.03N; P<0.05). M. plantaris  mass of old mice was not significantly 
smaller than that of adult mice. There was also no significant myofiber atrophy or myofiber 
loss. Specific muscle force of old mice was 25% lower than that of adult mice (0.55±0.05 vs. 
0.41±0.03N·mm-2, P<0.01).  In  addition,  with  age  the  proportion  of  type  IIB  myofibers 
decreased  (43.6% vs.  38.4%,  respectively),  while  the  connective  tissue  content  increased 
(11.6% vs. 16.4%, respectively).
Conclusion: The age-related reduction in maximal isometric plantaris  muscle force in 25-
month-old male C57BL/6j mice is mainly attributable to a reduction in specific force, which 
is for 5% explicable by an age-related increase in connective tissue, rather than myofiber 
atrophy and myofiber loss.
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1. Introduction 
Aging is associated with a progressive decline in muscle power generating capacity 
(Runge  et  al.,  2004)  that  contributes  to  an  increased  incidence  of  falls,  a  decreased 
independence  and  reduced  quality  of  life  (Kamel,  2003;  Roubenoff  and  Hughes,  2000). 
Improvement of muscle function in the older person may alleviate many of these problems. 
To develop strategies to preserve, slow or even reverse muscle weakness in advanced age, a 
profound understanding of the etiology of age-related muscle weakness is needed. 
An important  determinant of muscle  power is  the force generating capacity of the 
muscle. Muscle force generating capacity in humans can decrease as much as 60% between 
the age of 30 and 80 years (Faulkner et al., 2007a). Also in rodents a 25-65% age-related 
deterioration in the muscle force generating capacity has been reported (Ballak et al., 2014b; 
Brooks and Faulkner, 1988; Carter et al., 2010; Degens and Alway, 2003), which is not only 
due to a loss of muscle mass but also a reduction in the force generating capacity per muscle  
cross-sectional area, specific force (Degens et al., 2009a). It could be that during the initial 
stages of sarcopenia a reduction in specific force precedes the loss in muscle mass.
Concomitant with the loss of muscle force generating capacity there is a loss of muscle 
mass. In the human m. vastus lateralis this amounted to approximately 30% between 40 and 
80 years (Janssen et al., 2000; Klitgaard et al., 1990; Maden-Wilkinson et al., 2014b; Overend 
et al., 1992; Rice et al., 1989; Young et al., 1984; Young et al., 1985). In rodents, at ages 
representative of these ages in  humans,  a similar age-related reduction in muscle mass  is 
observed (Ballak et al., 2014b). Typically, the age-related decrease in muscle mass is due to 
both a reduction in myofiber number (Lexell et al., 1988; Lushaj et al., 2008; McKiernan et 
al., 2004; Sato et al., 1984; Zerba et al., 1990a) and (preferential type II) myofiber atrophy 
(Brown  and  Hasser,  1996;  Carter  et  al.,  2010;  Klitgaard  et  al.,  1990;  Larsson,  1978; 
Tomonaga, 1977; Verdijk et al., 2007). However, the loss in maximal muscle force with age is 
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more than proportional to the decrease in muscle mass (Degens et al., 2009a). This implies 
age-related  intrinsic  changes  of  the  muscle  affecting  the  quality of  the  remaining muscle 
tissue (Frontera et al., 2008b). In fact, several studies in both humans (Frontera et al., 2008b; 
Klein et al., 2001; Morse et al., 2005) and rodents (Degens and Alway, 2003; Degens et al., 
1995; Kadhiresan et al., 1996; Rice et al., 2005) have reported a reduced force per unit cross-
sectional  area (referred to  as specific  force)  during aging.  An increased connective tissue 
content (Brooks and Faulkner, 1994b; Lushaj et al., 2008; Overend et al., 1992), inclusion of 
denervated, and thus non-force producing myofibers (Urbanchek et al., 2001), and a selective 
atrophy of type II myofibers that reportedly have a higher specific force than type I fibers (Yu 
et al., 2007), may also contribute to the age-related reduction of specific muscle force. 
It thus appears that the three prime factors that contribute to the age-related muscle 
weakness are a reduction in myofiber number, myofiber atrophy and a reduction in specific 
force. Yet, these determinants of the age-related muscle dysfunction are hitherto not evaluated 
collectively, especially in early stages of sarcopenia. Since the contribution of each of these 
determinants  to  the  age-related  changes  in  muscle  force  generating  capacity  cannot  be 
investigated in humans, we used m. plantaris in adult (9-months) and old (25-months) mice. 
We hypothesized that skeletal muscle weakness in old age is in order of importance due to a) 
a loss in muscle quantity, b) a reduction in muscle quality. 
To investigate this we determined the maximal isometric force of mouse m. plantaris 
in situ.  To determine the relative contribution of the three abovementioned factors, tetanic 
force was related to m. plantaris mass, myofiber CSA, myofiber number and specific force. 
Histological  analysis  was  also  performed  to  determine  connective  tissue  content  and 
proportion of denervated, and hence non-force producing, myofibers. 
2. Methods
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2.1 Animals 
Experiments  were  performed on eleven 9-month-old  (adult)  and ten  25-month-old 
(old) male C57BL/6J mice (Janvier, France). Mice were housed individually and kept under 
specific-pathogen-free conditions at 20-22 ⁰C at a 12-h light/dark cycle. Animals were given 
free access to water and chow (Ssniff® S8189-S095). For the experiments described below we 
analyzed histological and contractile force characteristics of the right leg. At the age of 7.5 
(adult) or 23.5 (old) months, in the left leg of the mice the m. gastrocnemius and m. soleus 
were denervated to overload the  m. plantaris muscle for six weeks. The effects of overload 
are beyond the scope of the present study. 
All experiments were approved by the local animal use and care committee of the VU 
University Amsterdam and conformed to the guide of the Dutch Research Council for care 
and use of laboratory animals.
2.2 Surgery and preparation
Fifteen minutes  prior to the start  of the experiment,  mice received a  subcutaneous 
injection  of  0.06  mL 1%  Temgesic  (Reckitt  Benckiser,  UK)  as  an  analgesic  and  were 
anaesthetized with 4% isoflurane, 0.1 L·min-1 O2 and 0.2 L·min-1 air. Subsequently, the level 
of anesthesia was maintained with 1.5-2.5% isoflurane. A humidifier moistened the inhaled air 
to prevent dehydration due to respiration. The mice were placed on a heated pad to maintain 
body temperature at ~36.5 ⁰C. 
The experiments were performed as explained previously (Degens and Alway, 2003). 
The m. plantaris was dissected free from surrounding tissue while maintaining its innervation 
and blood supply. The sciatic nerve was severed and the proximal end was placed over an 
electrode for stimulation of the muscle. The distal tendon of the  m. plantaris was dissected 
free and tightened with a Kevlar thread via a small steel link to a force transducer, which was 
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mounted on the lever arm of an isovelocity measuring system. The femur was fixed by a 
clamp on the condyle of the femur. During the experiment, the muscle and its surrounding 
were kept moist at physiological temperature (34-36 ⁰C) with a water-saturated airflow. 
Figure 3.1 Experimental set-up as used during all measurements. This is a modification of the  
set-up used by de Haan et al. (de Haan et al., 1989). The anaesthetized mouse was placed on  
a heated pad, while the m. plantaris was attached to the force transducer, which allowed to  
measure muscle force in situ.
2.3  Experimental  setup  and 
force 
measurements 
Figure 1 shows a diagram 
of the experimental  setup  for  in  
situ muscle 
force  measurements  which  is  a  modification  of  that  described  (de  Haan  et  al.,  1989). 
Contractions were induced by supramaximal electrical stimulation of the sciatic nerve at a 
constant current (2 mA; 200-µs pulse width). Optimal muscle length (o) was defined as the 
muscle length at which maximal tetanic isometric force was generated. To determine o, first 
the length at which the muscle produced maximal twitch force was assessed. To fine adjust o 
tetani (150 Hz, 150 ms) were applied once every 2 minutes. Two minutes after the last tetanus 
the muscle was stimulated by applying a 400-Hz, 80-ms pulse train to determine the maximal 
rate of force development (MRTD). Finally, the muscle was stimulated by applying a 150-Hz, 
150-ms pulse trains once every second for 5 min to deplete the glycogen in fibers expressing 
type IIB myosin. Force and length signals (1–10 kHz) were stored on disk. At the end of the 
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experiment, the m. plantaris was excised and weighed and the mouse was killed by cervical 
dislocation. 
2.4 Analyses 
The m. plantaris was embedded at o  in a gelatin-tyrode (NaCl, 128.3 mM; KCl, 4.7 
mM; MCl2·2O, 1.05 mM; NaH2PO4·H2O, 0.42 mM; NaHCO3, 20.2 mM; EGTA, 15.0 mM; 
Gelatine 15% (w/v), pH 7.2) solution and frozen in liquid nitrogen. Subsequently,  m. soleus 
and m. gastrocnemius medialis were excised and also frozen in liquid nitrogen. All chemicals 
were obtained from Sigma Aldrich (The Netherlands) unless stated otherwise.
2.4.1 Cutting of histological sections 
Within a month after the contraction protocol, serial cross-sections (10 µm) were cut 
from the  midbelly  of  the  m.  plantaris using  a  cryostat  at  -20  ºC.  The  in  gelatin-tyrode 
embedded  sections  were  mounted  with  Tissue-Tek (Jung,  Leica  Microsystems,  Germany) 
onto a specimen holder, avoiding direct contact between Tissue-Tek and the part of the muscle 
that would be sectioned to prevent freeze-thaw artefacts. Sections were mounted on glass 
slides (Menzel-Gläser, superfrost® plus, Germany), air-dried and stored at -80 ºC until further 
use.
2.4.2 Myosin heavy chain composition 
Serial sections of the m. plantaris were immunohistochemically stained against type I, 
IIA, IIX and IIB MHC using monoclonal antibodies BAD5 (1µg/mL), SC-71 (1µg/mL), 6H1 
(10µg/mL)  and  BF-F3  (1-10µg/mL)  (Developmental  Studies  Hybridoma  Bank,  USA), 
respectively. In short, sections were fixed with acetone for 10 minutes at 4 ºC and washed in 
phosphate buffered saline with 0.05% tween (PBST) three times for 5 minutes. After blocking 
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with 10% normal swine serum for 30 minutes, the sections were incubated with the primary 
antibody for  90 minutes.  Subsequently,  sections  were  washed in  PBST three  times  for  3 
minutes and incubated in the dark with secondary antibody (Alexa 488 anti-mouse, 1:500, 
Life Technologies The Netherlands) for 30 minutes. After washing with PBST, incubating 
with wheat germ agglutinin (WGA, 1:50, Life Technologies, The Netherlands) for 20 minutes, 
washing with PBST and afterwards washing once more with PBS all in the dark, the sections 
were enclosed with Vectashield®-hardset  mounting medium with DAPI (1.5µg/mL; Vector 
Laboratories, USA). The public domain software ImageJ 1.45s (Rasband, W.S., ImageJ, U.S. 
National Institutes of Health, Bethesda, Maryland, USA) was used to count myofiber number, 
type and myofiber cross-sectional area. 
2.4.3 Determination of denervated myofibers by PAS-staining
The glycogen content of individual myofibers was determined in 10-µm thick sections 
using  the  periodic  acid-Schiff  (PAS)  staining  reaction  (van der  Laarse  et  al.,  1992).  The 
sections were air-dried and fixed for 5 min in 4% formaldehyde in 20 mL 0.2 M imidazole 
and 180 mL acetone. Subsequently, sections were incubated in 44 mM periodic acid solution 
for 30 minutes at room temperature. After incubation, sections were briefly washed in 0.1 M 
HCl and stained with Schiff’s reagents for 25 min at room temperature. 
2.4.4 Intramuscular connective tissue content 
Intramuscular connective tissue was determined using Sirius Red. The sections were 
air-dried and fixed for 30 min in Bouin solution. Next, sections were washed for 10 min, 
before 30 min incubation in Sirius red saturated with picric acid. Sections were dehydrated by 
rapidly dipping in absolute ethanol.  For a better  image quality sections were cleared with 
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xylene and mounted with DPX (Sigma Aldrich, UK). For each muscle the connective tissue 
was assessed by averaging the connective tissue of one picture in the glycolytic and another 
picture in the oxidative region of the muscle. A Matlab-script (version R2012a) was used to 
quantify the  connective  tissue  content  per  image.  The RBG threshold  was set  at  R>140, 
B<110, G<110, to create a binary image allowing to filter all red pixels. The same threshold  
was applied to all images that were stained at the same time. 
2.5 Statistics 
To determine significant differences between age-groups Student’s  t-tests were used. 
To test for differences in fiber CSA a two-way ANOVA was used with factors age and fiber 
type. Effects were considered significant at P<0.05. Data are expressed as mean±SEM. All 
calculations were performed using IBM SPSS version 20. 
3. Results
3.1 Mice characteristics
Table  3.1 shows that body mass, muscle optimum length (o),  myofiber number and 
muscle mass / body mass ratio  did not differ significantly between adult and old mice. The 
masses of the plantaris, gastrocnemius medialis and soleus muscles (PGMS) combined were 
~8% less in old than adult  animals (P=0.03; Table 3.1).  Mass of  m. plantaris alone was, 
however, not significantly reduced in the old compared to the adult group (P>0.05; Table 3.1).
Table 3.1 Mice characteristics
Adult mice (n=11) Old mice (n=10)
Body mass (g) 36.1±3.0 35.6±0.9
PGMS muscle mass (mg) 102.6±2.5 94.7±2.3a
Plantaris muscle mass (mg) 23.6±0.6 22.4±0.7
Muscle ACSA (mm2) 1.83±0.12 2.08±0.10
Pooled myofiber CSA (µm2) 1498±65 1546±110
o(mm) 12.7±0.37 12.88±0.38
Myofiber number (#) 1027±58 1104±55
88
Ratio muscle/body mass (mg·g-1) 0.67±0.04 0.63±0.03
Denervated myofibers (%) 
                   %total
                   %IIB
1.15±0.37
2.33±0.68
1.33±0.38
3.48±1.09
Specific force (N·mm-2) 0.55±0.05 0.41±0.03a
Specific force (N*g-1) 40.94±1.4 37.58±1.4
MRTD (mN·ms-1) 32.3±2.1 29.1±2.1
MRTD/Fmax (mN·ms-1·N -1) 36.4±2.2 37.9±1.5
RT50 (ms) 28.1±0.9 32.3±2.8 a
Values are mean±SEM. PGMS: Plantaris, gastrocnemius medialis and soleus.  o: plantaris  
muscle  length  at  which  tetanic  force  was  maximal.  MRTD:  Maximal  rate  of  force  
development. RT50: half relaxation time. a Significantly different from adult mice at P<0.05. 
Figure  3.2 
Maximal  
isometric  tetanus 
force  (N) 
during a  150-Hz  isometric  
tetanus 
plotted 
against  
time  (ms)  for  adult  and old m. plantaris of mice (A). Force (N) during a  
400-Hz isometric tetanus plotted against time for adult  and old m. plantaris of  mice (B).  
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Maximal force (mN) in adult mice was higher than that in old mice (*: P<0.05) (C). Specific  
force (N·mm-2) was less in old than adult m. plantaris (*: P<0.05). Values are mean±SEM.
 
3.2 Age-related changes in morphology and in situ force characteristics of m. plantaris 
The ACSA of the  m. plantaris muscle did not differ significantly between adult and 
old mice (Table  3.1). Maximal isometric force of  m. plantaris of old mice was 13% lower 
compared to that of adults (Figs.  3.2A and C; P<0.05).  Maximal tetanic force divided by 
muscles  ACSA (specific  tetanic  force)  of  old muscles  was 25% lower  than  that  of  adult 
muscle (P<0.01; Fig.  3.2D). Five percent of this lower specific force was explicable by the 
higher relative content of connective tissue in the old (16.4% vs. 11.6% in adult) muscles 
(specific  muscle  force  corrected  for  collagen  content:  adult:  0.63±0.06N·mm-2;  vs  old 
0.50±0.03N·mm-2;  P>0.05).  However,  specific  tetanic  force  expressed  as  maximal  tetanic 
force per muscle mass did not differ significantly between adult and old muscles (Table 3.1).
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Figure 3.3 Examples of immunofluorescent staining for type IIB myosin in an adult (A) and  
old (B) m. plantaris. Bar represents 500µm. Type IIB myofiber proportion (%) in adult and  
old mice was significantly different (P<0.05). Type I, IIA, IIAX, IIX and IIXB proportions did  
not change significantly (C). Myofiber CSA (µm2) did not significantly decline for any fiber  
type (P>0.05) (D). Note that type I myofibers were not included in this analysis, because of  
the low presence of type I myofibers within the m. plantaris  of C57Bl/6 mice.  Values are  
mean±SEM.
Figure 3.3 shows examples of m. plantaris cross-sections stained specifically for type 
IIB myosin heavy chain. The percentage of type IIB myofibers decreased with age (43.6% vs. 
38.4% in adult and old, respectively; P<0.05; Fig. 3C). The CSAs of type IIA, IIX and IIB 
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myofibers  did  not  differ  significantly  between  adult  and  old  mice  (Fig.  3.3D).  Likewise 
pooled CSA did not change significantly with age (Table 3.1).
 
Figure 3.4 Collagen staining of m. plantaris of adult (A) and old mice (B). Bar represents  
100µm.  Threshold  analysis  (C)  revealed  a  significant  age-related  increase  (*:  P<0.05).  
Values are mean±SEM. 
Figures 3.4A and 3.4B show examples of sirius red stained muscle cross-sections. The 
percentage of collagen in the m. plantaris was higher in the old group compared to that in the 
adult group (P=0.03; Fig. 3.4C). Figure 3.5 shows examples of serial muscle sections stained 
for type IIB myosin and PAS to quantify the number of denervated myofibers that express IIB 
myosin. The percentage of all fibers and the percentage of IIB myosin expressing myofibers 
that were denervated did not differ significantly between adult and old mice (Fig. 3.5E). 
Figures 3.4A and 3.4B show examples of sirius red stained muscle cross-sections. The 
percentage of collagen in the m. plantaris was higher in the old group compared to that in the 
adult group (16.4% vs. 11.6%, respectively; P=0.03; Fig. 3.4C). Figure 3.5 shows examples of 
serial  muscle  sections  stained  for  type  IIB  myosin  and  PAS  to  quantify  the  number  of 
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denervated myofibers that express IIB myosin. The percentage of all fibers and the percentage 
of IIB myosin expressing myofibers that were denervated did not differ significantly between 
adult and old mice (Fig. 5E). 
Figure  3.5  Serial  sections  
stained for type IIB myosin and PAS of adult (A and B) and old (C and D) muscles. Bar  
represents  100µm.  Corresponding  denervated  myofibers  are  specified  with  an  asterisk. 
Analysis revealed no significant difference between adult and old denervated myofiber count  
expressed as percentage of all IIB myofibers (E). Values are mean±SEM.
Maximal rate of force development (MRTD) did not significantly differ between adult 
and old plantaris muscles (Fig. 3.2B; Table 3.1). Also normalized MRTD (MRTD/Fmax) did 
not  decrease  with  age.  However,  half  relaxation  time  of  the  400-Hz  contraction  was 
significantly longer in the old than adult muscles (P<0.01) (Table 3.1), indicating that the old 
muscles were slower. 
4. Discussion
The main finding of the present study is that the age-related loss in maximal force of 
plantaris muscle in 25-month-old male C57BL/6 mice is mainly attributable to a reduction in 
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specific force. In contrast to our hypothesis, plantaris muscles of old mice did not show a 
reduction in total and functional myofiber number, nor myofiber CSA. 
4.1 Age-related decline in force generating capacity is explained by loss of muscle mass and  
reductions in specific force
Here we observed a 13% lower force generating capacity in 25- compared to male 9-
month-old  mice.  Our  aim  was  to  determine  to  what  extent  reductions  in  muscle  mass 
(quantity) and specific muscle force (quality) contribute to this age-related decline in muscle 
force generating capacity. 
Other studies in male mice have reported that the ~25% age-related decline in muscle 
force in both slow and fast hindlimb muscles is explained for 55% by the age-related loss of 
muscle mass, and for ~45% by a reduction in specific force in 26-28-month-old mice (Brooks 
and Faulkner, 1988; Brooks and Faulkner, 1991; Lynch et al., 2001; Zerba et al., 1990a). We 
did  not  observe  a  decrease  in  m.  plantaris mass  which  is  different  from what  has  been 
reported in other studies in which a 15-26% lower muscle mass was reported in 26-28-month-
old mice (Brooks and Faulkner, 1988; Jackson et al., 2011; Lynch et al., 2001; McArdle et al.,  
2004).  The discrepancy between the effects  of  aging on muscle mass  and maximal  force 
shown in our study and those previously reported is unlikely related to the muscles used, as 
other studies observed the effects of aging in both fast and slow muscles. It is more likely that  
the  use  of  older  animals  (26-28-months)  in  other  studies  than  in  our  study (25-months) 
contributes to the discrepancy, as larger effects of aging on maximal muscle force are likely to 
be observed in the older the animal (Ballak et al., 2014b; Brooks and Faulkner, 1988; Lynch 
et al., 2001; McArdle et al., 2004). Indeed (Chan and Head, 2010) observed that even in 20-
22-month-old mice specific force was already reduced without significant muscle atrophy. 
Combination of the data of these studies with slightly older and younger mice than the ones 
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used in the present study suggests that a reduction in muscle quality precedes a reduction in 
muscle mass. If so, it is likely that the contribution of a loss of muscle mass to the age-related  
muscle weakness increases with increasing age. 
 
4.2 Effects of aging on atrophy and loss in myofiber number
An age-related reduction in muscle mass can be the result of both a loss of myofibers 
and myofiber atrophy (Lexell et al. 1988; Lusjah et al. 2008). Here, no myofiber atrophy nor 
myofiber loss was observed. Our observations are in line with other reports in which age-
related decline in myofiber CSA could not be observed in m. extensor digitorum longus and 
m. soleus of 24- compared to 5-month-old mice (Sheard and Anderson, 2012; Zerba et al., 
1990a). It is possible that the age-related myofiber atrophy and loss occur only at a later age 
as  a  small  decrease  in  myofiber  number  of  10-15%  has  been  observed  in  m. extensor  
digitorum longus and  m. soleus of 24-27-month-old C57Bl/6 mice (Sheard and Anderson, 
2012; Zerba et al., 1990a). Also human myofiber loss has not unequivocally been reported. 
Recently, in m. vastus lateralis of healthy 70 year old subjects a decrease in muscle mass was 
solely explained by a decrease in type II fiber CSA, and not by a loss of myofibers (Nilwik et 
al., 2013). Overall, it appears that in 25-month-old male C57BL/6j mice myofiber number and 
size are well maintained. Therefore, if these factors are involved in aging related reduction in 
maximal muscle force, the impact on the decline in maximal isometric muscle force will be 
minor and may only become significant at later stages of the aging process.
4.3 Effects of aging on fibrosis, denervation and myofiber type changes
The specific  force  (force  per  anatomical  cross-sectional  area)  of  25-month-old  m. 
plantaris was  25% lower  compared  to  that  of  9-month-old  mice.  The  magnitude  of  the 
decrease in specific force was similar to that reported by others (Brooks and Faulkner, 1988; 
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Lynch et al., 2001; McArdle et al., 2004). Therefore, the age-related decrease in specific force 
appears to be an important factor contributing to an age-related decline in muscle force.
Theoretically, the loss of specific muscle force may be the result of an increase in 
connective  tissue  content,  a  larger  proportion  of  denervated  myofibers,  a  decrease  in  the 
proportion of fast type IIB myofibers, and/or a reduced force generating capacity of individual 
myofibers (reduced specific force). The fraction of intramuscular connective tissue within the 
m. plantaris was higher in muscles from old than adult animals. Others have also observed an 
increase in connective tissue content with age (Brooks and Faulkner, 1994c; Lushaj et al., 
2008; Overend et al., 1992). When we corrected the specific force for the connective tissue 
content the difference between adult and old muscles was not significant anymore. Thus, part 
of the reduction in specific force in muscles from old mice is attributable to an increased 
content of connective tissue.
Another factor that could potentially reduce specific muscle force is an age-related 
increase in the number of denervated myofibers as a result of motor neuron death (Hashizume 
et al., 1988a; Ishihara et al., 1987; Larsson and Ansved, 1995). Using glycogen depletion, we 
were able to assess the proportion of non-recruited, presumable denervated fibers. However, 
no significant difference in the proportion of non-recruited myofibers was observed between 
the age groups, and therefore the lower specific force in the older animals is not attributable to 
loss of functional myofibers. 
The proportion of  myofibers  expressing  type  IIB myosin decreased  with age.  The 
longer  half  relaxation  time  of  the  400-Hz  tetanus  in  aged  than  in  adult  muscle  fits  this 
observed reduction in the proportion of fibers expressing type IIB myosin. It is debatable, 
however, how much this actually contributes to the lower specific force. It is controversial 
whether the specific force of type IIB fibers is higher than that of other fiber types (Bottinelli  
et al., 1996; Widrick et al., 1996b) or not (Degens and Larsson, 2007; Larsson and Moss, 
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1993). Even if specific force of type IIB fibres was 1.41 times as high of that of other fibers 
(Larsson et al. 1993; Bottinelli et al., 1996 IIB vs. I) the decrease from 44% IIB fibres in adult  
to 38% in old muscle would only cause a 2% reduction in specific force. This is even an 
overestimation as the plantaris  muscle of the mouse barely contains type I fibres and the 
differences  in  specific  force between fast  fibres,  if  existent,  are  much smaller  than those 
reported in (Bottinelli et al., 1996) between type I and type IIB fibers. It is thus unlikely that 
the fiber type shift contributes to the observed age-related decline in specific force.
Finally, the observed age-related decrease in specific muscle force may be due to a 
loss of specific myofiber force with age (D'Antona et al., 2003; Gonzalez et al., 2000; Larsson 
et al., 1997a; Larsson et al., 1997b; Lowe et al., 2001; Thompson and Brown, 1999). This 
reduced skeletal  muscle  force  is  possibly related  to  a  decreased  number  of  cross-bridges 
(D'Antona et al., 2003), oxidative modifications (Degens and Larsson, 2007; Gilliver et al., 
2010b;  Lowe  et  al.,  2001),  protein  glycation  (Snow  et  al.,  2007)  and/or  an  impaired 
excitation-contraction  uncoupling  (Delbono,  2002;  Gonzalez  et  al.,  2000).  While  an  age-
related  Ca-release  may  cause  reductions  in  specific  force  during  a  given  submaximal 
stimulation  intensity and frequency,  this  will  not  cause  a  reduction  in  the  maximal  force 
generated during a tetanic contraction of the duration we applied (Andersson et al.,  2011; 
Delbono et al., 1997; Lamboley et al., 2015). Together, with the aforementioned factors, this 
may explain the decrease in specific muscle force observed in this study.
 4.4 Muscle aging in 25-month-old mice mimics the initial stages of sarcopenia in humans
The decreases in maximal muscle force observed in this and other mice studies are 
rather small, compared to the effects reported at a similar relative mean life expectancy (see 
for review (Ballak et al., 2014b). Nevertheless, the 13% decrease in muscle strength between 
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9- and 25-months of age in our C57BL/6J mice is comparable to that between the age of 25-
30 year old and 60-70year-old humans (Ballak et al., 2014b). 
4.5 Implications
Future  studies  could  investigate  the  time  course  of  the  relative  contribution  of 
decrements in specific force and muscle mass to the loss of muscle strength. To do so, both 
somewhat  younger  and also older  C57BL/6j  mice  (e.g.  26-30-months)  should be  studied, 
while making sure that the impact of disease is minimized. Furthermore, nutritional intake 
may be changed (e.g. lower protein intake) to observe whether a poor diet causes not only a 
lower specific muscle force and a larger loss of muscle mass at  a given age,  but also an 
accelerated rate of sarcopenia. 
To counteract sarcopenia it is essential to know the mechanisms and causes of muscle 
aging, especially in the initial stages of sarcopenia. The present data suggest that interventions 
should, at least during the early stages of sarcopenia, aim primarily to stop or reverse the age-
related decline in specific muscle force. This could be achieved by resistance training that has 
been shown to increase specific  force (Erskine et  al.,  2011).  The impact  of training may 
decrease with increasing age (Degens, 2012; Slivka et al., 2008) and it thus appears essential 
to start interventions before sarcopenia takes its toll. 
5 Conclusion
In conclusion, the age-related reductions in maximal isometric muscle force in male 
C57BL/6j mice were mainly attributable to a reduced specific force. Part of the reduction in 
specific force was due to an age-related increase in connective tissue content, but not to an 
increase in the percentage of denervated IIB myofibers. It is conceivable that the age-related 
reduction in specific force is the result of loss of specific force of individual myofibers. We 
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did not observe an age-related decline of myofiber number and myofiber CSA. Thus, our 
model  seems  to  mimic  force  reductions  similar  to  those  reported  in  the  early  stages  of 
sarcopenia in humans,  and it  is  suggested that the decline in  muscle  quality precedes the 
decline in muscle quantity with age. Therefore, interventions to constrain early sarcopenia 
should aim particularly to improve specific muscle force. 
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Chapter 4
Blunted hypertrophic response in old mouse muscle is  
associated with a lower satellite cell content and is not  
alleviated by resveratrol.
This chapter has been published as:
Sam B. Ballak, Richard T. Jaspers, Louise Deldicque, Sreeda Chalil, Eva L. Peters, Arnold de 
Haan, Hans Degens. Blunted hypertrophic response in old mouse muscle is associated with a 
lower satellite cell content and is not alleviated by resveratrol.  Experimental gerontology.62 
(2015) 23-31
Abstract
Background: Sarcopenia contributes to the decreased quality of life in the older person. While 
resistance  exercise  is  an  effective  measure  to  increase  muscle  mass  and  strength,  the 
hypertrophic response may be blunted in old age.
Objectives: To determine 1) whether hypertrophy in the m. plantaris of old mice was blunted 
compared to adult and 2) whether this was related to a reduced satellite cell (SC) density and 
3) how resveratrol affects hypertrophy in old mice.
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Methods: In adult (7.5 months, n = 11), old (23.5 months, n = 10) and old-resveratrol-treated 
(n  =  10)  male  C57BL/6J  mice,  hypertrophy  of  the  left  m.  plantaris was  induced  by 
denervation of its synergists. The contralateral leg served as control.
Results:  After  six  weeks,  overload-induced  myofiber  hypertrophy  and  IIB–IIA shift  in 
myofiber type composition were less pronounced in old than adult mice (P=0.03), irrespective 
of resveratrol treatment. Muscles from old mice had a lower SC density than adult muscles 
(P=0.002). Overload-induced SC proliferation (P < 0.05) resulted in an increased SC density 
in  old,  but  not  adult  muscles  (P=0.02),  while  a  decrease  occurred  after  resveratrol 
supplementation (P=0.044). Id2 and myogenin protein expression levels were higher in old 
than adult muscles (P < 0.05). Caspase-3 was expressed more in hypertrophied than control 
muscles and was reduced with resveratrol (P < 0.05).
Conclusion: The blunted hypertrophic response in old mice was associated with a lower SC 
density, but there was no evidence for a lower capacity for proliferation. Resveratrol did not 
rescue the hypertrophic response and even reduced, rather than increased, the number of SCs 
in hypertrophied muscles.
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1. Introduction
During aging there is a progressive loss of skeletal muscle mass and function (Ballak 
et al., 2014; Degens and Korhonen, 2012). While resistance exercise is a widely used strategy 
to counteract the age-related loss in muscle mass and strength (Brown et al., 1990; Frontera et  
al., 1988; Leenders et al., 2013), the hypertrophic response to resistance training or overload 
may be blunted in old humans (Grimby et al., 1992; Kosek et al., 2006; Martel et al., 2006; 
Raue  et  al.,  2009;  Slivka  et  al.,  2008)  and  rodents  (Alway  et  al.,  2002a;  Blough  and 
Linderman,  2000;  Degens  and  Alway,  2003).  It  has  been  postulated  that  the  age-related 
blunted  hypertrophy is  largely  due  to  a  decrease  in  the  number  of  functional  myofibers 
(Degens, 2012), but a reduced ability of old myofibers to hypertrophy may also contribute. 
The latter may be a consequence of a reduced mechanosensitivity of myofibers, a reduced 
number of satellite cells (SCs) and/or the SC's ability to proliferate and/or differentiate. 
Since the activation of the AKT/mTOR pathway during overload was not diminished 
in muscles from old rodents, it is unlikely that a blunted rate of protein translation is a major 
cause  of  the  attenuated  hypertrophic  response  in  old  age  (Mayhew  et  al.,  2009).  Since 
mechanical  growth  factor  (MGF)  and  IL-4  are  involved  in  SC  activation  (Aline  and 
Sotiropoulos,  2012;  Della  Gatta  et  al.,  2014),  an  attenuated  loading-induced induction  of 
MGF (Owino et al., 2001) and serum response factor, that controls the expression of IL-4, in 
old age (Lahoute et al., 2008) may result in impaired activation of SCs. This in turn could 
attenuate the accretion of myonuclei within the myofiber in aged muscle. SCs are thought to 
play  an  important  role  in  the  development  of  hypertrophy,  where  proliferation  and 
differentiation of SCs prevent an excessive increase in the size of the myonuclear domain, the 
amount of cytoplasm controlled by a myonucleus (Van der Meer et al., 2011a). The potential 
importance of the addition of new myonuclei to the hypertrophying myofiber is reflected by 
the observation that individuals that developed the largest degree of hypertrophy in response 
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to a training program also had the largest accretion of new myonuclei (Petrella et al., 2006) 
and the  highest  number  of  SCs  per  myofiber  before  training  (Petrella  et  al.,  2008).  This 
suggests that not only an age-related decline in SC number (Chakkalakal et al., 2012), but also 
impaired proliferation and/or differentiation may underlie the blunted hypertrophic response 
in old age. That this may indeed occur is reflected by the blunted increase in myogenin and 
MyoD  protein  expression  in  overloaded  m.  plantaris in  old  rat  (Alway  et  al.,  2002a), 
indicative for an impaired SC proliferation and differentiation, respectively. 
The  blunted  hypertrophic  response  in  old  rats  was  associated  with  an  increased 
expression of inhibitors of differentiation (Id) proteins and apoptosis (Alway et al., 2002a). 
An elevated expression of Id proteins is significant, as overexpression of these proteins leads 
to myofiber atrophy (Gundersen and Merlie, 1994), possibly by stimulating proliferation and 
apoptosis  (Florio et  al.,  1998) and inhibition of differentiation of SCs via  their  inhibitory 
action on the myogenic regulatory factors, such as MyoD and myogenin (Alway et al., 2003). 
Furthermore, increased oxidative stress and low-grade inflammation, often observed in aged 
muscle (Degens, 2010), have been linked to increased expression of Id proteins (Mueller et 
al., 2002). In addition, TNFα can impair the transcription of MyoD and myogenin (Guttridge 
et  al.,  2000)  and  stimulate  their  breakdown  in  the  proteasome  (Langen  et  al.,  2004) 
particularly when they are dimerized with Id proteins (Abu Hatoum et al., 1998). This then 
would  hamper  the  transcription  of  muscle  specific  genes,  as  in  fact  observed  in  old  rat 
plantaris muscle (Alway et al., 2002b). 
Treatment with an anti-inflammatory anti-oxidant may restore the SC proliferation and 
differentiation  and  thereby  the  hypertrophic  response  in  old  age.  Resveratrol  (3,5,4′-
trihydroxystilbene) is a polyphenol with anti-oxidant properties that has been associated with 
a number of health benefits. Its effect on myoblasts in particular seems to be anti-proliferative 
and pro-differentiation (Kaminski et al., 2012; Montesano et al., 2013; Saini et al., 2012). This 
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suggests  that  resveratrol  is  a  potent  supplement  to  counteract  sarcopenia  (Marzetti  et  al., 
2011),  enhance  SC  differentiation  and  restore  the  hypertrophic  response  to  mechanical 
overload in old age. 
Therefore,  the aim of this  study was threefold: 1) to test  whether the hypertrophic 
response to a 6-week period of overload by synergist denervation was blunted in old mice 
compared to that in adult mice; 2) to establish whether the blunted hypertrophy was related to 
a reduced number of SCs and 3) to assess whether resveratrol supplementation increases the 
number of SCs and restores the hypertrophic response in old muscles.
2. Methods
2.1. Animals
For this study we used the following groups of male C57BL/6J mice (Janvier, France): 
adult (9-month-old; n = 11), old (25-month-old; n = 10) and old-resveratrol-treated (old-res; 
25-months-old; n =10). In the left leg of the mice, the m. plantaris was overloaded to induce 
hypertrophy, while the right  m. plantaris served as an internal control.  Mice were housed 
individually under specific-pathogen-free conditions at 20–22 °C and a 12-h light/dark cycle. 
Animals  were  given  free  access  to  water  and  chow  (Ssniff®  S8189-S095,  the  same  as 
provided at the supplier). 
The mice in the old-res group received 0.4% resveratrol (98.57% pure, Polygonum 
cuspidatum extract; 21st Century Alternative, UK) in the chow. The food intake for these mice 
is about 3 g per day and given a body mass of ~35 g, the daily intake of resveratrol was 
approximately 0.4 mg per gram body mass per day.  Since the body mass did not change 
throughout the last six weeks prior to the terminal experiment and no difference was observed 
between the old and old-res group (P = 0.70), it  is likely that the food intake was similar 
between the old and old-res group. At the age of 7.5 or 23.5 months, the m. gastrocnemius and 
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m. soleus of the left leg were denervated to impose an overload onto the m. plantaris for six 
weeks as described previously (Degens and Alway, 2003), while the non-operated right leg 
served as internal control. 
All experiments were approved by the local animal use and care committee of the VU 
University Amsterdam and conformed to the Dutch Research Council's guide for care and use 
of laboratory animals. 
2.2. Preparation for in situ muscle function
Six weeks after induction of overload, the terminal experiment was conducted. Fifteen 
minutes prior to surgery, mice received a subcutaneous injection of 0.06 mL 1% Temgesic 
(Reckitt  Benckiser,  UK)  as  an  analgesic  and  were  anesthetized  with  4% isoflurane,  0.1 
L·min−1  O2  and  0.2  L·min−1  air.  After  nociceptive  responses  had  ceased,  the  level  of 
anesthesia was maintained with 1.5–2.5% isoflurane. A humidifier moistened the inhaled air 
to prevent dehydration due to respiration. The mice were placed on a heated pad to maintain 
body temperature  at  ~36.5  °C.  In  situ  force  measurements  were  performed  as  described 
previously (Degens and Alway, 2003). The m. plantaris was dissected free from surrounding 
Tissue while maintaining its innervation and blood supply. The sciatic nerve was severed and 
the proximal end was placed over an electrode to stimulate the muscle. The distal tendon of 
the m. plantaris was dissected free and tightened with a Kevlar thread via a small steel link to 
a force transducer, which was mounted on the lever arm of an isovelocity measuring system 
(de Haan et al., 1989). The femur was fixed by a clamp on the condyle of the femur. During 
the experiment, the muscle and its surrounding were kept at 34–36 °C with a water saturated 
airflow.
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2.3. Experimental setup and force measurements
The  order  of  the  experiments  was  randomized.  Contractions  were  elicited  by 
supramaximal electrical stimulation of the sciatic nerve at a constant current (2 mA; 200 μs 
pulse width). Optimal length (ℓo) was defined as the muscle length where maximal tetanic 
isometric  force  was  generated.  To  set  ℓo,  first  the  length  at  which  the  muscle  produced 
maximal twitch force was determined. To fine adjust ℓo, tetani (150Hz, 150ms) were applied 
once  every  2  min.  To  deplete  glycogen  in  the  fast  type  IIB  myofibers,  the  muscle  was 
subsequently stimulated for 5 min with 150-ms trains of 150 Hz once every second. Type IIB 
myofibers  that  were  not  glycogen  depleted  after  this  protocol  were  considered  to  be 
denervated myofibers. Force and length signals were digitized (1–10 kHz) and stored on disk. 
At the end of the experiment, the m. plantaris was excised, blotted dry and weighed. Then the 
mice were killed by cervical dislocation. 
2.4. Cryosectioning
The  m. plantaris was embedded at  ℓo in gelatin-tyrode (NaCl, 128.3 mM; KCl, 4.7 
mM; MCl2∗6H2O, 1.05 mM; NaH2PO4∗H2O, 0.42 mM; NaHCO3, 20.2 mM; EGTA, 15.0 
mM; gelatin 15% (w/v), pH 7.2) solution and frozen in liquid nitrogen. Subsequently, the m. 
soleus and m. gastrocnemius medialis were excised from the hind limbs and weighed. Within 
a month after the contraction protocol, serial cross-sections (10 μm) were cut from the mid-
belly of m. plantaris in a cryostat at −20 °C. Sections were mounted on glass slides (Menzel-
Gläser, Superfrost® plus, GER), air-dried and stored at −80 °C until further use. All chemicals 
were obtained from Sigma Aldrich (The Netherlands) unless stated otherwise. 
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2.4.1. Myofiber type composition
Serial sections of the m. plantaris were immunohistochemically stained against type I, 
IIA, IIX and IIB myosin heavy chains to distinguish myofiber types. Thereto, monoclonal 
antibodies BAD5, SC-71, 6H1 and BF-F3 (Developmental Studies Hybridoma Bank, USA) 
against types I, IIA, IIX, and IIB, respectively were used. In short, sections were fixed with 
acetone for 10 min at 4 °C and washed three times for 5 min in phosphate-buffered saline 
(PBS) plus tween (PBST). After blocking with 10% normal swine serum for 30 min, sections 
were incubated with primary antibody. Subsequently,  sections were washed three times in 
PBST for 3 min and incubated in the dark with secondary antibody (Alexa 488 anti-mouse, 
Molecular  Probes)  for  30  min.  After  washing  with  PBST,  incubating  with  wheat  germ 
agglutinin (WGA) (Life  Technologies)  for 20 min,  washing with PBST and subsequently 
washing once more with PBS all  in the dark,  sections were enclosed with Vectashield®-
hardset  mounting  medium  with  DAPI  (Vector  Laboratories,  USA).  The  public  domain 
software ImageJ 1.45s (Rasband, W.S., ImageJ, U.S. National Institutes of Health, Bethesda, 
Maryland,  USA) was  used  to  determine  the  number  of  myofibers  in  a  cross-section,  the 
myofiber  type  proportions  and  myofiber  cross-sectional  area.  Myofiber  outlines  were 
manually traced. 
2.4.2. Determination of denervated myofibers by PAS-staining
The glycogen content of individual myofibers was determined in 10-μm thick sections 
using the periodic acid-Schiff (PAS) staining (van der Laarse et al., 1992). Sections were air-
dried and fixed for 5 min in 4% formaldehyde in 20 mL 0.2 M imidazole and 18 mL acetone. 
Subsequently, sections were oxidized in 44 mM periodic acid solution for 30 min at room 
temperature. After incubation, sections were briefly washed in 0.1 M HCl and stained with 
Schiff's reagents for 25 min at room temperature.
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2.4.3. Intramuscular connective tissue content
Intramuscular  connective tissue was determined using Sirius  Red.  Briefly,  sections 
were air-dried and subsequently fixed for 30 min in Bouin fixative. Next, the sections were 
washed for 10 min with water and then incubated for 30 min in Sirius Red solution saturated 
with picric acid. The sections were dehydrated rapidly in absolute ethanol. For a better image 
quality, the sections were finally cleared with xylene and mounted with Entellan. A Matlab-
script  (version  R2012a)  was used  to  quantify % connective  tissue  per  picture.  The RBG 
threshold was set at R>140, B<110, and G <110, to create a binary image allowing to filter all  
red pixels. The same threshold was applied to all images. 
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Table 4.1 Mice' characteristics.
Adult mice (n=11)
Con       vs.      experimental
Old mice (n=10)
Con       vs.        experimental
Old-res mice (n=10)
Con       vs.        experimental
Body mass (gr) 36.1±3.0 35.6±0.9 35.9±1.2
Muscle mass (mg)
                  M. plantaris 
                  M. soleus
                  M. gastrocnemius 
24.2±0.7
13.3±0.3
65.2±1.8
32.1±1.2*
8.9±0.4*
26.5±0.6*
22.4±0.7a
12.2 ±0.4a
60.1 ±1.7a
28.1±1.1*
8.8±0.4*
28.1±0.8*
23.8±0.8
13.2±1.5
58.7±2.8
29.8±0.9*
9.3±0.7*
28.5±2.0*
Muscle length (mm) 12.8±0.4 12.8±0.4 12.9±0.4 13.0±0.3 12.3±0.3 12.7±0.3
Muscle CSA (mm2) 1.83±0.12 2.61±0.16* 2.08±0.10 2.48±0.12* 2.07±0.10 2.53±0.17*
Myofiber number (#) 1027±58 1098±67 1104±55 1299±73 1131±66 1235±47
Ratio muscle/body mass (mg·g-1) 0.67±0.04 0.89±0.03* 0.63±0.03a 0.77±0.05* 0.67±0.02 0.84±0.03*
Connective tissue (%) 11.6±1.1 12.0±1.3 16.4±1.8 14.1±1.4 12.8±1.3 11.6±1.7
Hybrid myofibers (%) 11.2±2.4 27.2±4.7* 6.4±3.1 20.2±3.6* 8.7±1.9 22.8±5.2*
Denervated myofibers (%total) 
Denervated myofibers (%IIB) 
1.2±0.4
2.3±0.7
0.8±0.1
3.8±1.0
1.3±0.4
3.5±1.1
1.1±0.3
2.7±0.6
1.3±0.3
2.7±0.8
0.9±0.2
2.5±0.6
Values are mean ± SEM.⁎ Significantly different compared to control muscle (P < 0.05). a and with adult muscle P < 0.05). c For the muscles in  
the experimental group, the m. plantaris was overloaded. b while the m. soleus and m. gastrocnemius were denervated. Note that in the second,  
but not the first study, the age-related decrease in muscle mass was significant. The apparent discrepancy is related to the fact that in study 2 the  
overloaded muscles of the old mice were also smaller than those in the adult mice, increasing in the ANOVA the power of the test. 
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2.4.4. Quantification of myonuclei and SC number
Sections were co-stained with DAPI and anti-Pax7 antibodies according to van der 
Meer et al. (2011b). Briefly, sections were fixed in 4% formaldehyde PBS for 10 min, washed 
with  PBST  and  blocked  in  10%  normal  donkey  serum  (NDS)  in  PBS  for  30  min. 
Subsequently, sections were incubated in a 0.1% bovine serum albumin (BSA)–PBS solution 
containing 4 μg·mL−1 Pax7 antibody (Developmental Studies Hybridoma Bank, USA) in the 
dark for 60 min, washed in PBST, incubated with Alexa Fluor 488 (1:500, Molecular Probes, 
Life  Technologies)  donkey  anti-mouse  secondary  antibody  (Invitrogen,  Breda,  The 
Netherlands) and washed with PBST. Then the sections were incubated in the dark for 20 min 
with Texas red-WGA (1:50) conjugate (Invitrogen, Breda, The Netherlands) and washed with 
PBS. Finally, the sections were enclosed with Vectashield®-hardset mounting medium with 
DAPI (Vector Laboratories, USA). The images were captured at 10× magnification using a 
CCD camera (PCOl Sensicam, Kelheim, Germany) connected to a fluorescence microscope 
(Axiovert 200M; Zeiss, Göttingen, Germany) with image processing software Slidebook 4.1 
(Intelligent Image Innovations, Denver, Colorado). The number of myonuclear fragments per 
myofiber cross-section was counted manually in an average of ~70 myofibers per muscle, 
while SC fragments per myofiber cross-section were counted throughout the whole muscle.
2.4.5. Western blots
Frozen muscle tissue (~5–10 mg)was homogenized with a Polytron mixer in ice-cold 
buffer (1:40, w/v) [50 mM Tris–HCl pH 7.0, 270 mM sucrose, 5 mM EGTA, 1 mM EDTA, 1 
mM sodium orthovanadate, 50 mM glycerophosphate, 5 mM sodium pyrophosphate, 50 mM 
sodium fluoride,  1 mM DTT, 0.1% Triton-X 100 and a complete protease inhibitor tablet 
(Roche Applied Science, Vilvoorde, Belgium)]. Homogenates were then centrifuged at 10,000 
g for 10 min at 4 °C. The supernatant was collected and immediately stored at  −80 °C. The 
protein concentration was measured using the DC protein assay kid (Bio-Rad laboratories, 
Nazareth,  Belgium). Forty micrograms of proteins was separated by SDS-PAGE (10–12% 
gels) and transferred to PVDF membranes. Subsequently, membranes were blocked with 5% 
non-fat milk for 1 h and afterwards incubated overnight (4 °C) with the following antibodies 
(1:1000): MyoD, myogenin,  Id2 (BD Biosciences,  Oxford,  UK), caspase-3, caspase-9 and 
eEF2  (Cell  Signaling,  Leiden,  The  Netherlands).  Horseradish  peroxidase-conjugated  anti-
mouse  (1:10,000)  or  anti-rabbit  (1:5000)  secondary  antibodies  (Sigma-Aldrich,  Bornem, 
Belgium)were used for chemiluminescent detection of proteins. Membranes were scanned and 
quantified with Genetools and Genesnap software (Syngene, Cambridge, UK), respectively. 
The results are presented as the ratio protein of interest/eEF2. eEF2 was used as a loading 
control  as  preliminary  experiments  showed  that  eEF2  expression  was  stable  across  the 
different treatments and conditions.
2.5. Statistics
To  test  for  differences  between  age  and  treatment  groups  we  used  an  univariate 
ANOVA with factors age and overload, or resveratrol and overload. Effects were considered 
significant at P < 0.05. Data are expressed as means ± standard error of the mean (SEM). All 
calculations were performed using IBM SPSS version 20.
Fig. 4.1. Effects of aging and resveratrol on maximal isometric force. (A) Maximal isometric  
force  (N)  of  rat  m.  plantaris  muscle  during  a  150-Hz  isometric  tetanus  and (B)  specific  
tension (N·mm−2) of the m. plantaris of male adult (9-months-old), old (25-months-old) and  
old-res  C57Bl/6  mice.  (A)  A  main  age  effect  was  observed  for  force  (P  < 0.05),while  
resveratrol had no effect (P > 0.05). Force was increased by overload in all groups (P  < 
0.001).  (B)  Muscle  specific  force  was  higher  for  adult  than  for  old  (P  < 0.01),  while  
resveratrol had no effect on muscle specific force (P > 0.05). An Age ∗ Overload interaction 
(P  < 0.05) was observed for specific tension,  which indicates that a reduction in specific  
tension after overload in adult but not in old m. plantaris had occurred.  *: different from 
control. a: different from adult. Values are mean ± SEM. 
Fig.  4.2.  Pooled  and individual  myofiber  CSA for  adult,  old  and old-res  m.  plantaris  of  
C57Bl/6  mice.  (A)  Overload  increased  myofiber  CSA (μm2)  in  all  groups  (P  < 0.001),  
however  this  increase  was  higher  in  adult  than  in  old  muscle  (interaction  effect  Age  ∗ 
Overload P=0.032). (B) Type IIA, (C) X and (D) B myofibers hypertrophied after overload for  
all  groups, however the magnitude of this  increase was higher for adult  muscle than old  
(interaction effect Age  ∗ Overload for all three myofiber types P < 0.05).  *: different from 
control. Values are mean±SEM.
3. Results
3.1. Mice and muscle characteristics
The data of the control muscles have been published previously (Ballak et al., 2014a), 
but  are  included here for  comparison with the overloaded muscles  and resveratrol-treated 
mice.  Body mass,  muscle  length,  myofiber  number,  number of denervated myofibers and 
connective tissue were not significantly affected by age,  overload or resveratrol treatment 
(Table  4.1).  In  all  groups,  masses  of  the  denervated  gastrocnemius  medialis  and  soleus 
muscles were significantly smaller than those of the contralateral leg (P < 0.001). M. plantaris 
mass was lower in aged mice compared to that in adult mice (P < 0.01). The overloaded m. 
plantaris were  ~30%  heavier  than  control  muscles  (P  <  0.001),  irrespective  of  age  or 
resveratrol treatment. In addition, overload induced an increase in muscle cross-sectional area 
(P < 0.001; Table 4.1). 
3.2. Muscle function
Maximal isometric muscle force was 13% lower in muscles from old than adult mice 
(P = 0.02) and was 27% higher in overloaded than in control muscles (P < 0.001; Fig. 4.1A). 
The absence of an interaction between age and overload indicates that the increase in force 
was  similar  in  adult  and  old  overloaded  muscles.  Resveratrol  had  no  effect  on  maximal 
isometric muscle force. Specific tension was lower in the  m. plantaris from old than adult 
mice (P < 0.01). The significant interaction between age and overload is reflected by a lower 
specific tension in overloaded adult muscle (P= 0.047), but not old muscles. In both adult and 
old muscles,  the pooled myofiber  CSA (FCSA) increased during overload (P=0.01),while 
resveratrol had no significant effect. The increase in pooled FCSA was, however, more in 
adult than in old m. plantaris (Age ∗ Overload interaction; P = 0.03; Fig. 4.2A). This Age ∗ 
Overload interaction was also shown for each individual myofiber type (Age ∗ Overload P < 
0.05; Figs. 4.2B–D). In addition, in all groups the hypertrophic response was larger for IIA 
myofibers (56%), than IIX (40%) and IIB (21%) myofibers. Note that the proportion of type I 
myofibers was so small (<1%) that it was left out of all analyses. The proportion of type IIB  
myofibers  decreased  with  overload,  but  less  so  in  old  than  adult  mice  (Fig.  4.3;  Age  ∗ 
Overload P=0.013). This decrease in the proportion of type IIB myofibers was accompanied 
by an increase in the proportion of hybrid (type IIA/X and IIX/B) (Table 4.1; P < 0.001) and 
in adult also type IIA myofibers (Fig. 4.3; Age  ∗ Overload P=0.002). Resveratrol had no 
significant  impact  on  myofiber  type  proportions  (Fig.  4.3).  Examples  of  whole  muscle 
myofiber type staining for adult (Figs. 4.3D–F), old (Figs. 4.3G–I) and old-res (Figs. 4.3J–L) 
are provided. 
4.3. The proportion of type IIA, IIX and IIB myofibers inside the m. plantaris of adult, old and  
old-res C57Bl/6 mice. (A) No effect of age or resveratrol was observed in the proportion of  
type  IIA myofibers.  (B)  No  effect  of  age,  resveratrol  or  overload  was  observed  for  the  
proportion of type IIX myofibers. (C) In both adult and old-res mice the proportion of type IIB  
myofibers  decreased  after  overload  (P  < 0.01),  but  not  for  old.  Overload  increased  the  
proportion of IIA myofibers and decreased the proportion of IIB myofibers more in adult than  
old muscle (interaction effect Age ∗ Overload P < 0.01 and P < 0.05, respectively). Examples  
of immunohistochemical staining for type IIA, IIX and IIB myofibers in adult (Fig. 3.3D–F),  
old (Fig. 3.3G–I) and old-res (Fig. 3.3J–L) muscles are provided.*: different from control.  
Values are mean ± SEM. 
Fig.  4.4. Effects of  aging, overload and resveratrol on SC density. SCs were identified in  
plantaris muscle cross-sections by co-localization of DAPI and staining of Pax7 of C57Bl/6  
mice. Example of a section stained for (A) Pax7 (SC; green) and DAPI (nuclei; blue), (B)  
Pax7 (green) and WGA (membranes; red), (C) DAPI (blue) and WGA (red) and (D) Pax7  
(green), DAPI (blue) and WGA (red) merged. Arrows indicate SCs. Bar represents 50 μm. (E)  
Number of SC fragments expressed per muscle CSA (mm2) was higher for adult than for old  
muscle (P  < 0.01). A significant Age  ∗ Overload interaction (P  < 0.05) is reflected by an  
increase in the number of SC fragments permm2 for old, but not for adult muscle. Resveratrol  
decreased the number of SC fragments permm2 after overload (interaction effect Resveratrol  
∗ Overload P  < 0.01). (F) Number of SC fragments expressed per myofiber cross-section  
tended to be higher in the adult than old group (P =0.06). Overload increased the number of  
SC fragments  per  myofiber  cross-section  in  both  adult  and  old,  but  not  in  old-res  mice  
(interaction effect Resveratrol ∗ Overload P > 0.05). (G) Overload increased the number of  
myonuclear fragments per myofiber cross-section in adult and old (Fig. 3.4G; P < 0.01), but  
not for old-res muscles (P > 0.05). *: different from control. a: different from adult. b: different  
from old. Values are mean±SEM.
3.3. Effects of age and resveratrol on SC number
The number of SCs per muscle CSA (mm2) or SC density was higher in adult than old 
muscle (Fig. 4.4E; P = 0.002). The number of SCs per myofiber tended to be higher for adult 
compared to old muscle (Fig. 4.4F; P = 0.06). Hypertrophy was accompanied by an increase 
in the number of SCs per myofiber in both adult and old mice (Fig. 4.4F; P < 0.05). However,  
only in old, but not adult, muscle hypertrophy was accompanied by an increase in SC density 
(Fig. 4.4E: Age ∗ Overload P = 0.02). In old-res mice, the number of SCs per myofiber (Fig. 
4.4F; Resveratrol  ∗ Overload P=0.044) and SC density (Resveratrol   ∗ Overload P=0.005; 
Fig. 4.4E) had decreased, rather than increased in the hypertrophied muscles. The number of 
myonuclei per fiber had increased in overloaded adult and old muscles (Fig. 4.4G; P < 0.01), 
but not in overloaded old-res muscles. 
3.4. Proteins related to SC proliferation and differentiation
MyoD protein expression was not significantly affected by age, overload or resveratrol 
(Fig.  4.5A).  Myogenin and Id2 protein expressions were higher  in old compared to  adult 
muscle, but did not significantly change with hypertrophy or resveratrol treatment (P < 0.05; 
Figs. 4.5B & C). In all groups, overload was accompanied by an increased expression of total 
caspase-3 (P < 0.05; Fig. 4.5D), while resveratrol induced a decrease in the expression of 
caspase-3 expression (Fig. 4.5D; P < 0.05). No cleaved caspase-3 was detected. There were no 
significant effects of age, overload or resveratrol on caspase-9 expression in the m. plantaris 
(Fig. 4.5E; P > 0.05).
Fig. 4.5. Protein content in m. plantaris for MyoD, myogenin, Id2 and caspase-3. (A) MyoD  
protein expression was not affected by age or overload (P > 0.05). (B) Myogenin and (C) Id2  
protein content were higher in old muscle than in adult muscle (P < 0.01), but unaffected by  
resveratrol (P > 0.05). (D) Caspase-3 protein content was increased by overload in all groups  
(P < 0.05) and decreased by resveratrol (P < 0.05). (E) No age-, overload- or resveratrol-
induced  changes  were  observed for  caspase-9  expression.  (F)  Western  blot  examples  for  
MyoD, myogenin Id2, caspase-3, caspase-9 and eEF2 protein expression.  *: different from 
control. b: different from old. Values are mean ± SEM.
4. Discussion
The main finding of this study is that the m. plantaris of 25-month-old male C57BL/6J 
mice showed a blunted hypertrophic response to a 6-week overload stimulus. In addition, the 
type IIB to IIA myofiber type transition during hypertrophy was less pronounced in the  m. 
plantaris of old than of adult mice. The blunted hypertrophic response was not attributable to 
a lower proliferative capacity of SCs in old mice, but may rather be a consequence of the 
lower SC density in old than in adult muscles. Resveratrol may have decreased proliferation 
and/or differentiation, as reflected by a lack of increase in response to overload in SC density 
and number of myonuclei per myofiber in old-res mice. In contrast to our hypothesis, in old 
muscle resveratrol did not rescue the attenuated hypertrophy to overload.
4.1. The hypertrophic response in adult and old mice
In this study overload was induced in the left m. plantaris of 7.5- and 23.5-month-old 
male mice by denervation of its synergists. This technique has previously been shown to be an 
effective way to induce hypertrophy in rodents, with less inflammation than in, for instance, 
overload induced by ablation of synergistic muscles (Lowe and Alway, 2002). Here we show 
that the anatomical CSA of the m. plantaris increased by only 20% in the old, in contrast to 
the 40% increase in anatomical CSA in adult mice, while fiber numbers were similar in the 
plantaris muscles in adult and old mice. The blunted hypertrophy in old mice was thus not 
attributable to a lower number of myofibers, but rather to blunted hypertrophy of the existing 
myofibers,  similar  to  what  has  been  observed  in  older  people  (Kosek  et  al.,  2006). 
Interestingly,  the  hypertrophic  response  in  IIA myofibers  exceeded  that  of  IIX  and  IIB 
myofibers in both adult and old animals. This is in agreement with a report, studying overload 
in 4-month-old female Wistar rats (Degens et al., 1995b). In addition, overload decreased the 
proportion of type IIB myofibers, however more so in adult than in old muscle. Thus, not only 
the development of myofiber hypertrophy, but also the transition of myofiber types during 
hypertrophy is partly lost in 25-month-old compared to adult mice.
4.2. The effect of mechanical overload on muscle force generating capacity in adult and old  
mice
Resistance exercise in both adult and old humans is associated with an increase in 
maximal force that is proportionally larger than the increase in muscle mass (Degens et al.,  
2009; Erskine et al., 2011; Jones et al., 1989; Morse et al., 2005). Here we did not find such 
an increase in specific tension with overload in neither adult nor old mouse muscles, similar 
to what has been reported before in rats (Degens et al., 1995a; Roy et al., 1982). It remains to 
be seen what causes this discrepancy, but part of the apparent increase in specific tension in 
human muscles is attributable to improved maximal voluntary activation (Erskine et al., 2011; 
Morse et al., 2005), which does not play a role in the maximally stimulated isolated muscle 
preparation in mice (Degens, 2012).
4.3. SC number during overload in adult and old mice
Many studies have shown that overload-induced hypertrophy is accompanied by the 
acquisition of new myonuclei, requiring proliferation and differentiation of SCs (Allen et al.,  
1999; Van der Meer et al., 2011a). An explanation for a blunted myofiber hypertrophy in aged 
muscle may thus be a lower number, a decreased mechanosensitivity, impaired proliferation 
and/or differentiation of SCs. Here we found that the SC density was lower in old than adult 
muscle,  which  is  in  accordance  with  others  (Day  et  al.,  2010).  Despite  the  age-related 
reduction in SC density, overload did induce SC proliferation not only in adult, but also in old
muscles. Similarly in old human muscle SC proliferation and hypertrophy have been observed 
in elderly men after resistance training (Verdijk et al., 2009). In our study, the proliferation 
was such that the SC density remained constant in adult, while it was even increased in old 
hypertrophied muscles. The observation that the SC density in old hypertrophied muscles was 
even elevated above that of the age matched control muscles indicates that SC proliferation 
was likely not the limiting factor for the development of hypertrophy in the old muscles. 
Rather, it suggests that the lower absolute number of SCs and/or impaired SC differentiation 
and SC apoptosis contributed to the impaired hypertrophic response in aged muscle.
4.4. Expression of proteins related to SC proliferation and differentiation
An elevated expression of Id proteins is a crucial step for SC proliferation (Lluís et al.,  
2006), but expression beyond a certain threshold, depending on cell environment, may cause 
apoptosis rather than proliferation (Yokota and Mori, 2002). Even though the number of SCs 
was lower in old than adult muscle, the expression of Id2 proteins was elevated. This has also 
been observed in muscles from old rats and in that case elevated Id2 expression levels were 
associated with apoptosis and blunted hypertrophy (Alway et al., 2002b). Here, however, we 
did not find evidence of increased apoptosis in old muscles, as reflected by similar caspase-3 
expression in adult and old muscles. Therefore, it is possible that the increase in myogenin 
served to stimulate differentiation to compensate for an impaired function of SCs in the old 
muscles. Interestingly, it has been observed previously that the most atrophied muscles in old 
rats exhibited the largest increase in MRF and IGF-I mRNAs, suggesting no problem with the 
regenerative drive (Edstrom and Ulfhake, 2005), which corresponds with our data.
In contrast to previous observations in overloaded rat muscles (Alway et al., 2002a), 
we did not observe an overload-induced increase in MyoD and myogenin in the adult mice. It  
should  be  noted,  however,  that  in  that  study  (Alway  et  al.,  2002a)  the  muscles  were 
overloaded only for 2 weeks, the period of muscle growth, while we studied them when they 
had reached a new steady state at 6 weeks after induction of overload (Degens et al., 1995b).
In contrast to previous studies in humans (Whitman et al., 2005) and rodents (Pistilli et 
al., 2006; Phillips & Leeuwenburgh, 2005) we did not find evidence for increased apoptosis in 
muscles of the old mice, as reflected by similar caspase-3 expressions in adult and old mice. 
Nevertheless,  in  both  adult  and  old  muscles  caspase-3  was  significantly  elevated  during 
hypertrophy. This may reflect previous and repeated activation of the pathway. In addition, 
overload induced a considerable IIB–IIA myofiber type transition and a concomitant increase 
in hybrid myofibers in the absence of a change in myofiber number.  This implies that in 
individual myofibers type IIB myosin must be broken down to be replaced by type IIA or IIX 
myosin. While the ubiquitin proteasome pathway plays an important role in the breakdown of 
muscle proteins, it is thought that caspase-3 is involved in the breakdown of large myosin 
molecules (Powers et al., 2007) and first cleaves the myosin molecule in smaller fragments 
that can subsequently be broken down in the proteasome (Du et al., 2004). It is thus possible 
that the increase in caspase-3 in hypertrophied muscles is a prerequisite for the breakdown of 
type  IIB  myosin  (in  this  case)  and  hence  the  observed  myofiber  type  transition  during 
hypertrophy.
4.5. Resveratrol decreases the SC density after overload
Oxidative  stress  and systemic  inflammation  are  factors  that  contribute  to  the  age-
related muscle wasting and weakness (Degens, 2010). Resveratrol has been shown to prevent 
TNF-α induced muscle atrophy (Wang et al., 2014) and to alleviate oxidative stress also in old 
mice (Jackson et al., 2011). Therefore, we investigated whether resveratrol attenuates the age-
related muscle wasting and normalizes muscle hypertrophy in old mice. In the present study, 
muscle  mass,  force  and specific  force  were  not  affected  by resveratrol.  Furthermore,  the 
hypertrophic response was not rescued by 0.4% resveratrol supplementation in the old mice. 
This is in accordance with others, who found that 0.05% resveratrol supplementation was not 
sufficient to attenuate the age-related muscle wasting even though it alleviated oxidative stress 
(Jackson et  al.,  2011).  It  thus appears that  resveratrol does not have beneficial  effects  on 
muscle mass or quality in 25-month-old mice at a dose of 0.4%. 
Resveratrol may have decreased proliferation and/or differentiation, as reflected by a 
lack of increase in response to overload in SC density and number of myonuclei per myofiber 
in old-res mice. In contrast to our hypothesis, in old muscle resveratrol did not rescue the 
attenuated hypertrophic response to overload. Note, however, that despite the lack of increase 
in myonuclear number in old-res muscle, the hypertrophic response was similar to that in the 
untreated old muscle. The preserved hypertrophy suggests that the increase in myonuclei was 
not required to induce a ~20% hypertrophy by overload, which is in line with the observation 
that even in SC depleted muscles myofiber hypertrophy was not attenuated (McCarthy et al., 
2011). Although resveratrol has been reported to stimulate myoblast differentiation (Kaminski 
et al., 2012; Montesano et al., 2013) and to block the proliferation (Montesano et al., 2013) 
we did not find an altered expression of Id2, MyoD and myogenin, important regulators of SC 
proliferation and differentiation. Resveratrol did, however, decrease total caspase-3 protein 
content,  which  is  in  accordance  with  others  where  resveratrol  decreased  mitochondrial 
caspase-dependent apoptotic signaling pathways (Bennett et al., 2013; Marzetti et al., 2011). 
However,  the total  caspase-9 protein content (mitochondrial dependent apoptotic pathway) 
was not affected by resveratrol. Therefore, in 25-month-old mice, resveratrol seems to block 
proliferation and subsequent differentiation of SCs after overload independent of MyoD or 
myogenin.
5. Conclusion
In  conclusion,  the  m.  plantaris of  25-month-old  male  mice  showed  a  blunted 
hypertrophic response, in terms of an increase in myofiber size and myofiber type transition 
compared to  the  m. plantaris from 9-month-old  mice.  The blunted  myofiber  hypertrophy 
could  partly  be  explained  by an  age-related  decrease  in  SC density.  Resveratrol  did  not 
alleviate the age-related decrease in muscle force, specific tension or mass. Nor did it restore 
the  ability  to  develop  hypertrophy  to  levels  observed  in  adult  mice.  On  the  contrary, 
resveratrol blunted the SC response to overload in 25-month-old mice, possibly caused by a
diminished proliferation and differentiation of SCs. 
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Abstract
The method of capillary domains has often been used to study capillarization of 
skeletal and heart muscle. However, the conventional data processing method using a 
digitizing tablet is an arduous and time-consuming task. Here we compare a new semi-
automated capillary domain data collection and analysis in muscle tissue with the standard 
capillary domain method. The capillary density (1481±59 vs. 1447±54 caps·mm-2; R2:0.99; 
P<0.01) and heterogeneity of capillary spacing (0.085±0.002 vs. 0.085±0.002; R2:0.95; 
P<0.01) were similar in both methods. The fiber cross-sectional area correlated well between 
the methods (R2:0.84; P<0.01) and did not differ significantly (~8% larger in the old than new 
method at P=0.08). The latter was likely due to differences in outlining the contours between 
the two methods. In conclusion, the semi-automated method gives quantitatively and 
qualitatively similar data as the conventional method and saves a considerable amount of 
time. 

1 Introduction
An adequate blood supply to the muscle is not only important for delivery of oxygen 
to  the  working muscle,  but  also  for  the  removal  of  metabolites  and heat.  This  exchange 
between  blood  and  muscle  fibers  takes  place  in  the  capillaries  and  an  adequate  muscle 
capillarization  is  thus  crucial  for  muscle  function.  The  capillary  supply  to  a  fiber  is 
determined  by  the  fiber  its  size,  type,  mitochondrial  content  and  metabolic  activity  of 
surrounding fibers (Ahmed et  al.,  1997;  Degens et  al.,  1992; Wust et  al.,  2009a).  During 
hypoxia (Wust et al.,  2009b) and hypertrophy (Degens et al.,  1992) capillary proliferation 
ensures adequate muscle oxygenation. 
The method of capillary domains has been used to study the capillarization in skeletal 
(Degens et al., 1992; Wust et al., 2009a) and heart muscle (Hoofd et al., 1985). The strengths 
of the method are that it not only provides measures of overall capillary supply, such as the 
capillary density (CD in caps·mm-2) and capillary to fiber ratio, but also the capillary supply to 
individual  fibers.  It  is  also  unique  in  that  it  gives  an  indication  of  the  heterogeneity  of 
capillary spacing, which can have a significant impact on muscle oxygenation (Al-Shammari 
et al., 2012; Degens et al., 2006; Degens et al., 1994; Liu et al., 2012), and is an accurate 
method  to  estimate  the  oxygen  supply  areas  of  individual  capillaries  and  is  an  indirect 
indicator  of  tissue  oxygenation  (Al-Shammari  et  al.,  2014).  The  data  obtained  with  the 
method of capillary domain can be fed into models of tissue oxygenation (Al-Shammari et al., 
2012; Degens et al., 1994; Wust et al., 2009b). The drawback of the method is, however, that 
data collection is a manual and time-consuming process. First, pictures have to be printed, 
fibers  and capillaries  manually traced on paper  and then traced again on a  digitizer.  The 
coordinates of the capillaries and fiber outlines are then processed and analyzed with AnaTis 
(BaLoH Software, www.baloh.nl) (Hoofd and Degens, 2013). 
Automation would significantly reduce the data processing time, potentially reduce 
human errors and improve the accuracy of the data processing. A semi-automated method 
would also provide the possibility to  expand the analysis  by introducing new parameters. 
Therefore, the aim of this study was to compare the conventional method with a new semi-
automated Matlab® based software.
2 Methods
2.1 Immunohistochemistry
The left m. plantaris of ten 9-month-old C57BL/6j mice were excised, frozen in liquid 
nitrogen at optimal length and stored at -80°C for further analysis. Sections of 10 μm were cut 
in a cryostat at -20°C and stained with biotinylated lectin (Griffonia simplicifolia) to identify 
capillaries as described previously (Wust et al., 2009a). 
2.2 Analysis of capillarization
The capillarization was analyzed first as described previously (Degens et al., 1992; 
Wust et al., 2009a). In short, the coordinates of the capillaries and the outlines of the muscle 
fibers were manually delineated with a digitizing tablet (Summagraphics MM1201) and the 
data  fed  into  AnaTis  (BaLoH  Software,  www.baloh.nl)  to  calculate  capillary  domains. 
Domains  are  areas  surrounding  a  capillary  delineated  from  surrounding  capillaries  by 
equidistant boundaries (Hoofd et al.,  1985). It also gives an index of the heterogeneity of 
capillary spacing as the logarithmic standard deviation of the domain radii  (LogRSD) and 
overall indices of capillarization, such as capillary density (CD; cap·mm-2). In addition,  the 
program  calculates  the  fiber  cross-sectional  areas  (FCSA)  and  provides  indices  of  the 
capillary supply to individual fibers: the local capillary to fiber ratio (LCFR). It is calculated 
as the sum of the fractions of the capillary domains overlapping a given fiber. The capillary 
fiber density (CFD; cap·mm-2 of a given fiber) is the LCFR divided by the FCSA of that fiber. 
We  developed  a  semi-automated  program  for  capillary  domain  analysis,  as  originally 
described by Hoofd et al. (Hoofd et al., 1985) based on Voronoi tessellations. Two annotation 
tools were developed using Matlab® libraries. The first annotation tool was used to select the 
capillary and border coordinates.  The second annotation tool delineated the fiber outlines. 
Subsequently,  a data analysis  function was implemented to calculate the capillary domain 
(Fig. 5.1). Capillary domains or fiber outlines crossing the border were considered border 
domains or fibers. The domain size, CD, FCSA, LCFR and CFD were calculated with custom 
Matlab® functions. All statistics and metrics were compiled from these data. 
Fig 5.1 Calculated capillary domains using Voronoi tessellations in the conventional (A) and  
new (B) method. 
2.3 Statistical analysis
The  data  of  the  two  methods  were  compared  with  a  paired  Student’s  t test  and 
correlations (R2). Data are presented as mean±standard error of the mean (SEM). A value of P 
< 0.05 was considered significant. 
3 Results
Figure 4.2A shows a comparison of the CD obtained with the conventional and new 
method. The CD in the conventional and the new method (1481±59 vs. 1447±54 cap·mm-2) 
are  highly  correlated  (R2:0.99,  P<0.01).  The  same applied  to  the  capillary  domain  areas 
(R2:0.97,  P<0.01;  Fig.  5.2B).  Figure  5.2C  shows  the  heterogeneity  of  capillary  spacing 
(LogRSD)  for  the  conventional  and the  new method  (0.085±0.002  vs.  0.085±0.002).  The 
LogRSD for both methods are strongly correlated (R2:0.95,  P<0.01). The correlation for the 
FCSA between the two methods is strong (R2:0.87,  P<0.01; Fig. 4.2D) but the new method 
gives  consistently,  but  not  significantly lower  FCSAs than  the  old  method  (1693±66 vs. 
1531±55 µm2; P=0.08). 
Fig 5.2 The correlation between the old and new method for CD (cap·mm-2) (R2=0.99;  
P<0.01) (A), domain area (µm2) (R2=0.97; P<0.01) (B), LogRSD (R2=0.95; P<0.01) (C) and 
FCSA (µm2) (R2=0.87; P<0.01) (D) compared between the conventional (x-axis) and new 
method (y-axis). The line represents the line of identity. 
Table 5.1 shows that the percentage of connective tissue (%CT) did correlate between 
the two methods (R2:0.43,  P=0.01).  Although the LCFR and the CFD correlated strongly 
(R2:0.80 and 0.86;  P<0.01), the new method gave consistently lower values for both LCFR 
and CFD than the old method (P<0.01 and P=0.01). 
Table 5.1 Correlations and P-values of indices of capillary supply 
Conventional 
method
New method R2 P-value
%CT (%) 11.5±0.6 16.7±1.4 0.43 0.01
LCFR 2.503±0.076 1.998±0.070 0.80 0.00
CFD (mm-2) 1564±56 1252±46 0.86 0.00
Correlations and P-values of indices of capillary supply to individual fibers (LCFR: local  
capillary to fiber ratio; CFD: capillary fiber density) and % connective tissue (%CT) between  
the two methods in m. plantaris of 9-month-old male C57Bl/6j mice.
4 Discussion
The  main  finding  of  this  study  is  that  a  newly  developed  Matlab® based  semi-
automatic  method of  capillary domains  provides  a  quantitatively and qualitatively similar 
outcome  for  parameters  of  overall  capillary  supply  as  the  traditional  manual  method. 
Although the FCSA is underestimated in the new method, affecting quantitatively also indices 
of the capillary supply to individual fibers, this is a systematic underestimate. Therefore, the 
qualitative outcome is similar for the two methods and the newly developed method can be 
readily used for comparative studies on changes in muscle or cardiac capillary supply.
The  CD and  LogRSD obtained  by the  two  methods  were  virtually  identical.  This 
indicates  that  the  coordinates  recorded  for  each  capillary  were  comparable  between  the 
methods. It also indicates that the calculation of the capillary domains is comparable between 
the two methods, since for the calculation of the LogRSD the surface areas of the individual 
domains and the radius of circles with corresponding surface areas have to be calculated. 
There was, however, a small difference in the way the fiber outlines were traced; the 
FCSA was systematically underestimated in the new method. In the conventional method, 
accidental fiber overlap could be accounted for, while in the Matlab® based software fibers 
overlapping each other are joined and assessed as one large fiber. Even with good tracing 
skills,  a researcher may avoid tracking the borders too close to each other to prevent this 
fusion of two separate fibers; in other words, the experimenter may intentionally draw the 
fibers slightly too small, resulting in a smaller fiber area. On the other hand, the conventional 
method could lead to a small overestimation of the size of the fibers since overlapping areas 
will be counted twice. Together, this stresses the importance of good tracing skills in both the 
new and the old method.
The difference in fiber size, caused by the difference in tracing the outlines of the 
fibers, also has an impact on the % CT, which was significantly higher in the new method. 
The differences in fiber size also work through in the LCFR and CFD, which were lower in 
the new than in the old method, even though the correlation between the two methods was 
strong. Thus, while there is a systematic qualitative difference between the two methods, the 
new method is readily applicable in comparative studies.
We  are  currently  working  on  the  tracing  algorithm  to  adjust  the  systematic 
underestimation of the FCSA in the Matlab® based software. The main aim of this study was 
to evaluate the validity of this technique before looking into that issue.
It is clear that the method of capillary domains has limitations, as it does not consider 
the 3-dimensional structure of the capillary network, differences in flow between capillaries 
or decrements in oxygen content of the blood from the arteriolar to the venous side of the 
capillary. Other investigators have tried to address this (Beard and Bassingthwaighte, 2000; 
Weerappuli  and  Popel,  1989),  but  this  was  outside  the  scope  of  the  present  study. 
Nevertheless, the method of capillary domains has successfully been used to calculate the 
domain size in venous and arterial capillaries (Suzuki et al., 1997) and using assumptions of 
the decrement in capillary oxygen tension from the arteriolar to venular side of the capillary, 
estimates can be made of the oxygenation in successive planes of tissue (Hoofd, 1995). In 
addition, in a mathematical model also the impact of flow heterogeneity on tissue oxygenation 
can be incorporated (Hoofd and Degens, 2009) illustrating the usefulness of the collected data 
in the 2 dimensional plane to get an estimate of tissue oxygenation under different conditions. 
The new Matlab® based program saves on average about 1.5 hour per section/photo. 
This will increase even more when additional analyses are automated further. In addition, the 
Matlab® based program makes analysis more flexible and allows the implementation of new 
variables in the future. This new time-sparing method is the first step in fully automating the 
process  and  assessment  of  capillary  domains.  Future  research  should  focus  on  fully 
automating the sampling of capillary and fiber outline coordinates. 
5 Conclusion
In conclusion, the new semi-automated Matlab® based method is highly comparable to 
the standard method of capillary domain analysis when considering indices of overall muscle 
capillarization. However, due to differences in the way of tracing the fiber outlines there are 
small difference in FCSA, which also affect indices of capillary supply to individual fibers. 
Together,  this  new method  appears  to  be  a  valid  way to  qualitatively  and  quantitatively 
analyze the capillarization in cardiac and skeletal muscle. 
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Abstract 
Background: We hypothesise that the attenuated hypertrophic response in old mouse muscle 
1. is partly due to a reduced capillarisation and angiogenesis, which is 2. accompanied with a 
reduced oxidative capacity and fatigue resistance in old control and overloaded muscles, that 
3. can be rescued by the anti-inflammatory anti-oxidant resveratrol.
Methods: To investigate  this,  the hypertrophic response,  capillarisation,  oxidative capacity 
and fatigue resistance of m. plantaris were compared in 9- and 25-month-old non-treated and 
25-month-old resveratrol-treated mice. 
Results: Capillarisation was not significantly affected by age. Overload increased the local 
capillary  to  fibre  ratio  more  in  adult  than  old  muscle  (P<0.05),  indicating  attenuated 
angiogenesis  in  old  muscles.  Although  muscles  of  old  mice  had  a  higher  succinate 
dehydrogenase (SDH) activity (P<0.05) and a slower fibre type profile (P<0.05), the isometric 
fatigue resistance was similar in 9- and 25-month-old mice. In both age groups, the fatigue 
resistance was increased to  the same extent  after  overload (P<0.01),  without  a significant 
change  in  SDH activity,  but  an  increased  capillary density.  Interestingly,  integrated  SDH 
activity for a given fibre size was higher in overloaded than control muscles.  Resveratrol 
supplementation  had  no  significant  effect  on  hypertrophy,  capillarisation,  or  fatigue 
resistance. 
Conclusion: Attenuated  angiogenesis  during  overload  may  contribute  to  the  attenuated 
hypertrophic  response  in  old  age.  Neither  was  rescued  by  resveratrol  supplementation. 
Changes in fatigue resistance with overload and ageing were dissociated from changes in 
SDH activity, but paralleled those in capillarisation. This suggests that capillarisation plays a 
more important role in fatigue resistance than oxidative capacity.
1. Introduction
Ageing is  accompanied  by a  progressive  decline  in  muscle  mass  (sarcopenia)  and 
power (Roseberg, 1989). These changes not only result in a decreased peak performance, but 
also in a reduced maximal sustainable power of the muscles as a larger proportion of the 
available muscle mass has to be recruited for a given task. The latter can be aggravated by a 
reduced aerobic capacity to generate ATP. Together, these changes will ultimately limit the 
ability to perform daily life activities and reduce the quality of life (Maden-Wilkinson et al., 
2014a; Paterson et al., 2007).
During ageing, maximal whole-body oxygen consumption (VO2max) is reduced (Fleg 
and Lakatta, 1988), even when corrected for lean leg muscle mass (Fitts et al., 1984), indeed 
suggesting that the oxidative metabolism is impaired in old muscle. Such a situation can occur 
due to a lower oxidative enzyme activity and/or a diminished muscle capillarisation, which 
both  have  been  observed  in  aged  humans  (Konopka  et  al.,  2014)  (Coggan  et  al.,  1992; 
Degens, 1998; Hepple et al., 1997) and rats (Degens et al., 1993b; Skorjanc et al., 2001).
It  is  equivocal  whether  muscle  fatigue  resistance  decreases  with  age.  Fatigue 
resistance has been reported to be increased, unaltered or decreased in old age, depending on 
the protocol used to induce fatigue (Avin and Law, 2011; Callahan and Kent-Braun, 2011; 
McPhee et al., 2014). Fatigue elicited by intermittent isometric contractions is related to the 
oxidative capacity of single muscle fibres and motor units (Degens and Veerkamp, 1994). 
Since aerobic metabolism requires an adequate supply of oxygen via the capillaries, it is likely 
that  fatigue induced by such protocols is  also related to  the capillarisation of  the muscle 
(Hudlicka et al., 1977). Thus major determinants of the fatigue resistance are, besides muscle 
mass (Fleg and Lakatta, 1988), the oxidative capacity (Layec et al.,  2013; Marzetti et al.,  
2013)  and  capillarisation.  But  how changes  in  aerobic  capacity  and capillarisation  affect 
intermittent isometric fatigue resistance during ageing and overload are not well understood. 
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For a muscle fibre to make use of its oxidative capacity, an adequate capillary network 
is required to supply the muscle fibre with oxygen. In human m. vastus lateralis the number 
of capillaries per fibre has been reported to be strongly correlated with the oxidative capacity 
of the fibre (Bekedam et al., 2003). The higher capillary density in oxidative than in more 
glycolytic regions of a given muscle illustrates that this relationship also applies to capillary 
supply of a muscle region (Degens et al., 1992). Several studies indicate that the capillary 
supply to a muscle fibre is positively related to cross-sectional area in both control (Ahmed et 
al., 1997; Wust et al., 2009a) and overloaded, hypertrophic muscle (Degens et al., 1994). This 
relationship is tightly regulated as reflected by the similar time course of fibre hypertrophy 
and capillary proliferation in a rat model of compensatory hypertrophy (Egginton et al., 2011; 
Plyley et al.,  1998). This suggest that a reduction in muscle capillarisation during ageing, 
which would increase the diffusion distance for oxygen and limit  the oxygenation of the 
muscle (Degens, 2012; van der Laarse et al., 2005), may partly be responsible for the age-
related  impaired  hypertrophic  response  in  aged  muscle  (Ballak  et  al.,  2015;  Degens  and 
Alway, 2003).
Muscle fibre size and oxidative metabolism are inversely related (van der Laarse et al., 
1998;  van  Wessel  et  al.,  2010),  which  suggests  that  muscle  fibre  size  and  oxidative 
metabolism  are  under  coordinated  control.  The  coordinated  control  would  be  reflected 
according  to  this  relationship  by  a  decrease  in  aerobic  capacity  during  muscle  (fibre) 
hypertrophy.  However,  how  this  relationship  is  affected  by  ageing  and  hypertrophy  is 
unknown.
If a reduced angiogenic response and impaired mitochondrial function contribute to 
the attenuated muscle function and hypertrophic response, agents that improve angiogenesis 
and mitochondrial function may rescue muscle function and the hypertrophic response in old 
age. Resveratrol (3,5,4’-trihydroxystilbene), a polyphenol with anti-inflammatory properties 
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(Jackson et al., 2011; Ryan et al., 2010) may be such an agent. Resveratrol has been shown to 
enhance expression of PGC-1α, improve mitochondrial function in mouse muscle (Jackson et 
al.,  2011)  and to  increase  expression  of  the  mitogenic  vascular  endothelial  growth factor 
(VEGF) and its receptor Flk-1 (Fukuda et al., 2006), even in old rodents (Leick et al., 2009; 
Murase et al., 2009). These properties of resveratrol may rescue the hypertrophic response in 
old muscle.
The  objectives  of  this  study were  to  assess  (1)  whether  the  blunted  muscle  fibre 
hypertrophy is  associated with attenuated angiogenesis,  (2) how muscle fatigue resistance 
changes with age and overload and how this is related to changes in mitochondrial content 
and/or  capillarisation  and  (3)  whether  resveratrol  improved  the  oxidative  capacity  and 
capillarisation in 25-month-old mice and rescued the hypertrophic response. To investigate the 
effects of ageing on the hypertrophic response, capillarisation, aerobic capacity and fatigue 
resistance in m. plantaris we used 9- and 25-month-old and 25-month-old resveratrol-treated 
mice. 
2. Methods
2.1 Animals 
At the terminal experiment, adult (Adult; n = 11) and old (Old: n = 10) male C57BL/6J 
mice (Janvier, France) were 9 and 25 months old, respectively. Mice were kept under specific-
pathogen-free  conditions  and housed individually at  20-22  ⁰C at  a  12-h  light/dark  cycle. 
Animals were given free access to water and chow (Ssniff® S8189-S095, the same as provided 
at the supplier). Another group of old mice (old-res) received 0.4 % resveratrol (98.6 % pure, 
Polygonum cuspidatum extract; 21st Century Alternative, UK) in the chow. At the age of 7.5 
or 23.5 months, the m. gastrocnemius and m. soleus of the left leg were denervated to impose 
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an overload onto the m. plantaris for six weeks as described previously (Ballak et al., 2015; 
Degens and Alway, 2003). The right leg served as internal control.
All experiments were approved by the local animal use and care committee of the VU 
University Amsterdam and conformed to the Dutch Research Council’s guide for care and use 
of laboratory animals. 
2.2 Preparation for in situ muscle function
Fifteen minutes prior to surgery, mice received a subcutaneous injection of 0.06 mL 1 
% Temgesic  (Reckitt  Benckiser,  UK)  as  an  analgesic  and  were  anaesthetized  with  4  % 
isoflurane,  0.1 L·min-1 O2 and 0.2 L·min-1 air.  After nociceptive responses had ceased, the 
level of anaesthesia was maintained with 1.5-2.5 % isoflurane. A humidifier moistened the 
inhaled air to prevent dehydration due to respiration. The mice were placed on a heated pad to 
maintain body temperature at ~36.5 C. ⁰
All experiments were performed as described previously (Ballak et al., 2014a; Degens 
and  Alway,  2003).  The  m.  plantaris was  dissected  free  from  surrounding  tissue  while 
maintaining its innervation and blood supply. The sciatic nerve was severed and the proximal 
end was placed over an electrode for stimulation of the muscle. The distal tendon of the m. 
plantaris was dissected free and tightened with a Kevlar thread via a small steel bar to a force  
transducer, which was mounted on the lever arm of an isovelocity measuring system (de Haan 
et  al.,  1989).  The femur  was fixed by a  clamp on the  condyle  of  the femur.  During the 
experiment, the muscle and its surrounding were kept moist at physiological temperature (34-
36 ⁰C) with a water-saturated airflow. 
2.3 Experimental setup and fatigue measurements 
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The experimental procedures have been described previously (Ballak et al., 2014a).  
Contractile  properties  were  determined  of  both  the  overloaded  and  contralateral  control 
muscle.  The  order  of  the  experiments  was  randomised.  Contractions  were  elicited  by 
supramaximal electrical stimulation of the sciatic nerve at a constant current (2 mA; 200 µs 
pulse width). Optimal length (o) was defined as the muscle length where maximal tetanic 
isometric force was generated. To set o, the length at which the muscle produced maximal 
twitch force was determined. To fine adjust  o, tetani (stimulation frequency: 150 Hz, 150 
ms) were applied once every 2 min. We adjusted the stimulation frequency for the fatigue test 
so that the force was ~40 % of the maximal isometric force (test modified for mice from 
(Degens and Alway,  2003)).  This fatigue test  consisted of 330-ms stimulation trains once 
every 2 sec at the pre-determined frequency, for 4 minutes. Potentiation was calculated as 
Fmax/F1·100, where Fmax is the maximal force during the protocol and F1 is the tetanic force 
during the first contraction. The fatigue index (FI) was calculated as the F120/1, but to correct 
for the effect of the potentiation we also calculated the F120/max, where F120 is the force of the 
last contraction. 
2.4 Histology
The  m. plantaris was embedded at  oin gelatin-tyrode (NaCl, 128.3 mM; KCl, 4.7 
mM; MCl2, 1.05 mM; NaH2PO4, 0.42 mM; NaHCO3, 20.2 mM; EGTA, 15.0 mM; Gelatin 15 
% (w/v), pH 7.2) solution and frozen in liquid nitrogen. Subsequently, the m. soleus and m. 
gastrocnemius medialis were excised from the hind limbs and weighed. Within a month after 
the contraction protocol, serial cross-sections (10 µm) were cut from the mid-belly of the m. 
plantaris in  a  cryostat  at  -20 ºC.  Sections  were mounted  on glass  slides  (Menzel-Gläser, 
superfrost®  plus, GER), air-dried and stored at -80 ºC until further use. All chemicals were 
obtained from Sigma Aldrich (The Netherlands) unless stated otherwise.
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One section was stained for succinate dehydrogenase (SDH), a marker of oxidative 
capacity, according to the protocol described previously (van der Laarse et al., 1989). SDH 
activity was calculated as the absorbance at 660 nm per µm section thickness per second of 
staining time (ΔA660·µm-1·s-1). The integrated SDH was calculated as the product of muscle 
fibre CSA and SDH activity.
Capillaries  were  depicted  by  staining  sections  with  biotinylated  lectin  (Griffonia 
simplicifolia). Sections were fixed in ice-cold acetone for 15 min and washed with HEPES-
buffer (HEPES, 5 mM; NaCl, 74.9 mM; CaCl2, 0.1 mM, pH 7.5) for 5 min. After blocking 
with 0.1 % bovine serum albumin (BSA) in HEPES for 60 min the sections were washed with 
HEPES again and incubated with hydrogen peroxide for 30 min. Subsequently, sections were 
washed with HEPES for 5 min, incubated with lectin for an hour (Vector Laboratories, UK) 
and washed three times with HEPES for 5 min. After incubation with VIB substrate (Vector 
Laboratories, UK), sections were washed with dH2O for 5 min before enclosing with glycerin-
gelatin. 
Serial sections of  m. plantaris were immunohistochemically stained for type I, IIA, 
IIX and IIB MHC to distinguish muscle fibre types as described previously (Ballak et al.,  
2014a).  Thereto,  monoclonal  antibodies  specific  against  type  I,  IIA,  IIX,  IIB were  used; 
BAD5,  SC-71,  6H1  and  BF-F3  (Developmental  Studies  Hybridoma  Bank,  USA), 
respectively. In short, sections were fixated with acetone for 10 min at 4  ºC and washed in 
phosphate-buffered saline (PBS) plus tween (PBST) three times for 5 min. After blocking 
with  10  %  normal  swine  serum  for  30  min,  sections  were  incubated  with  the  primary 
antibody. Subsequently, sections were washed in PBST three times for 3 min and incubated in 
the dark with secondary antibody (Alexa 488 anti-mouse, Molecular Probes) for 30 min. After 
washing with PBST, incubating with wheat germ agglutinin (WGA) for 20 min, washing with 
PBST and  subsequently  washing  once  more  with  PBS -  all  in  the  dark  -  sections  were 
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enclosed  with  Vectashield®-hardset  mounting  medium  with  DAPI  (Vector  Laboratories, 
USA). 
2.4.1 Morphometric analysis
The method of capillary domains has been used and described previously to analyse 
muscle capillarisation,  fibre type composition and relationship between capillarisation and 
SDH activity (Degens et al., 1992; Hoofd et al., 1985; Wust et al., 2009a). Recently, a semi-
automatic domain method has been developed and validated (Ballak et al., 2014c), based on 
the calculations in AnaTis (BaLoH Software, www.baloh.nl). This method has been shown to 
reliably assess muscle oxygenation (Al-Shammari et al., 2014). Briefly, coordinates of fibre 
outlines  and  capillaries  were  traced  and  stored.  Capillary  domains  were  constructed  by 
applying Voronoi tessellations, which create equidistant boundaries around the coordinates of 
each  capillary.  The  fibre  cross-sectional  area  (FCSA)  and  capillary  domain  sizes  were 
calculated. Besides the usual indices of capillary density (CD; cap·mm-2) and capillary to fibre 
ratio (C:F), the method allows the calculation of the capillary supply to individual fibres, even 
those lacking direct capillary contacts. The capillary supply to a fibre was expressed as the 
local capillary to fibre ratio (LCFR; sum of the fractions of the capillary domains overlapping 
a given fibre), domains around fibre (DAF; number of domains overlapping a given fibre) and 
the  capillary fibre  density  (CFD; LCFR divided by the  FCSA of  a  particular  fibre).  The 
logarithmic standard deviation of the radius of the capillary domains provides an index of the 
heterogeneity of capillary spacing (LogrSD). This analysis was performed for the glycolytic 
and oxidative regions of the muscle separately.
2.4.2 Western blot 
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Frozen muscle tissue (~5-10 mg) was homogenised with a Polytron mixer in ice-cold 
buffer (1:40, w/v) [50 mM Tris-HCl pH 7.0, 270 mM sucrose, 5 mM EGTA, 1 mM EDTA, 1 
mM sodium orthovanadate, 50 mM glycerophosphate, 5 mM sodium pyrophosphate, 50 mM 
sodium fluoride,  1 mM DTT, 0.1 % Triton-X 100] supplemented with a phosphatase and 
protease inhibitor tablet (Roche Applied Science, Vilvoorde, Belgium). Homogenates were 
then  centrifuged  at  10,000  g  for  10  min  at  4  °C.  The  supernatant  was  collected  and 
immediately stored at -80 °C. The protein concentration was measured using the DC protein 
assay kid (Bio-Rad laboratories, Nazareth, Belgium). Forty µg of protein was separated by 
SDS-PAGE (10-12 % gels) and transferred to PVDF membranes. Subsequently, membranes 
were blocked with 5 % non-fat milk for 1 h and then incubated overnight (4 °C) with the 
following  antibodies:  SDH (1:10,000,  Santa  Cruz,  UK),  cytochrome c  oxidase  subunit  4 
(COX-4) (1:1,000, Abcam, Cambridge, UK), Flk-1 (1:500, Santa Cruz, UK) and eukaryotic 
elongation factor 2 (eEF2) (1:1,000, Cell Signaling Technology, Leiden, The Netherlands). 
Horseradish peroxidase-conjugated anti-mouse (1:10,000) or anti-rabbit (1:5,000) secondary 
antibodies (Sigma-Aldrich, Bornem, Belgium) were used for chemiluminescent detection of 
proteins.  Membranes were scanned and quantified with Genetools and Genesnap software 
(Syngene, Cambridge, UK), respectively. eEF2 was used as a loading control as preliminary 
experiments  showed  that  eEF2  content  was  stable  across  the  different  treatments  and 
conditions.  The results  are  presented  as  the ratio  protein  of  interest/eukaryotic  elongation 
factor 2 (eEF2). 
Table  6.1.  Muscle  mass,  maximal  isometric  force,  potentiation  and  fatigue  resistance  in  
control and overloaded m. plantaris of adult, old and old-res mice.
Adult mice (n=7)
Con       vs.        Ovl
Old mice (n=10)
Con       vs.        Ovl
Old-res mice (n=10)
Con       vs.        Ovl
Muscle mass (mg) 24.2±0.7 32.1±1.2* 22.4±0.7a 28.1±1.1* 23.8±0.8 29.8±0.9*
Max force (mN) 497±34 663±50* 470±22 579±36* 529±30 557±39*
Potentiation (%) 31.5±5.6 29.2±6.8 47.8±6.8 35.4±3.9 51.3±4.3 19.3±6.1*/
FI120/1 49.9±1.0 66.2±4.9* 51.6±8.2 70.0±5.6* 58.0±3.8 64.3±5.2*
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FI120/max 38.3±1.4 51.8±4.4* 34.2±5.1 52.5±5.5* 38.4±2.5 54.3±4.6*
Muscle mass was reported previously (Ballak et al., 2015), Max force: the maximal achieved  
force  during  the  fatigue  protocol.  FI120/1:  Fatigue  index  for  ~40%  of  tetanic  force  (not  
reported here), dividing the force of the 120th contraction by the first. FI120/max: Fatigue index 
for ~40% of tetanic force (not reported here), dividing the force of the 120th contraction by the  
maximal achieved force during the fatigue protocol. *: different from control condition at  
P<0.05,  a: different from adult at P<0.05,  o: Overload * Resveratrol interaction at P<0.05.  
Values are mean±SEM
2.5 Statistics 
To test for differences between age and treatment groups we used a univariate ANOVA 
with  factors  1)  age,  muscle  region  and  overload,  or  2)  resveratrol,  muscle  region  and 
overload. The  factor  ‘muscle  fibre  type’ was  also  added  where  applicable.  Effects  were 
considered significant at P<0.05. Data are expressed as means ± standard error of the mean 
(SEM). All calculations were performed using IBM SPSS version 20. 
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Figure  6.1.  Effects  of  age,  overload  and  resveratrol  on  in  situ  plantaris  muscle  fatigue  
resistance.  Plantaris  force  (% of  the  force  during  the  first  contraction)  is  expressed  as  
contraction number percentage of first contraction in the m. plantaris for adult (circle), old  
(triangle)  and  old-res  (square)  mice  in  both  control  (black)  and  overloaded  (white)  
conditions. 
3. Results
3.1 Effects of age, overload and resveratrol on fatigue resistance and potentiation
Table 6.1 shows that overload resulted in an increase in muscle mass and maximal 
tetanic  force  in  both  adult  and  old  mice  (P<0.05)  (Ballak  et  al.,  2014a).  Resveratrol 
supplementation did not significantly affect muscle mass or the maximal tetanic force.
Figure 6.1 shows tetanic force normalised for the tetanic force of the first contraction 
during the fatigue test. The potentiation during the fatigue protocol was similar in adult and 
old  muscles.  Overload did not  significantly alter  the  potentiation  in  adult  or  old  muscle. 
Resveratrol  reduced  potentiation  in  overloaded  muscle  only  (Resveratrol*Overload 
interaction P<0.05; Table 6.1).
After the initial potentiation, the force of all control muscles dropped rapidly to ~50 % 
of the initial value at the end of the test. There was no significant difference in the fatigue 
resistance between adult and old control muscles. In both adult and old overloaded muscles, 
fatigue resistance was improved compared to control muscles; the forces at the end of the 
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protocol were 65-70 % of the initial values (Table 6.1; Fig. 6.1; P<0.05). Resveratrol did not 
significantly affect fatigue resistance. 
Figure 6.2. Effects of age, overload and resveratrol on m. plantaris FCSA. FCSA was smaller  
in old compared to adult muscle (a; P<0.05), bigger in old-res than old muscle (o; P<0.05) 
and increased after overload in adult and old (*; P<0.01), but not in old-res muscle. Values  
are mean±SEM.
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Table 6.2. Effects of age, overload and resveratrol supplementation on muscle fibre type area  
and fibre cross-sectional area.
FCSA (µm2) Fibre type area % 
ConG ConO OvlG OvlO ConG ConO OvlG OvlO
Adult IIA 458±59 642±37g 894±123* 1046±42*/g 7.1±3.4 21.0±1.4g 9.3±3.0 30.9±3.3g
IIA
X
503±64 839±83g 1066±188* 1260±49*/g 3.0±3.2 5.6±2.0 11.3±1.7* 17.1±1.9*
IIX 1023±123 1284±65g 1616±196* 1883±125*/g 19.0±7.4 29.8±2.7 38.4±5.8* 36.4±4.0
IIX
B
1234±400 1284±334 1770±172* 1875±72*/g 0.9±1.2 2.3±1.5 9.4±3.9* 2.6±0.9
IIB 1790±185 1785±71 2361±221* 1868±173* 70.0±15.
2
41.3±2.7g 31.7±9.2* 9.7±3.5g/*
Old IIA 504±49 840±70g 654±98a 918±146g 11.2±2.2 34.1±5.6 7.0±1.7 34.5±6.5
IIA
X
535±86 1064±193g 592±83a 985±106g 1.8±0.1 2.9±1.2a 2.7±1.2a 7.5±2.8*/a
IIX 864±80a 1408±179g 1086±102a 1355±206g/a 25.8±1.0 36.0±3.2 27.2±3.7* 34.1±3.4
IIX
B
585±190a 1398±379g 1168±186*/a 1543±107*/g 1.6±0.5 2.5±0.8 3.0±1.0*/a 4.6±2.0
IIB 1446±201a 1929±263 1726±130a 1676±144 60.4±1.7a 24.6±6.2 60.1±6.0*/a 20.2±5.8
Resveratr
ol
IIA 509±62 757±86g 873±126*/o 986±117g/* 4.3±2.4o 24.1±3.2o/g 6.0±1.6 36.8±3.6g
IIA
X
772±92o 831±129g 986±132o 1116±202g 1.6±0.7 3.5±0.9 5.7±1.4* 9.9±3.0*
IIX 1270±112o 1557±153g 1608±80*/o 1686±134g 19.8±2.7 34.1±4.6 34.1±5.0 31.9±1.8
IIX
B
1547±249o 1498±288 1469±84o 1227±253 2.9±1.1o 3.5±1.7 10.8±4.9*/o 3.6±1.9
IIB 1776±137o 1970±152 2115±188o 1866±183 71.4±5.4o 34.9±6.0g 43.5±11.5 16.4±4.5g
Glycolytic (ConG) and oxidative (ConO) regions of the m. plantaris in control condition were  
separated for analysis of FCSA and fibre type area %. The same was done for glycolytic  
(OvlG)  and  oxidative  (OvlO)  regions  in  overloaded  condition.  a significantly  different  
compared to  adult  muscle  (P<0.05),  *  significantly  different  compared to  control  muscle  
(P<0.05),  o significantly  different  from old  muscle  (P<0.05),  t significantly  different  from 
other fibre types and g significantly different from glycolytic region. Values are mean±SEM.
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3.2  Effects  of  age,  overload  and  resveratrol  on  muscle  fibre  size  and  muscle  fibre  type  
composition
For all three groups, FCSA was larger for fast (i.e. IIB and IIX) than for slow fibres 
(IIA) and in the oxidative region of the m. plantaris FCSA for all fibres, expect of IIB, was 
larger than in the glycolytic part (Table 6.2; P<0.01). The FCSA was lower in old than adult  
muscle, but increased by overload in both groups (Fig. 6.2; P<0.05). In type IIA, IIAX and 
IIX fibres, overload increased the FCSA in both adult and old muscle (P<0.01), but more so in 
adult than old muscle (Age*Overload P<0.01; Table 6.2). Resveratrol increased the CSA in 
both old control and old overloaded pooled (Fig. 6.2; P<0.05) and IIAX, IIX, IIXB and IIB 
fibres  (Table  6.2;  P<0.05).  There  was  no  significant  Resveratrol*Overload  interaction, 
indicating that resveratrol attenuated or reversed the age-related atrophy, but did not enhance 
the hypertrophic response. 
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Figure 6.3. SDH activity and integrated SDH activity per fibre type for adult, old and old-res  
muscle. SDH activity for adult, old and old-res muscle in control and overloaded condition  
for type A, X and B fibres in the oxidative (A) and glycolytic (B) region of the muscle. (C)  
Mean SDH for adult, old and old-res mice in both control (black) and overloaded (white)  
conditions. SDH activity in old muscle was higher than in adult muscle (a; P<0.05). SDH 
activity  was  higher  in  old  compared  to  adult  muscle  for  all  three  fibre  types  (P<0.05).  
Furthermore, the SDH activity in IIB of the glycolytic region of the muscle was lower than of  
type IIB fibres in the oxidative region (g; P<0.05). Resveratrol did only increase SDH activity  
in type IIB fibres of the glycolytic region of the muscle (P<0.05). SDH activity was lower in  
type IIB compared to  IIX fibres  (χ;  P<0.01) and lower in  IIX compared to  IIA fibres  (α;  
P<0.01). Integrated SDH activity for adult, old and old-res muscle in control and overloaded  
condition for type A, X and B fibres in the oxidative region (D) and glycolytic (E) region of  
the muscle. (F) Mean integrated SDH for adult, old and old-res mice in both control (black)  
and overloaded (white) conditions. Integrated SDH activity increased after overload for all  
three fibre types (P<0.01). Old muscle showed a higher integrated SDH activity in type IIA  
fibres, compared to adult (P<0.01). Type IIX fibres had a lower integrated SDH activity in the  
glycolytic region, compared to the oxidative region (P<0.01). Data shown are mean±SEM.
Age did not significantly affect the percentage area covered by each fibre type.  In 
adult mice, overload did result in an increased proportion of the muscle area covered by IIA, 
IIAX, IIX and IIXB at  the expense of that  covered by IIB fibres,  but  not in  old muscle 
(Age*Overload  P<0.05;  Table  6.2).  Resveratrol  supplementation  resulted  in  a  larger  area 
occupied by IIB fibres (P<0.05), which was obliterated after overload (Resveratrol*Overload 
P<0.05). 
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3.3 Effects of age, overload and resveratrol on SDH activity 
Type IIB fibres had the lowest and type IIA the highest SDH activity, with that of type 
IIX fibres in between (Figs. 6.3A and B; P<0.01). Furthermore, SDH activity in IIB fibres in 
the glycolytic region was lower than that in the oxidative region of the muscle (Figs. 6.3A and 
B;  P<0.05).  The  SDH activity  was  20  % higher  in  old  than  in  adult  muscle  (Fig  6.3C; 
P<0.05),  suggesting  a  higher  oxidative  capacity  in  aged  muscle.  Overload  did  not 
significantly affect the SDH activity (P>0.05), while resveratrol increased the SDH activity in 
type IIB fibres of the glycolytic region only (Fig. 6.3B; P<0.05). 
Figure 6.4. Flk-1, SDH and COX-4 protein expression in adult, old and old-res muscle. (A)  
SDH protein expression was similar in adult and old muscle, while COX-4 protein expression  
was decreased in old muscle (a; P<0.05). The SDH/COX-4 ratio (B) was not significantly  
different in aged muscle. (C) Flk-1 protein expression in m. plantaris, an important receptor  
for VEGF, was decreased in old compared to adult muscle (a; P<0.05), but not affected by  
overload or  resveratrol.  The results  are presented as  the ratio  protein of  interest/loading  
control (eEF2).Values are mean±SEM.
Figure 6.5. Effects of age, overload and resveratrol on CD, C:F and LogrSD.  (A) CD was  
unaffected  by  age,  however  increased  by  overload  (P<0.01).  Resveratrol  blunted  the  
overload-induced  increase  in  CD,  but  only  in  the  glycolytic  region  of  the  muscle  
(Resveratrol*Overload P<0.05). (B) C:F was increased by overload (P<0.01), but unaffected  
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by  age  or  resveratrol.  Both  CD and C:F were  higher  in  the  oxidative  region of  the  m.  
plantaris  compared to the glycolytic  region. (C) LogrSD for adult,  old and old-res control  
(black) and overloaded (white) muscle in the oxidative and glycolytic muscle regions. Log rSD 
was  higher  in  the  glycolytic  than  in  the  oxidative  region  of  the  m.  plantaris  muscle  (g;  
P<0.01), but not affected by age. Overload reduced LogrSD (*; P<0.01), while resveratrol did  
not affect the LogrSD (P>0.05). Values are mean±SEM. 
Type IIB fibres showed a significantly lower integrated SDH activity than IIX fibres 
(P<0.01), while the integrated SDH activity of IIA fibres was comparable with that of IIX 
fibres (P>0.05). Type IIX fibres in the glycolytic region had a lower integrated SDH activity 
than those in the oxidative region of the muscle (P<0.01). A further analysis per fibre type 
showed that  the  integrated  SDH activity for  type  IIA fibres  was  lower  in  adult  than  old 
muscles (Figs. 6.3D and E; P<0.01). Overload increased the integrated SDH in all groups in 
all three muscle fibre types (P<0.01). The increase in integrated SDH activity, but not in SDH 
activity, suggests that mitochondrial biogenesis and fibre hypertrophy during overload were 
proportional. Resveratrol did not significantly affect the integrated SDH activity (Figs. 6.3D 
and E). 
In  contrast  to  the  elevated  SDH activity  western  blot  analyses  revealed  that  SDH 
protein expression was not significantly affected by age (Fig. 6.4A). This suggests that the 
specific activity of the SDH complex was increased by age. COX-4 protein expression did 
decrease with age (Fig. 6.4A; P<0.05). Despite the lower COX-4 expression, the SDH/COX-4 
ratio was not significantly altered by age (Fig. 6.4B; P>0.05). 
3.4 Muscle capillarisation and angiogenesis
Both CD and C:F were significantly higher  in the oxidative region of the muscle, 
compared to  the glycolytic  (P<0.01;  Figs 6.5A and B).  CD was not  affected by age,  but 
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increased by overload (P<0.01). Resveratrol did not affect CD, however in resveratrol-treated 
muscle overload only increased CD in the oxidative region (Resveratrol*Overload P<0.05; 
Fig 6.5A). C:F was unaffected by age, but increased by overload (P<0.01; Fig 6.5B). This 
increase  was  higher  for  adult  than  for  old  muscle  (Age*Overload  P<0.05).  Resveratrol, 
however, did not affect C:F. LogrSD was higher in the glycolytic than in the oxidative region of 
the m. plantaris muscle (P<0.01), indicating a larger heterogeneity in capillary spacing in the 
glycolytic than in the oxidative region of the muscle. LogrSD was not significantly affected by 
age (Fig. 6.5). Overload reduced LogrSD indicating a more homogeneous distribution of the 
capillaries (P<0.01), while resveratrol did not significantly affect LogrSD (P>0.05). 
Figure 6.6. Effects of age, overload, muscle area and resveratrol supplementation on local  
capillary to fibre ratio and capillary fibre density. LCFR for adult control (black), overloaded  
(white), old control (dashed) and overloaded (striped) muscle for type A, X and B fibres in the  
oxidative (A) and glycolytic (B) region of the muscle. LCFR activity for old control (black),  
overloaded (white), old-res control (dashed) and overloaded (striped) muscle for type A, X  
and B fibres in the oxidative (C) and glycolytic (D) region of the muscle. Overload increased  
the LCFR in all fibres types in both regions (P<0.05), except for oxidative type IIB fibres  
(P>0.05). An interaction effect (Age*Overload) showed that the increase in LFCR was larger  
for adult than for old muscle (P<0.05). Resveratrol did not affect the LCFR (P>0.05). For  
both old and old-res muscle the LCFR was higher in the oxidative, compared to the glycolytic  
part (P<0.01). CFD (mm-2) for adult control (black), overloaded (white), old control (dashed)  
and overloaded (striped) muscle for type A, X and B fibres in the oxidative (E) and glycolytic  
(F) region of the muscle.  CFD (mm-2) for old control (black), overloaded (white),  old-res  
control (dashed) and overloaded (striped) muscle for type A, X and B fibres in the oxidative  
(G) and glycolytic (H) region of the muscle. CFD showed an Age*Overload interaction for  
type IIAX and IIX fibres, only in the glycolytic region (P<0.05). Resveratrol decreased the  
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CFD for IIAX, X and B fibres in the glycolytic region of the muscle (P<0.05). For type AX  
fibres overload increased the CFD in both old and old-res muscle (P<0.05). Furthermore, in  
IIX  and  IIB  fibres  CFD  was  lower  in  the  glycolytic,  compared  to  the  oxidative  region  
(P<0.01). Data shown are mean±SEM.
For all groups LCFR was higher in the oxidative than in the glycolytic region (Fig 6.6; 
P<0.01). LCFR of all  muscle fibre types was not significantly affected by age.  However, 
overload increased LCFR in fibres of all types (Figs. 6.6A and B; P<0.05), except that of type 
IIB  fibres in the oxidative region (Fig.  6.6A). The overload-related increase in LCFR was 
higher for adult than old muscle (Age*Overload; P<0.05), indicating attenuated angiogenesis 
in old overloaded muscles. Resveratrol did not affect LCFR (Figs. 6.6C and D). 
In  both  old  and  old-res,  but  not  adult  muscle,  CFD  was  lower  in  the  glycolytic 
compared to the oxidative region of the muscle for type IIX and IIB fibres (Figs. 6.6E-F; 
P<0.01). In most cases, the CFD was not significantly affected by age or overload (Figs. 6.6E 
and F), but there was a significant Age*Overload interaction (P<0.05) for type IIAX and IIX 
fibres, reflected by a decrease in CFD in old, but not adult, plantaris muscle after overload. 
Resveratrol  decreased  CFD  of  IIAX  fibres  in  the  glycolytic  region  of  the  muscle 
(Resveratrol*Region interaction: P<0.05).
Flk-1 protein expression, a receptor for vascular endothelial growth factor (VEGF), 
was decreased by age (Fig. 6.4C; P<0.05), but unaffected by overload and resveratrol.
3.5 Overload affects inverse relationship between SDH and FCSA 
Figure  6.7  shows values  for  SDH activity of  the  pooled  fibres  of  each  individual 
muscle  expressed  as  a  function  of  FCSA.  For  both  adult  and  old  there  is  an  inverse 
relationship between SDH activity and FCSA (R2 = 0.74 and R2 = 0.67, respectively, both 
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P<0.01). Overload induced a right-ward shift of the fitted hyperbola, compared to the control 
muscle.
The LCFR of adult  and old muscle correlated strongly with the FCSA (R2  = 0.52, 
P<0.05), but not with the integrated SDH-activity (R2 = 0.07, P>0.05). Suggesting that the 
capillary supply to a fibre is more related to the size of the fibre than its oxidative capacity.
Figure 6.7. SDH activity and FCSA are inversely related. The figure shows the relationship  
between mean SDH activity per muscle and FCSA for adult and old muscles. Overload affects  
this relationship by inducing a right-ward shift (R2=0.74; P<0.01), compared to the control  
(R2=0.67; P<0.01). The black line represents the best fit hyperbola. Values are mean±SEM.
4. Discussion
Here we investigated whether sarcopenia and the blunted hypertrophic response in old 
mouse muscle 1.  are  partly due to a  reduced capillarisation and angiogenesis,  that  are  2. 
accompanied  with  a  reduced oxidative  capacity  and fatigue  resistance  in  old  control  and 
overloaded muscles, that 3. can be rescued by the anti-inflammatory anti-oxidant resveratrol. 
The main observations were that both overload-induced hypertrophy and angiogenesis of the 
m. plantaris were attenuated in old mice. Despite the diminished angiogenic response and the 
unaltered aerobic capacity, the fatigue resistance was increased to a similar extent in adult and 
old m. plantaris of C57BL/6J mice after 6 weeks overload. Interestingly, the aerobic capacity 
and  size  of  the  muscle  fibres  showed  a  proportional  increase  after  overload.  This  was 
unexpected as the inverse relationship between fibre size and oxidative capacity (van der 
Laarse et al., 1998) suggests that oxygen diffusion limitations may impose a size constraint on 
muscle  fibres.  It  is  possible  that  the  more  homogeneous  distribution  of  capillaries  in  the 
overloaded muscles improves muscle oxygenation (Degens et al., 1994; Goldman et al., 2006; 
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Turek  et  al.,  1989)  and  makes  such  an  adaptation  possible  in  vivo.  While  resveratrol 
supplementation  did  rescue  some of  the  age-related  atrophy,  it  did  not  affect  the  fatigue 
resistance or rescue the angiogenic and hypertrophic response in old age. It is thus possible 
that impaired angiogenesis contributes to the attenuated hypertrophic response in old age, 
which cannot be rescued by resveratrol.
4.1.1 Age-related changes in muscle capillarisation and oxidative capacity
An adequate capillarisation is vital for muscle function and any impairment in oxygen 
delivery could have major implications for fatigue resistance. It has been observed in Wistar 
rats that the capillary supply to fibres is reduced in old age (Degens et al., 1993b), suggesting 
an age-related capillary rarefaction. This is, however, not shown in the present study, where 
the capillary density and capillary to  fibre  ratio  were  similar  in  adult  and old mouse  m. 
plantaris.  The discrepancy maybe related to the different species, but suggests that in 25-
month-old mice, the capillary bed is not yet affected by age. Nevertheless, in the current study 
we did find a reduced Flk-1 expression in old muscle, similar to a previous study in mice 
(Wagatsuma, 2006), indicative of a reduction in angiogenic signalling in old muscle.
SDH, or complex II, is both part of the citric acid cycle and the respiratory chain.  
While it has been reported that the SDH activity in the muscle decreases with age (Proctor et 
al.,  1995;  Roseberg,  1989)  others  (Doran  et  al.,  2008)  and we  found an  increased  SDH 
activity in old compared to adult m. plantaris. In western blots, however, we observed no age-
related change in the expression of SDH, suggesting that the specific activity of the SDH 
complex was increased.  The age-related increase in  SDH activity in  our  study may be  a 
compensation for the decrease in COX expression, which has also been observed by others 
(Bua et al., 2006; Lee et al., 1998), leading to an increased SDH/COX ratio, in an attempt to 
maintain aerobic capacity with increasing age. 
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The absence of any age-related differences in  fatigue resistance during a  series  of 
intermittent  isometric  contractions  in  our  study  was  similar  to  that  observed  in  the  m. 
plantaris  of 13- and 25-month-old Wistar rats during a similar test (Degens et al., 1993a). 
This observation was unexpected, considering the age-related increase in the SDH-activity 
and the type IIB to type IIA fibre type transition.  Interestingly,  after  overload the fatigue 
resistance  was increased with no change in  SDH-activity.  The dissociation  of  changes  in 
fatigue  resistance  and  oxidative  capacity  suggest  that  the  fatigue  test,  while  useful  to 
distinguish fatigable and fatigue resistant motor units (Larsson et al., 1991) and to predict the 
aerobic capacity in single muscle fibres, is not as powerful a predictor of aerobic capacity in  
whole  muscle  (Degens  and  Veerkamp,  1994).  The  reason  for  this  may be  related  to  the 
nonlinear  and more severe increase in  metabolites  during whole muscle fatigue protocols 
compared  to  single  motor  unit  fatigue  (Gardiner  and  Olha,  1987).  If  indeed  lactate 
accumulation from glycolytic fibres may have a negative impact on the neighbouring fatigue 
resistant aerobic fibres, one may expect that a higher capillarisation may help enhance the 
removal of lactate and be associated with a higher fatigue resistance. Consistent with this we 
found that changes in fatigue resistance during ageing and overload paralleled changes in 
muscle  capillarisation.  Nevertheless,  in  rats  older  than  26 months  there was a  significant 
reduction in fatigue resistance with a similar test (Degens and Alway, 2003). This, and our 
previous  observations  that  25-month-old  mice  already  show  age-related  deteriorations  in 
determinants of muscle force generating capacity similar to 60-70-year-old humans (Ballak et 
al., 2014b) is in line with our suggestion that these mice present a model for early age-related 
changes in muscle structure and function. 
4.2 Effects of mechanical overload in old age on muscle morphology and fatigue resistance 
157
Overload increased the FCSA more in adult than in old muscle, confirming the blunted 
hypertrophic response in old age (Ballak et al., 2015; Degens and Alway, 2003). In both adult 
and old muscle, hypertrophy was accompanied by a proportional increase in the number of 
capillaries and fibre size as reflected by the maintained capillary fibre density. However, the 
increase in LCFR, reflecting the number of capillaries per fibre, was less in old than in adult  
hypertrophied  muscles,  indicating  impaired  angiogenesis.  Part  of  the  impaired  angiogenic 
response maybe related to the age-related decrease in Flk-1 protein expression, the receptor 
for the vascular endothelial growth factor (VEGF), an important endothelial mitogenic factor 
(Wagatsuma, 2006). An impaired angiogenic response has also been seen in ischaemic hind 
limbs that  was due  to  impaired  VEGF expression and HIF-1α activity in  muscles  of  old 
animals  (Rivard  et  al.,  2000;  Rivard  et  al.,  1999).  Others  and we have  found a  positive 
relationship between the size of a fibre and the capillary supply in both normal (Ahmed et al.,  
1997; Wust et al., 2009a) and hypertrophied muscle (Degens et al., 1993b) and a similar time 
course of hypertrophy and angiogenesis (Egginton et al., 2011; Plyley et al., 1998). Whatever 
the cause, the impaired angiogenesis we observed in the old muscle may thus well contribute, 
in addition to a reduced Id2 expression and lower satellite number (Ballak et al., 2015), to the 
blunted hypertrophic response in old age.
As discussed briefly above, the fatigue resistance of the muscle was elevated after 
overload despite an unaltered SDH-activity. While this suggests that the fibre hypertrophy and 
mitochondrial biogenesis are proportional, it also indicates that the used fatigue test is not a 
powerful indicator of the aerobic capacity of a muscle. In addition, the fibre capillary density 
was similar in adult and old overloaded and control muscles, indicating that mitochondrial 
biogenesis, angiogenesis and fibre hypertrophy were proportional, reinforcing the concept of a 
coordinated control of aerobic capacity, size and capillary supply to a fibre (Ahmed et al., 
1997; Wust et al., 2009a). 
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The elevated fatigue resistance in spite of an unaltered aerobic capacity and capillary 
density in overloaded muscles may be attributable to an increased proportion of slower fibres 
(type IIB to IIA shift),  that are more economical during isometric contractions than faster 
fibres  (Stienen  et  al.,  1996).  The  fibre  type  transition  is,  however,  unlikely  to  play  a 
significant role, as the overload-induced fast-to-slower shift was less in old than adult muscle, 
while the overload-induced increase in fatigue resistance was similar in adult in old muscle. In 
theory,  an  enhanced  myoglobin  concentration  could  facilitate  the  diffusion  of  oxygen 
(Kreuzer  and  Hoofd,  1987),  but  this  has  been  shown to  not  significantly  change  during 
overload (Masuda et al., 1997). Interestingly, the CD was increased and the distribution of 
capillaries became more homogeneous in both adult  and old overloaded muscle,  which is 
expected to improve the oxygenation of the muscle (Degens et al., 2006; Turek et al., 1991) 
and thereby potentially contribute to the enhance fatigue resistance in the overloaded muscles. 
Further  support  for  the  potential  significance  of  the  distribution  of  capillaries  in  muscle 
fatigue  resistance  is  the  absence  of  a  change  in  both  CD and  heterogeneity of  capillary 
spacing on the one hand and fatigue resistance on the other during ageing. It is admittedly a 
tenuous link that needs further investigation.
We observed a similar fatigue resistance and capillarisation in adult and old muscle, 
while SDH levels were higher in old muscle.  In addition,  overload increased both fatigue 
resistance and capillary density, but not the oxidative capacity. Together this implies that the 
capillary density may be a more important determinant of fatigue resistance than the oxidative 
capacity.
 
4.3 Effect of resveratrol on muscle morphology and muscle fatigue in old overloaded muscle
Resveratrol is thought to induce its effects via Sirt-1 (Yun et al., 2012) and/or AMP-
activated  protein  kinase  activation  (Park  et  al.,  2012)  that  controls  PGC-1α  expression 
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(Jackson et al., 2011). PGC-1α plays an important role in mitochondrial biogenesis (Goffart 
and Wiesner, 2003) and has been reported to stimulate angiogenesis (Olesen et al., 2010). In 
line we this, resveratrol supplementation has been shown to improve mitochondrial function, 
endurance performance and muscle fatigue resistance in rodents (Hart et al., 2013; Lagouge et 
al., 2006; Murase et al., 2009; Selsby et al., 2012), without changes in FCSA (Jackson et al., 
2011).  In  contrast  to  our  expectation,  resveratrol  did  not  improve  capillarisation, 
mitochondrial function or fatigue resistance, but it did result in an increased FCSA in the old 
animals. However, a recent study also did not find any beneficial effects of resveratrol on 
muscle capillarisation in 15-months old mice (Ringholm et al., 2013). In addition, resveratrol 
was even shown to limit training-induced angiogenesis in old men (Gliemann et al., 2014). 
The discrepancy in the published literature and our findings may be related to the dose of 
resveratrol and the degree of oxidative stress in the muscle (Bosutti and Degens, 2015), where 
we administered 0.4 % resveratrol per g body mass and others a lower dose (0.05 % per g 
body mass). It is also possible that because in these studies and the present study muscle 
capillarisation did not show any age-related deteriorations, the beneficial effects of resveratrol 
on  fatigue  resistance  and  the  capillary bed may only become apparent  when the  muscle 
capillarisation is already impaired.
4.4 Relationship between fibre size and aerobic capacity
The SDH activity correlates strongly with the maximal oxygen uptake of a muscle 
fibre (van der Laarse et al., 1989). The inverse relationship between SDH activity and fibre 
cross-sectional area was suggested to be determined by diffusion limitations (van der Laarse 
et al., 1998). Such a relationship was also observed in our study, and did not change during 
ageing. To our surprise, however, the relationship in overloaded muscles was shifted upwards, 
indicating  that  the  maximal  oxygen uptake  for  a  fibre  with  a  given FCSA was larger  in 
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overloaded  than  control  muscles.  It  is  likely that  the  improved homogeneity of  capillary 
distribution that improves muscle oxygenation (Degens and Veerkamp, 1994; Turek et al., 
1991), has made this adaptation possible. 
5 Conclusion
In conclusion, even though capillarisation in muscles from old and adult mice was 
similar, overload-induced angiogenesis was blunted. The impaired angiogenic response may 
at  least  partly  contribute  to  the  blunted  hypertrophic  response  in  old  age.  Despite  the 
attenuated angiogenesis, the fibre hypertrophy and mitochondrial biogenesis in response to 
overload were all proportional, so that the relationships between fibre capillarisation, aerobic 
capacity and size were similar  in  control  and overloaded muscle.  The increased maximal 
oxygen uptake for a fibre of a given size and the increased fatigue resistance of overloaded 
muscles may be partly attributable to an increased capillary density and a more homogeneous 
distribution of capillaries, while the SDH activity was unchanged with overload. Resveratrol 
supplementation attenuated age-related muscle wasting, but did not improve fatigue resistance 
or capillarisation. 
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Chapter 7
General Discussion
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General discussion
Age-related muscle wasting is the main cause for a decreased independence in older 
people.  It  is  also  related  to  an  increased  incidence  of  falls  and  related  injuries,  greatly 
decreasing the quality of life of the older person and causing a burden on healthcare systems. 
The aim of this thesis was therefore to investigate in a mouse model, the effects of age on 
determinants  of  muscle  force  generating  and  endurance  capacity,  as  well  as  muscle 
hypertrophy. This chapter provides an overview of what this thesis added to the literature and 
gives some suggestions for future investigations. 
We completed a literature review about the effects of age on determinants of muscle 
force generating capacity, in which we compared data of different male rodent models with 
men at similar relative lifespans (chapter 2). In chapter 3, 4 and 6 male 9- and 25-month-old 
mice were used. In the strain of mice we used, 9 months is an adult age and 25 months is the  
average lifespan. Overall, the effects of age on determinants of muscle force showed similar 
directions, but were relatively smaller. 
We used 9- and 25-month-old mice as models for young adults and older people to 
study age-related changes in muscle structure and function. It was shown, that the lower force 
generating capacity of muscles from 25- than 9-month-old mice was mainly attributable to a 
reduction in specific force, rather than myofibre atrophy and loss of myofibres (Chapter 3). 
Part of the decline in muscle specific force was due to an age-related increase in connective 
tissue, but not to an increased proportion of non-functional, denervated (type IIB) myofibres. 
In chapter 4 we showed, that 25-month-old mice had an impaired hypertrophic response to a 
6-week  overload  stimulus,  compared  to  9-month-old  mice.  The  attenuated  hypertrophic 
response  was  characterised  by  an  attenuated  myofibre  hypertrophy,  but  not  by  fewer 
myofibres. The attenuated myofibre atrophy was associated with a lower SC density in old 
muscle. Resveratrol, an anti-oxidant, was not effective in alleviating age-related decreases in 
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muscle  mass  and  function  and  even  abolished  the  increase  in  SC  density  seen  in  non-
resveratrol-treated  old  mice  after  overload.  In  chapter  5 a  semi-automated  method  of 
capillary  domain  analysis  was  validated,  which  was  subsequently  used  in  chapter  6.  In 
chapter  6  we  observed  that  an  attenuated  angiogenesis  may  contribute  to  the  attenuated 
hypertrophic  response  in  old  age,  while  neither  one  of  them was  rescued  by resveratrol 
supplementation. 
Subsequently,  the  effects  of  age  and  overload  on  SC content  and  fatigue  will  be 
discussed and how this may be modulated with resveratrol supplementation. Based on the 
observations of this thesis some recommendations are given regarding possible intervention 
programs to improve muscle function, power and endurance, in (pre-) sarcopenic subjects. 
The discussion closes with recommendations for future research.
Ageing
It is well-known that ageing is accompanied with a reduction in the force generating 
capacity of a muscle. It is, however, difficult if not impossible, to simultaneously assess in 
humans to what extent ageing affects myofibre size, myofibre number and specific tension of 
myofibres, which are the key factors that determine the force generating capacity. This can, 
however, be studied systematically in mice. In our mice, the 25-month-old animals reflected 
the initial stages of sarcopenia. In this model, we were able to establish that the quality of the 
muscle declines before quantity. Therefore, it is likely that the loss of muscle mass comes 
more into play with the progression of sarcopenia. A situation where the age-related loss of 
muscle mass affects muscle function is to be expected in 26-28 month-old mice . Therefore, 
studying  those  old  animals  would  be  an  important  continuation  of  the  research  done  in 
chapter 3.
It would also be relevant to study at what age specific muscle force starts to decline in 
both humans and rodents. In addition, measurement of the contractile force characteristics of 
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skinned single myofibres of aged mouse and human muscle may help to explain the decrease 
in specific muscle force. 
Overload model
To study the hypertrophic response of the plantaris muscle in adult and old mice we 
denervated its synergists. This model induces a 30-35% hypertrophy of rat plantaris muscle in 
6 weeks’ time and we observed a similar magnitude of hypertrophy in mice. The hypertrophy 
was accompanied with an increase in muscle force and endurance capacity. Although it is a 
chronic  intervention,  dissimilar  of  traditional  strength  training  interventions,  it  has  been 
suggested to be an adequate model of resistance exercise and for the study of the hypertrophic 
response , even in old muscle. The results from chapter 4 and 6 show that the hypertrophic 
response in old muscle was attenuated compared to adult muscle. This was associated with a 
lower SC density, without evidence for a lower capacity for SC proliferation, as well as an 
attenuated angiogenesis. 
SCs ageing and hypertrophy
In chapter 4 of this thesis we showed that the SC density was less in old than in adult 
muscle. This observation is in accordance with results of other studies which reported a loss 
of SCs with increasing age (Timson, 1990), with greater losses in faster myofibres . Since SCs 
play an important role in myofibre growth and repair (Timson, 1990), a loss of SCs could lead 
to a decreased adaptive response to injury or anabolic stimuli. SC loss has even been shown to 
precede age-related myofibre atrophy (Kadi et al., 2004). Therefore, we hypothesized that at 
old age the hypertrophic response was attenuated, and if so that this would be due to a lower 
satellite cell content. Indeed, we showed that although SC content increased after overload, 
lower levels of SCs in old control muscle were associated with an impaired hypertrophic 
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response in overloaded old compared to adult  muscle.  This is in accordance with another 
study, which observed that the degree of hypertrophy correlated positively with the number of 
SCs before training . These findings support the idea that SC content is a key factor for FCSA 
size regulation and that an age-related loss of SCs leads to muscle atrophy and a diminished 
myofibre hypertrophy.
Apart from the SC content, it is important to know whether there is an effect of age on 
the proliferation and differentiation of SCs. We found no change in MyoD, but an age-related 
increase in myogenin protein expression, which is a factor involved in SC differentiation . In 
addition,  we also observed an age-related increase in Id2 protein expression, which when 
overexpressed may induce apoptosis and inhibition of differentiation . Together this suggests 
that  both  proliferation  and  differentiation  were  increased  to  compensate  for  the  loss  of 
myonuclei. Interestingly, it has been observed that regenerative factors are increased most in 
muscles  of  most  severely  affected  sarcopenic  rodents,  suggesting  an  upregulation  of  the 
regenerative drive to combat the atrophy at old age  (Hawke and Garry, 2001). Therefore, it 
seems that the capacity to adapt to a stimulus, remains even at old age, only the magnitude 
and the efficiency of the adaptation decrease. 
The effect of resveratrol on hypertrophy and SCs
Since low-grade systemic inflammation and oxidative stress in old age may contribute 
to  muscle  wasting  (Brack  et  al.,  2005),  the  presumption  was  that  treatment  with  0.4% 
resveratrol, an anti-inflammatory anti-oxidant, would at least partly counteract the effects of 
ageing on muscle function and mass.  However,  except  from an attenuation of atrophy in 
chapter 6, in this series of experiments, we could not find a beneficial effect of resveratrol on 
the  magnitude  of  overload-induced  hypertrophy,  force  generating  capacity  or  fatigue 
resistance. The lack of effect of resveratrol on the above mentioned variables is in contrast to 
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studies reporting an increased aerobic performance even in old , but are in agreement with 
those of other studies also reporting no effects of resveratrol on muscle contractile properties . 
Resveratrol does seem to protect against oxidative stress in aged rodent muscle . In line with 
this, we found a reduced caspase-3 protein expression in old mouse plantaris muscle after 
resveratrol supplementation, but this was not sufficient to ameliorate age-related reduction in 
muscle  strength,  hypertrophy  and  angiogenesis.  Rather  than  having  beneficial  effects  on 
muscle function, resveratrol even abolished the overload-induced increase in SC number in 
old mice. The reason for this remains elusive, since no changes in myogenin, Id2 and MyoD 
protein  expression  were  observed.  Yet,  the  degree  of  hypertrophy  was  not  decreased, 
suggesting that the hypertrophy was attained by an increase in the myonuclear domain size as 
was indeed observed in chapter 4. That SCs are not essential for hypertrophy is supported by 
a study that showed that inactivation of SCs by tamoxifen did not attenuate the hypertrophic 
response in adult mice . Thus, resveratrol does not ameliorate age-related changes in muscle 
function  and  mass  in  25-month-old  mice.  Therefore,  the  efficacy  of  resveratrol 
supplementation as a sarcopenic intervention remains questionable. 
Fully automating the technique of capillary domain
In  this  thesis  we  automatized  the  capillary  domain  method,  which  has  been  used 
extensively in our lab . We developed a software package that was validated in chapter 5. To 
further develop this semi-automated method to a fully automated system, several additional 
steps have to be taken. The automatic location of capillaries is the first challenge. It proved 
difficult to identify capillaries in grey-scaled images automatically, but this may be enhanced 
by fluorescently  staining  the  capillaries.  A second  step  is  the  fully  automated  tracing  of 
complete myofibre outlines. At the moment adjacent myofibres are occasionally seen as one 
myofibre. Also here fluorescent staining of myofibres may help to improve this. The next step 
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is combining the fluorescence staining for both capillaries and myofibre outlines. When this 
works, the next step is to automatically distinguish different myofibre types. 
Relation between attenuated angiogenesis and hypertrophy
The  capillary  bed  becomes  less  dense  with  age,  therewith  decreasing  the  oxygen 
supply to and removal of waste products from the muscle. In  chapter 6 we observed that 
reduced angiogenesis may partly explain the attenuated hypertrophic response. In support of 
this,  a  previous  study  observed  a  strong  relationship  between  fibre  hypertrophy  and 
angiogenesis (Hawke and Garry, 2001). The impaired angiogenic response in old muscle may 
at least partly be attributable to a reduced protein expression of the VEGF receptor Flk-1.
Another factor which may have contributed to the blunted hypertrophy is the reduced 
activity of old mice. Old mice show a reduced daily activity compared to adult mice (Edstrom 
and Ulfhake, 2005). The lower daily activity level may explain the 5% lower muscle mass in 
the old mice (chapter 2). It is, however, unlikely that this explains the age-related attenuated 
hypertrophic response. Due to the lower muscle mass and the lower muscle mass/body mass 
ratio in old mice (chapter 2), the overload stimulus in old muscle was likely higher than in  
adult muscle. In addition, it is conceivable that the  m. plantaris also replaced the postural 
function  of  the  m. soleus.  Since overload consisted  of  a  chronic  stimulus,  comparable to 
resistance  training  (Degens,  2010), combined  with  the  limited  time  needed  to  induce  a 
significant hypertrophic response, the possibility that a reduced activity pattern in old muscle 
may have caused the attenuated hypertrophic response in old age, is negligible. In addition, if 
old muscles are less activated, because of decreased daily activity levels, than the chronic 
overload stimulus, which mimics resistance training, may actually be more interspersed with 
postural activity in old muscle. This may be considered as concurrent training, which may 
limit muscle hypertrophy  (Degens, 2010), more so in old than in adult mice. These factors 
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should be considered in future research, to better establish the relationship between attenuated 
angiogenesis and hypertrophy in old age.
Previously, SDH activity of muscle fibres from a wide variety of species expressed as 
a function of the FCSA revealed an inverse hyperbolic relation . From this relation it has been 
calculated that over the range of species the critical interstitial oxygen tension for a muscle 
fibre to  attain its  VO2max was  14 mmHg. The observation that  muscle  fibres  of  the mice 
described in this thesis were below the hyperbola suggests that mitochondrial function was 
not limited by the oxygen supply. However, after the overload, FCSA and SDH activity of 
muscle fibres of both adult and old mice fitted with the previously described hyperbola, which 
suggests that in the hypertrophic conditions maximal oxygen diffusion was limited by the 
diffusion  distance  for  oxygen.  Given  the  FCSA and SDH activities  of  the  old  and adult 
overloaded muscles, it is conceivable that a reduced LCFR indicates an insufficient supply of 
oxygen and hence a blunted hypertrophic response (see for review ).
Practical implications and future research
Muscle mass and function decline with age, causing not only a decreased quality of 
life,  but  also  social  and  economic  problems.  Therefore,  the  aim  of  this  thesis  was  to 
investigate factors that contribute to the impaired muscle function and hypertrophy in old age. 
We addressed this by studying 9- and 25-month-old mice. Interventions to counteract age-
related muscle wasting are needed and the findings of this thesis provide indications where 
such interventions should be aiming at. 
First of all, the results of chapter 3 show that a decline in muscle quality, in terms of 
force generating capacity per unit muscle mass occurred without large decreases in muscle 
mass. This may suggest that a decrease in muscle quality precedes the age-related loss of 
170
muscle mass in 25-month old mice. Therefore, training programs for the elderly should aim 
specifically at increasing or at least maintaining specific muscle force. Furthermore, when the 
age-related effects on muscle mass and force are still modest, old muscle is still capable of 
showing a  robust  hypertrophic  response.  Thus,  the  timing and  start  of  an  intervention  is 
crucial. Since the fatigue resistance in old muscle was not impaired, increasing muscle force 
may have beneficial effects on the absolute fatigue resistance as the older person has to recruit 
a smaller proportion of the available muscle mass for a given task. 
The  results  of  our  studies  show  that  the  attenuated  myofibre  hypertrophy  in  old 
muscles was associated with a lower SC density and impaired angiogenesis. Future studies 
should  focus  on the  question  whether  an  age-related  reduction  in  SCs  may contribute  to 
(myofibre) atrophy.  This can be done through studies using more age groups, particularly 
around the threshold age, the age where age-related muscle wasting starts to develop. There is 
also the open question as to what causes the age-related loss of muscle specific force and how 
it develops over time. To study this, the specific tension should be determined in mice of 
many ages between 9- and 25-month of age, with additional studies on skinned myofibres.
This thesis provides a first start of a fully automated capillary domain analysis. Further 
work  is  needed  to  make  this  system  fully  automatic.  Immunofluorescent  labelling  of 
capillaries  and  myofibre  outlines  may  greatly  facilitate  the  automatic  detection  of  these 
morphological structures. 
Lastly, the results of chapter 5 indicates that an age-related reduced angiogenesis may 
explain part of the blunted hypertrophic response observed in the old animals. Therefore, to 
improve their effectiveness, future interventions counteracting sarcopenia should also focus 
on maintaining a fully functional capillary bed. 
Therefore, the findings presented in this thesis lead to the following questions, which 
should be addressed in future studies:
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• What is  the contribution of a decrease in  specific  force,  myofibre loss  and 
atrophy to the age-related loss in animals of different ages?
• At  what  age  does  the  muscle  specific  force  decline  and  what  causes  this 
reduction in specific tension?
• Does an age-related reduction in SC density lead to muscle (fibre) atrophy over 
time?
• How does  resveratrol  abolish  the  overload-induced  increase  in  SC content, 
observed  in  non-treated  old  animals,  and  what  does  happen  with  the 
myonuclear domain size?
• Could  the  use  of  immunofluorescence  staining  help  to  fully  automate  the 
capillary domain analysis?
• Does age-related attenuated angiogenesis cause blunted hypertrophy observed 
in old muscle?
The original aim of this thesis was to answer the question what causes the impaired 
muscle function and hypertrophy at old age. Although this thesis has shed some light on this  
topic  and provides new information,  there is  still  much to explore about  the aetiology of 
muscle  ageing.  To  further  expand  our  knowledge  more  studies  should  be  carried  out  in 
different  rodent  models  in  which  all  determinants  of  muscle  force  generating  capacity, 
endurance  capacity  and  hypertrophy  are  taken  into  account,  to  attain  a  profound 
understanding about processes of muscle degeneration during the ageing process. What this 
thesis adds to the existing knowledge, is that although with increasing age mice lose muscle 
mass and function, the ability of muscle to adapt to stimuli remains until old age. This ability 
of old mouse muscles to adapt to overload stimulates development of novel interventions in 
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humans, which will increase the number of years with an independent life style and quality of 
life, simultaneously decreasing the burden on healthcare systems. 
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